Identification of novel retinoid receptors and their roles in vertebrate and invertebrate nervous systems by Charter, Christopher J
Identification of novel retinoid receptors and their roles in 
vertebrate and invertebrate nervous systems 
Christopher J. Carter, Hon. B.Sc. 
f 
A thesis submitted to the Department of Biological 
Sciences in partial fulfillment of the requirements for 
the degree of Doctorate of Philosophy 
July 18,2011 
Brock University 
St. Catharines, Ontario 
© Christopher J. Carter, 2011 
Abstract 
In vertebrates, signaling by retinoic acid (RA) is known to play an important role 
in embryonic development, as well as organ homeostasis in the adult. In organisms such 
as adult axolotls and newts, RA is also important for regeneration of the CNS, limb, tail, 
and many other organ systems. RA mediates many of its effects in development and 
regeneration through nuclear receptors, known as retinoic acid receptors (RARs) and 
retinoid X receptors (RXRs). 
This study provides evidence for an important role of the RA receptor, RAR~2, in 
,( 
'. 
regeneration ofthe spinal cord and tail of the adult newt. It has previously been proposed 
that the ability of the nervous system to regenerate might depend on the presence or 
absence of this RAR~2 isoform. Here, I show for the very first time, that the regenerating 
spinal cord of the adult newt expresses this ~2 receptor isoform, and inhibition of retinoid 
signaling through this specific receptor with a selective antagonist inhibits tail and spinal 
cord regeneration. This provides the first evidence for a role of this receptor in this 
process. 
Another species capable of CNS ~~generation in the adult is the invertebrate, 
" 
Lymnaea stagnalis. Although RA has been detected in a small number of invertebrates 
(including Lymnaea), the existence and functional roles of the retinoid receptors in most 
invertebrate non-chordates, have not been previously studied. It has been widely 
believed, however, that invertebrate non-chordates only possess the RXR class of retinoid 
receptors, but not the RARs. In this study, a full-length RXR cDNA has been cloned, 
which was the first retinoid receptor to be discovered in Lymnaea. I then went on to clone 
2 
the very first full-length RAR eDNA from any non-chordate, invertebrate species. The 
functional role of these receptors was examined, and it was shown that normal molluscan 
development was altered, to varying degrees, by the presence of various RXR and RAR 
agonists or antagonists. The resulting disruptions in embryogenesis ranged from eye and 
shell defects, to complete lysis of the early embryo. These studies strongly suggest an 
important role for both the RXR and RAR in non-chordate development. 
The molluscan RXR and RAR were also shown to be expressed in the adult, non-
regenerating eNS, as well as in individual motor neurons regenerating in culture. More 
specifically, their expression displayed a non-nuclear distfibution, suggesting a possible 
non-genomic role for these 'nuclear' receptors. It was shown that immunoreactivity for 
the RXR was present in almost all regenerating growth cones, and (together with N. 
Farrar) it was shown that this RXR played a novel, non-genomic role in mediating 
growth cone turning toward retinoic acid. Immunoreactivity for the novel invertebrate 
RAR was also found in the regenerating growth cones, but future work will be required to 
determine its functional role in nerve cell regeneration. 
Taken together, these data provide evidence for the importance of these novel 
'. 
retinoid receptors in development and regeneration, particularly in the adult nervous 
system, and the conservation of their effects in mediating RA signaling from 
invertebrates to vertebrates. 
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1.01 General Introduction 
Many signaling molecules that were once thought to only be important during the 
process of development are now known to be just as important in critical processes after 
embryogenesis. In the adult, these molecules can be important for processes such as 
regeneration of various tissues and organs, maintenance of cell proliferation, and synaptic 
plasticity. Due to the preservation of this signaling from embryo to adult, many believe 
that events such as organ regeneration are similar to the events that occur during 
development of that same organ. Retinoic acid (RA) is a molecule that has long been 
known to have an important role in the development of ,cm1bryonic structures including 
" 
the nervous system and notochord of chordates. In adults of many species, RA has also 
been implicated in regeneration of several organ systems including eye, gut, limb and tail 
(Collins and Mao, 1999; Maden and Hind, 2003). In the adult nervous system, RA is 
known to influence neurite outgrowth and affect synaptic plasticity in the hippocampus 
(Bonnet et aI., 2008). 
Previously, a large portion of research has focused on the role of RA in vertebrate 
systems, and much less is known regarding the role of RA in development and 
regeneration of invertebrates., The work thai I present in this study investigated the role of 
RA in both vertebrates and invertebrates. In particular, I have identified novel retinoid 
receptors in the vertebrate newt, Notophthalmus viridescens, and the invertebrate 
mollusc, Lymnaea stagnalis. I have also investigated the roles of these novel receptors in 
spinal cord and tail regeneration in the newt, and in development and nerve regeneration 
in the mollusc. 
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1.02 Retinoic Acid Synthesis 
RA is classified as a retinoid, which encompasses any compound, biologically 
active or inactive, that is an analogue of retinol. Retinol is one of the forms of vitamin A 
(in animals) which is derived from the metabolism of carotenoids found in many different 
fruits and vegetables. Alternatively, animals can obtain retinol by eating animal tissues 
that have already converted carotenoids to retinol. Dietary intake in most animals is the 
only method for obtaining retinoids, since de novo synthesis pathways are not present 
(Theodosiou et aI., 2010). These compounds can be stored in the body as retinyl esters 
(mainly in the liver) and upon specific signals, can be co~~erted back to retinol for use in 
other areas of the body. Retinol is transported through the bloodstream to target areas 
bound to retinol-binding proteins (RBPs) (Maden, 2007). Retinol then uncouples from 
RBP and enters the cytoplasm of target cells through interaction with a transmembrane 
protein known in vertebrate systems as STRA6 and is immediately bound to cellular 
retinol-binding protein (CRBP). Once inside the cell, retinol can be converted to retinal 
by the action of alcohol dehydrogenase (ADH) or short-chain dehydrogenase/reductase 
(SDR) enzymes. The last step in RA synthesis is the irreversible conversion of retinal to 
RA by an oxidation reaction .~nvolving reti~~ldehyde dehydrogenase (RALDH). Once RA 
is produced, it is bound to cellular RA-binding proteins (CRABPs) which aid in the 
transport of RA within the cell (autocrine signaling) or for transport out of the cell 
(paracrine signaling) (Fig. 1). When signaling in an autocrine fashion, RA can uncouple 
from CRABPs, readily pass through the nuclear membrane where it binds with ligand 
activated nuclear transcription factors, known as retinoid receptors, which can lead to 
changes in gene activity. 
15 
vitamin A 
retinol - RBP4 
t 
non-target tissue 
CYP26 
.. RA -+ degradation t ADH/RDH _............... .,.-
RALDH .... ~-----------
retinol.. ~ retinaldehyde -+ RA ....... 
retinyl 
ester RA-generating tissue 
............... 
.. ~-~~~ 
Figure 1. Retinoic acid synthesis and signaling pathway (Duester, 2008). 
In the formation of RA within the cytoplasm of the cell, multiple isoforms can 
result, including the major isoforms all-trans RA and 9-cis RA (Fig. 2). There still exists 
some uncertainty regarding whether all-trans RA and 9-cis RA are formed through 
separate pathways from 9-cis and all-trans retinol, or whether there is an isomerization 
reaction that exists between them after the action of RALDH (Maden and Hind, 2003). 
For example, there is some evidence in vertebrates for the existence of a 9-cis retinol 
dehydrogenase enzyme that suggests a separate pathway for the synthesis of 9-cis RA 
(Romert et aI., 1998; Tryggvason et aI., 2001). 
A B 
~~~eOOH 
all-trans RA eOOH 
9-cisRA 
Figure 2. Retinoic acid (RA) isomers (A) all-trans RA and (B) 9-cis RA. 
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To control the levels of RA in cells and tissues of the body, there needs to be a 
balance between synthesis and catabolism. Catabolism of RA is accomplished through 
the action of enzymes from the CYP26 family. These enzymes oxidize RA to polar 
water-soluble metabolites such as 4-hydroxy RA and 4-oxo RA, that can subsequently be 
excreted in bile and urine (Blomhoff and Blomhoff, 2006). 
1.03 Retinoid-dependent signaling 
The effects of RA are generally mediated through binding to members of the 
nuclear receptor family called retinoid receptors. These ,Fetinoid receptors are grouped 
<" 
into two classes, retinoic acid receptors (RARs) and retinoid X receptors (RXRs). The 
RARs mediate gene expression by binding as heterodimers with RXRs, to the retinoic 
acid response elements (RAREs) in target genes, thus eliciting changes in their 
expression (see Fig. 1). In human, rat, and mouse, there are three RARs (a.,p,y) and three 
RXRs (a.,p,y) and each of these various subtypes has its own associated isoforms (e.g. 
RARP 1 to 5). The RARs and RXRs are thought to bind different isoforms of RA in order 
to be activated. Studies have found that RARs can be activated by both all-trans RA and 
9-cis RA (Allenby et aI., 19~~), whereas ~Rs almost exclusively bind 9-cis RA, at least 
in vertebrates (Heyman et aI., 1992). In numerous vertebrate species, both RARs and 
RXRs have been identified, but to date, only RXRs have been cloned in non-chordate 
invertebrates. 
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1.04 Retinoid receptor structure 
Similar to other known nuclear receptors, RAR and RXR have a modular 
structure consisting of 6 regions of homology classified as A to F regions from the N-
terminal to the C-terminal region (Fig. 3). The most conserved areas are the C and E 
regions which encompass the DNA-binding domain (DBD) and the ligand binding 
domain (LBD). The other regions NB, D and F are poorly conserved but still have 
important functions in mediating RA signaling (Rochette-Egly and Germain, 2009). 
Ugand binding 
I I ~ f i 
AlB I C I °1 E I F 
L,J I L,J AF-1 AF-2 
DNA binding 
Figure 3. Schematic representation of a nuclear receptor with functional 
domains A to F 
The NB region is also known as the N-terminal activation function (AF)-1 
domain (NTD) and acts autonomously and ligand-independently. One interesting feature 
of this AF-l domain is that it contains consensus phosphorylation sites for proline-
dependent kinases, which have been proposed to playa role"in controlling transcription of 
RA target genes (Nagpal et aI., 1993). The C region (or DBD) confers sequence-specific 
DNA recognition and is comprised of two zinc-fmger domains which contact the RARE 
sites specific to that receptor. The D region has traditionally been considered as the 
'hinge' region, allowing rotational flexibility between the DBD and the LBD and 
avoiding steric hindrance. The E region (or LBD) contains the ligand-binding pocket and 
is comprised of mainly hydrophobic residues that form a shape that matches the volume 
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of the RA ligand. This E region is also known to contain the main dimerization domain 
and the ligand-dependent activation function-2 (AF-2). The F region contains a helical 
region called helix 12, but its function is still poorly understood. One study has suggested 
that the F region (in the absence of ligand) may control the ability of RARs to interact 
with corepressors (Farboud and Privalsky, 2004). Another study has shown evidence that 
the F region may be capable of binding to specific mRNAs and controlling their 
translational capabilities (Poon and Chen, 2008). 
1.05 RA signaling and embryonic development 
Both experimental and clinical approaches have revealed that retinoids exert a 
wide variety of effects on the embryonic body plan and formation of various organs, cell 
proliferation, differentiation, and apoptosis (Mark et aI., 2009). Normal development is 
based on precise levels of RA regulated by synthesis and catabolism pathways of the cell. 
If these levels are altered from their normal levels (either increased or decreased), 
abnormal body growth and development occurs (McCaffery et aI. , 2003). In fact, if 
embryos are treated with higher than normal levels of exogenous RA, almost every organ 
can be affected if the RA i~. given at a sp_~cific time during development (Zile, 2001). 
Furthermore, if vitamin A function is diminished in embryos (often as a result of 
elimination from diet), they develop gross abnormalities in their central nervous systems, 
cardiovascular systems and trunk, eventually leading to death. Interestingly, these 
vitamin A-deficient abnormalities in the developing embryo can be rescued by 
administering the natural ligand for RAR, all-trans RA. 
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In contrast to altering retinoid levels, many studies have used transgenic mice that 
contain mutations introduced at loci encoding RAR and RXRs. Many of the 
abnormalities in these mutant mice resemble those observed in the vitamin A-deficient 
embryos (Mark et aI., 2009). However, the major advantage of these mutation 
experiments is that the importance of specific RAR and/or RXR subtypes can be 
elucidated. For example, it has been well established that RXRa is the main RXR subtype 
involved in embryogenesis (Mark et aI., 2009). RXRa-null mutants display multiple heart 
abnormalities and eye defects, whereas RXR~- and RXRy-null mutants do not display 
any obvious morphological defects (Krezel et aI., 1996!{ Through compound mutants 
involving RXR and RAR, it has been determined that retinoic acid signals are transduced 
by specific RXRalRAR heterodimers during the course of development. In other words, 
RXRaIRARa, RXRalRAR~ and RXRalRARy heterodimers have been shown to be the 
functional units for RA signaling during vertebrate embryogenesis. 
RA is also an important signaling molecule involved in the normal development 
of the central nervous system. All-trans RA is essential for cellular growth and 
differentiation in developing animals. It ha~.been found that all-trans RA is present in the 
" 
embryonic spinal cord and also detected at relatively high levels after development in 
both the brain and spinal cord of adult vertebrates (Maden et aI., 1998; Werner and 
Deluca, 2002). Depletion of vitamin A in quail embryos revealed the need for vitamin A 
in proper segmentation of the posterior hindbrain, neurite outgrowth and neural crest 
survival (Gale et aI., 1999). Retinoid receptor knock-out experiments revealed a similar 
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importance for RA signaling in proper hindbrain and neural crest formation in mice (Zile, 
2001). 
1.06 RA signaling and regeneration 
Although many studies have focused on the role of vitamin A and RA in 
embryonic development, it has recently become evident that RA is also required for many 
regenerative processes in the adult. In particular, in the adult CNS, RA signaling is 
important in the olfactory bulb and the subventricular zone, areas known to retain 
synaptic plasticity into adulthood (Thompson et aI., 2002,). RA has also been implicated 
" 
in postnatal differentiation of pyramidal neurons in various cortical areas of the brain, the 
mature basal ganglia and in the hippocampus (Wagner et aI., 2002). Interestingly, the 
basal ganglia area (in the forebrain) has been shown to express multiple RA receptors, 
CRBPs and is supplied with RA, from the action of RALDH within surrounding 
dopaminergic nerve terminals (McCaffery and Drager, 1994). Disruption ofRA synthesis 
in this area can lead to Parkinson's-type symptoms (e.g. catatonia) and even basal ganglia 
, I 
lesions (McCaffery and Drager, 1994) 
In the developing nervous system, _~ -deficiency in quail embryos can prevent 
neurite outgrowth from the spinal cord into the periphery (Maden et aI., 1996). Since this 
indicated a role for RA in permitting neurite outgrowth from the CNS, it was postulated 
that perhaps RA would also promote outgrowth from damaged axons of neurons in the 
adult CNS. Corcoran et ai. (2002) performed a study in which they showed that although 
all-trans RA could induce neurite outgrowth from mouse embryonic neurons and 
embryonic spinal cord, the adult spinal cord did not respond to all-trans RA in the same 
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manner. The authors suggested that during the transition from embryo to adult, some of 
the RA machinery responsible for the induction of neurite outgrowth may have become 
inactive. In fact, in vertebrates that retain the ability to regenerate eNS tissue in 
adulthood, all-trans RA is still able promote neurite outgrowth (Dmetrichuk et aI., 2005). 
This may suggest that these regeneration-capable species (such as the newt) retain the 
expression of necessary RA machinery. 
One of the most fascinating events in the field of adult regeneration is the ability 
to regenerate full limbs and tails after amputation. This occurs in newts, axolotls and 
many species of salamanders. Early experiments wi~? axolotl limbs showed that 
treatment with exogenous all-trans RA induced a concentration-dependent increase in the 
amount of regenerated tissue in the proximo-distal axis. For example, high levels of all-
trans RA applied after amputation of the axolotl limb at the mid-radius and ulna caused 
an extra elbow joint to appear along with all of the other distal limb structures (Fig. 4B). 
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Figure 4. Defective regeneration after limb amputation and vitamin A treatment. (A) 
eontrollimb regenerate showing the normal complement of cartilages. H = humerus, RU = radius 
and ulna, c = carpals, d = digits 1 to 4. (B) Increasing vitamin A treatment proximalized the limb 
regenerate. (e) At very high doses, duplication can take place. (modified from Maden et aI., 1998) 
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In some species such as Rana temporaria, high levels of RA can induce regeneration of 
multiple limb structures (Maden, 1983) (Fig 4C). The opposite effect was seen in 
amputated axolotl limbs treated with disulfiram, which inhibits the action of the RA 
synthesizing enzyme, RALDH (Maden, 1998). Disulfiram treatment produced almost 
complete inhibition of limb regeneration. 
1.07 Vertebrate model species, Notophthalmus viridescens (Eastern newt) 
Amphibians have long been used in the study of regeneration processes, as they 
have an amazing ability to regenerate numerous structuresjncluding limbs, tails, jaws and 
-; 
the lens of the eye. The ability to regenerate these complex structures is considered by 
many authors to be ancestral and to have been lost in other vertebrate species, including 
humans (Sanchez, 2000). In some cases, regeneration shows many parallels with 
development. For example, gene expression analyses in Xenopus tadpoles have shown 
that subsequent limb and tail regeneration involves the re-activation of various 
developmental signaling pathways involving proteins such as fibroblast growth factors 
and Homeobox genes (Beck et aI., 2006). However, there are also some different 
processes involved that are u~ique to rege~~ration. For example, regeneration-competent 
wound healing is generally rapid and involves covering the wound surface with a 
specialized epidermis that lacks an underlying dermis and basement membrane (Neufeld 
et aI., 1996). Following wound healing, the differentiated cells of the stump must 
dedifferentiate and re-enter the cell cycle, or else reserve stem cell populations must be 
mobilized and recruited to the wound site. 
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It has been clearly demonstrated that the presence of nerves is essential for normal 
limb and tail regeneration in vivo (Singer, 1952). Regeneration of the spinal cord also 
occurs in close conjunction with tail regeneration and has been shown to play an essential 
role in its maintenance. In the newt, Notophthalmus viridescens (Fig. 5), it has 
previously been shown that all-trans RA can increase both the number and length of 
axons extending from spinal cord explants (Prince and Carlone, 2003). It was also shown 
that the tail blastema (a mass of dedifferentiated cells from which a new tail will form), 
co-cultured with spinal cord explants had the same effect on the number and length of 
regenerating axons as seen with the all-trans RA treatm~t (Prince and Carlone, 2003) 
" 
suggesting that the tail blastema is a source of all-trans RA. However, this study did not 
identify a specific retinoid receptor that may be involved in the regenerative response to 
all-trans RA. 
,i 
Figure 5. The amphibian, Notophthalmus viridescens (red-spotted newt). 
In the regenerating limb tissue of the newt, four full-length RAR isoforms have 
been detected to date, two a and two (5 types (equivalent to the mammalian RARy), but 
the RARP isoform has been reported to be absent (Maden and Hind, 2003). RARP 
(specifically the RARP2 subtype), found in other ·vertebrates, appears to specifically 
mediate the effects of RA on neurite outgrowth in the peripheral nervous system, which 
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has the ability to regenerate. For example, Corcoran et aI. (2000) showed that all-trans 
RA could stimulate neurite extension in cultured embryonic dorsal root ganglion (DRG) 
neurons and that this response involved the upregulation of RAR~2. More importantly, it 
was shown in adult DRG neurons (that do not respond to all-trans RA) that transduction 
with an RAR~2-expression vector alone was enough to stimulate neurite extension 
(Corcoran et aI., 2002). Our lab has recently shown in N. viridescens, that RA-stimulated 
neurite outgrowth from newt spinal cord explants was abolished in the presence of 
antagonists selective for RAR~ (Dmetrichuk et aI., 2005) (Fig. 6). This was a curious 
finding since, as mentioned previously, it was reported t~~t newts do not contain RAR~ 
isoforms (Maden and Hind, 2003). Interestingly, the same RAR~-selective antagonist 
(LE135) also inhibited limb regeneration in the closely related species of the axolotl, 
Ambystoma mexicanum (del Rincon and Scadding, 2002). Given these findings that 
RAR~-selective antagonists decrease regeneration, it is possible that a newt RAR~ does 
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Figure 6. An RARp-selective antagonist significantly decreased RA-induced axonal 
outgrowth from newt spinal cord. (A) Spinal cord explants cultured in RA (containing 
the vehicle control, DMSO) or (B) RA and LE135. Scale bar: 50llm (C) Graph depicting 
significant reduction in RA-induced axonal outgrowth in the presence of RAR~ 
antagonist. *RA treatment elicited significantly more axons than in the presence of the 
antagonist solution (p < 0.05). (modified from Dmetrichuk et aI., 2005) 
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exist and that this receptor plays an important role in tail and eNS regeneration in newts, 
as it does in other vertebrate cells. 
1.08 Axon guidance 
Axon guidance IS an important aspect of nervous system development and 
regeneration. As growing axons extend towards their targets, they are guided by a variety 
of extracellular cues that are either diffusible or surface-bound. At the growing end of the 
axon, a structure known as the growth cone (Fig. 7A) can steer axons toward (attraction), 
or away from (repulsion) the source of the signal. Sinc~ these signals can change the 
"' 
direction of the developing growth cone, internal changes within the growth cone itself 
must first occur. Many of these changes involve synthesis of proteins that affect the 
internal actin cytoskeleton and are responsible for the overall shape of the growth cone 
(Dos Remedios et aI., 2003). Actin filaments within the growth cone are dynamic in 
nature, and movement is generated by extending or retracting finger-like projections 
called filopodia and membranous sheets called lamellipodia (Brown et aI., 2000) (Fig. 
7B). 
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Figure 7. Structure of a regenerating growth cone (A) Phase contrast picture of a 
Lymnaea growth cone from a cultured PeA neuron. Scale bar: 25)lm (B) A schematic 
view of the growth cone at the end of the axon highHghting the lamellipodiurri and 
filopodia. The arrows indicate the direction of the extending filopodia (from Smith, 
1988). 
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Numerous molecules have been implicated as chemoattractants in axon guidance. 
These include ephrins, netrins, slits, and semaphorins (Huber et aI., 2003). Several 
morphogens (substances that define different cell fates) have also been shown to playa 
role in growth cone guidance including bone morphogenic protein (BMP), Wnt family 
members, and sonic hedgehog (SHH) (for review, see Farrar and Spencer, 2008). Many 
of these signals that the growth cone can encounter ultimately activate pathways that 
involve intracellular regulators of the Rho GTPase family. The most widely studied Rho 
GTPases are Rho, Rac and Cdc42, which play important roles in regulating cytoskeletal 
dynamics for processes such as growth cone guidance. I~tis the interplay between these 
various Rho GTPases and their spatial distribution that dictates whether a growth cone 
will be attracted to or repelled from a particular extracellular guidance cue. 
1.09 RA as a chemotropic molecule 
The first evidence implicating RA as a guidance molecule used dissociated 
cultures of embryonic chick neural tissue. Using a custom designed Dunn chamber, a 
gradient of all-trans RA was produced, and the regenerating neurons responded by 
growing up the gradient towards the sQurce of RA (Maden et aI., 1998). Later 
.' 
Dmetrichuk et ai. (2005) showed directional outgrowth towards RA from cultured newt 
adult spinal cord explants. Beads soaked in all-trans RA were co-cultured with the newt 
spinal cord explants, and it was shown that the newly regenerating axons grew 
preferentially towards the beads (Dmetrichuk et aI., 2005). Dmetrichuk et ai. (2006) then 
went on to show for the first time in any species that RA could induce turning of a single 
growth cone. More importantly, using cells from the CNS of Lymnaea stagnalis (Fig 8A), 
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it was shown that both the all-trans and 9-cis isomers of RA displayed similar 
chemotropic effects, although the signaling machinery involved was not previously 
identified (Dmetrichuk et aI., 2006; Dmetrichuk et aI., 2008). 
1.10 Lymnaea stagnalis as a model for studying RA 
The CNS of Lymnaea stagnalis has previously proven a useful model system for 
the study of regeneration and neurite outgrowth (Fig. 8B). In fact, a previous study has 
shown that identified L. stagnalis neurons can functionally regenerate primary neurites 
after nerve crush in vivo (Wildering et aI., 2001). As preyiously mentioned, our lab has 
" 
also shown that RA can induce neurite outgrowth in Lymnaea neurons and act as a 
chemoattractive factor, inducing growth cone turning toward a source of RA (Dmetrichuk 
et aI., 2006; Dmetrichuk et aI., 2008). Additionally, it was found that both all-trans and 9-
cis RA exerted neurotrophic effects on Lymnaea neurons and maintained their electrical 
excitability and resting membrane potential (RMP) for up to 6 day in culture. Through 
the use of HPLC and mass spectrophotometry, Dmetrichuk et ai. (2008) also showed the 
presence of both RA isomers in the CNS and hemolymph of L. stagnalis. Other work in 
our lab showed that RA enh~nced neurite 1?ranching in intact Lymnaea CNSs after nerve 
crush injury (Vesprini and Spencer, 2010). Despite all of RA's effects on outgrowth and 
regeneration, there is no previous evidence for receptors or RA signaling pathways in 
Lymnaea. 
Recently, the first cloned molluscan RXR cDNA was reported in the freshwater 
snail Biomphalaria glabrata (BgRXR), which is very closely related to Lymnaea 
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Figure 8. The invertebrate model system of study. (A) The mollusc, Lymnaea 
stagnalis. (B) The dissected central ring ganglia of Lymnaea stagnalis. LBuG and 
RBuG: left and right buccal ganglia; LCeG and RCeG: left and right cerebral ganglia; 
LPeG and RPeG: left and right pedal ganglia; LPIG and RPIG: left and right pleural 
ganglia; LPaG and RPaG: left and right parietal ganglia; VG: visceral ganglion. Scale 
bar: 1 mm (Feng et aI., 2009). 
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stagnalis. It was also shown that this molluscan RXR sho~ greater sequence identity with 
the mouse RXRa than with other known arthropod homologues and can bind with 
vertebrate RXR ligands. The BgRXR was shown to bind 9-cis RA (the natural ligand of 
vertebrate RXRs) and this binding induced transcriptional activation (Bouton et aI., 
2005). Thus, there is evidence for the existence of molluscan retinoid receptors (RXRs) 
suggesting that a Lymnaea RXR may also be present and possibly mediating tropic and 
trophic effects of RA, specifically the 9-cis isomer. However, RXRs in vertebrates do not 
have appreciable affinity for the all-trans RA isomer. Given the evidence for all-trans RA 
in the Lymnaea CNS and irs role in exerting trophic and tropic effects in vitro and 
enhancing regeneration in situ, it is conceivable that a separate signaling pathway may 
exist for this isomer. The all-trans RA isoform is the natural ligand for the RAR, and in 
vertebrates, both RXR and RAR are known to exist and exert the effects of 9-cis and all-
trans RA accordingly. To date, no RARs have been cloned from any invertebrate non-
chordate speci~s, although there are recent reports of orthologs that have been predicted 
from genomic databases (Albalat and Canestro, 2009; Campo-Paysaa et aI., 2008). Given 
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all of the evidence provided here, it may thus be possible that signaling pathways 
involving RAR are present in Lymnaea. 
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1.11 Objectives 
From studies using RAR~-selective antagonists (del Rincon and Scadding, 2002; 
Dmetrichuk et aI., 2005), there is compelling functional evidence for the existence of a 
RAR~ in the newt, Notophthalmus viridescens. My first aim for this study was to clone a 
full-length RAR~ receptor cDNA from the eNS of the newt and if successful, to study its 
specific role in tail and spinal cord regeneration. 
Our lab has also provided evidence for trophic and tropic effects of RA on 
molluscan neurons from the eNS of Lymnaea stagnalis, but despite evidence for RA in 
the eNS, no components of the retinoid signaling path\\{ay have yet been identified in 
\ 
this species. My aim was to identify various components of the RA signaling pathway. In 
particular, I first aimed to clone the RXR cDNA, as there was previous evidence for the 
existence of molluscan RXRs. I then aimed to characterize its expression and investigate 
its functional role in non-chordate development and regeneration. 
A full-length, non-chordate RAR had never been cloned, but there was evidence 
from genome screening for the presence of an RAR ortholog in another non-chordate, 
molluscan species. My next aim was to clone the first full-length, non-chordate RAR 
cDNA and to then also characterize its ~xpression and to attempt to investigate its 
functionality. 
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Chapter 2: 
Cloning and expression of a retinoic acid receptor 132 
subtype from the adult newt: Evidence for a role in tail 
and caudal spinal cord regeneration. 
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2.01 Abstract 
Adult urodele amphibians such as the newt, Notophthalmus viridescens, have a 
unique ability to regenerate limbs, tail, spinal cord, eye structures and many vital organs. 
It has previously been shown that a retinoic acid receptor antagonist, selective for the 
RARP sub-type, was able to inhibit RA-induced neurite outgrowth from cultured adult 
newt spinal cord (Dmetrichuk et aI., 2005), as well as epimorphic regeneration of the 
limb (del Rincon and Scadding, 2002). However, the existence of a newt homologue of 
the RARP subtype has been controversial. In the present study, I have cloned the first 
J 
full-length RARP cDNA from adult newt CNS tissue. This receptor shares a high degree 
of homology with the RARP2 isoform, which has recently been implicated as the key 
transducer of the retinoic acid signal during regeneration. For example, RARP2 
expression has been implicated in the ability of CNS tissue to regenerate in response to 
retinoic acid (Corcoran et aI., 2002). 
The newly cloned N viridescens RARP2 cDNA (termed NvRARP2) was found to 
be expressed in various adult organs that are capable of regeneration, such as the spinal 
cord, gut and liver. NvRARP2 transcripts are expressed in the regenerating tail of adult 
.. 
newts, predominantly in the regenerating spinal cord, in addition to the blastema 
mesenchyme located just below the wound epidermis. Interestingly, following 
amputation of the tail, both the RARP2 mRNA and protein are upregulated over 21 days 
post-amputation. Pharmacological inhibition of RARP, immediately following 
amputation, caused a significant decrease in the length of tail regenerate, when measured 
. after 21 days. Although somewhat unexpected, a synthetic RARp2-selective agonist also 
significantly reduced tail regenerate length after 21 days of treatment. 
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Together, these data provide the first evidence for a newt RAR~2 isoform, and 
support an important role for this NvRAR~2 in caudal spinal cord and newt tail 
regeneration. 
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2.02 Introduction 
Unlike the adult mammalian CNS, the spinal cord and brain of adult urodele 
amphibians are capable of extensive functional regeneration after injury (Chernoff, 1996; 
Endo et aI., 2007). One of the conditions in which the spinal cord of the urodeles 
undergoes regeneration is when the tail (which contains spinal cord) is amputated and a 
new tail regenerates. 
Tail regeneration in newts occurs in two major steps: first the dedifferentiation of 
adult cells into a stem cell state similar to embryonic cells, and second, the development 
,f 
of these cells into new tissue. The regeneration process begins immediately after 
amputation and results in the epidermis migrating to cover the stump (in less than 12 
hours), to form a structure called the wound epithelium. Over the next several days there 
are changes in the underlying stump tissues that eventually result in the formation of a 
structure called the blastema about 9-10 days later; (Iten and Bryant, 1976). The blastema 
consists of a' mass of dedifferentiated, proliferating mesenchymal cells which will 
eventually differentiate into a variety of cell types, including osteoblasts (bone cells), 
chondrocytes (cartilage cells) and adipocytes (fat cells) (Zipori, 2004). 
This process of tail ,# regeneration is also closely ·· accompanied by ependymal 
outgrowth from the severed spinal cord. Ependymal cells are classified as glial cells that 
form an epithelial lining in the central canal of the mature spinal cord. It has previously 
been shown that these ependymal cells act in a neurotrophic manner and are essential for 
successful tail regeneration. After tail amputation, the cells lining the ependymal canal 
proliferate and give rise to an ependymal tube (which terminates in a structure called the 
ependymal bulb) in which neurogenesis occurs (Benraiss et aI., 1999). The ependymal 
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tube extends into the blastema, and will ultimately lay the foundation for the formation of 
new spinal cord. The ependymal cells provide a favourable substratum as well as 
guidance cues for the actively regenerating spinal cord axons (Nordlander and Singer, 
1978). The ependymal cells have also been implicated in possibly providing a source of 
neuronal precursors (Benraiss et aI., 1999) for the new spinal cord. 
It has been well established that RA is an important molecule in the development, 
patterning and regeneration of CNS tissue (Maden and Hind, 2003). For example, in 
urodele amphibians (eg. newts and axolotls) where regeneration of CNS, limb and tail 
tissues occurs naturally, RA can have significant effects on neurite outgrowth 
" 
(Dmetrichuk et aI., 2005), the establishment of proximal-distal, anterior-posterior and 
dorsal-ventral positional information (Pecorino et aI., 1996), as well as cellular 
proliferation and differentiation in the limb blastema mesenchyme and wound epithelium 
(Maden, 1998; Viviano and Brockes, 1996). 
Normally, RA exerts its effects on these processes by entering the nucleus and 
binding to two classes of ligand-activated nuclear transcription factors: the retinoic acid 
receptors (RARs) and the retinoid X receptors (RXRs) (Maden and Hind, 2003). In the 
regenerating newt limb, five .~R isoform~. have been detected, two a and three 8 types, 
with the newt 8 type being the equivalent to the mammalian y type (Maden, 1996). No 
RXRs have yet been isolated from urodele amphibians (however, see Appendix 1), but at 
least three are suspected to be expressed and bind as heterodimers with the five RAR 
isoforms (Maden, 1997; Maden and Hind, 2003). Each specific combination of 
heterodimer could potentially be responsible for the varying effects of RA on 
development and regeneration in these species (Maden, 1997). For example, in vivo 
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activation of a single RAR82 isoform in blastema mesenchyme (by biolistic transfection 
of a chimeric thyroid-hormone/RAR 82 receptor), mediates proximal-distal specification 
of positional information (Pecorino et aI., 1996). 
In mammals, another isoform, RAR~2, appears to specifically mediate the effects 
of RA on neurite outgrowth in peripheral nervous tissue capable of regenerating neurites 
(namely embryonic and adult dorsal root ganglia (DRG) neurons). Importantly, 
expression of this specific ~2 isoform is consistent with the ability of mouse embryonic 
spinal cord neurons to regenerate (Corcoran et aI., 2002). However, spinal cord explants 
( 
from adult mice can not regenerate and RAR~2 expressiofi is absent; exogenous RA does 
not produce neurite extension from these explants (Corcoran et aI., 2002). Interestingly, 
transduction of adult mouse and rat spinal cord in vitro with a minimal equine infectious 
anemia virus constitutively expressing RAR~2 led to prolific neurite outgrowth in these 
tissues (Corcoran et aI., 2002). Similar effects on neurite outgrowth and functional 
recovery in vivo have been obtained with over-expression of RAR~2 by lentiviral vectors 
in adult DRG or corticospinal tract (CST) neurons in models ofCNS injury (Wong et aI., 
2006; Yip et aI., 2006). 
We have previouslY"demonstrated"that spinal cord explants from adult newts 
show extensive neurite outgrowth in response to exogenous RA (Dmetrichuk et aI., 2005; 
Prince and Carlone, 2003). Similar results in response to exogenous RA were obtained 
with spinal cord explants from larval salamanders (Hunter et aI., 1991). Interestingly, the 
RA-stimulated outgrowth from newt spinal cord neurons was abolished in the presence of 
a selective antagonist of RAR~, LE135 (Dmetrichuk et aI., 2005). These data strongly 
suggest that a RAR~ subtype might be mediating the neurite-stimulating effects of RA in 
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the newt, as is known to occur in mammalian embryos. Curiously, it has been previously 
reported that newts do not contain any RAR~ isoforms (Maden and Hind, 2003), despite 
an earlier report of a partial RAR~-1ike receptor from adult newt limb tissue (Giguere et 
aI., 1989). 
In this study, I have cloned a full-length newt homolog of RAR~ from the adult 
newt, Notophthalmus viridescens that displays highest similarity to other vertebrate 
RAR~s, specifically the RAR~2 isoform. I next determined the expression pattern of this 
newt RAR~ (termed NvRAR~2) in various organs and tissues, including the caudal spinal 
cord and tail during various stages of tail regeneratiOI{ With the use of an RAR~­
selective agonist and antagonist, I then investigated a potential functional role for this 
newt RAR~ in adult newt tail regeneration. 
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2.03 Material and Methods 
Animal care and surgery 
All procedures were approved by the Brock University Animal Care and Use 
Committee. Adult Eastern red-spotted newts, Notophthalmus viridescens were used for 
all experiments and were acquired from Boreal Northwest (St. Catharines, Ontario). 
Adults were housed in plastic containers for the duration of experiments and fed a diet of 
liver and brine shrimp three times per week, with dechlorinated water being changed 
following feeding. 
For all surgical procedures, newts were anesthetized by full immersion in 0.1 % 
solution ofm-aminobenzoic acid ethyl ester methane sulfonate (pH 7.0, MS-222, Sigma). 
For all regeneration experiments, the tail was amputated approximately lcm caudal to the 
cloaca. Following surgery, newts were allowed to recover on ice for approximately 20 
minutes, at which time they were placed onto a damp paper towel to recover fully. 
Cloning of N. viridescens RARP2 
Total RNA was isol~ted from a l11ixture of newt brain and spinal cord tissue 
according to procedures outlined in the GenElute™ Mammalian Total RNA Purification 
Kit (Sigma-Aldrich). cDNA was generated from the total RNA using random hexamer 
and oligo-dT primers according to instructions in the ThermoScript™ RT kit 
(Invitrogen). Touchup-PCR was performed using the GoTaq® Hot Start Polymerase kit 
(Promega) using the following degenerate primers: 5' -cactacggcgtctccgcntgygarggnt-3' 
and 5' -ggtgatcttcatcaggatctttggraacatrtg-3'. Amplification was performed according to 
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the following cycling program: 94°C for 2 min, 94°C for 30 sec, 42°C for 30 sec and 
72 °C for 50 sec, followed by 29 cycles at increasing annealing temperatures in 
increments of +0.4 ° C per cycle. This was followed by 15 cycles at 94 ° C for 30 sec, 58 ° C 
for 30 sec and 72°C for 50 sec, followed by a final extension at noc for 5 min. Using 
this initial PCR product as a template, a second round of PCR was performed using the 
same program with nested degenerate primers: 5' -ccggaacgaccggaayaaraaraa-3' and 
5' -ggccgaagccggcrttrtgcat-3', to produce a product of 437 bp. All sequencing was 
performed by York University (Toronto, Ontario) using a 3730 DNA sequencer from 
Applied Biosystems. Full-length cDNA was obtained thrQugh multiple rounds of 5' and 
3' RACE with cDNA prepared from the same newt brain and spinal cord preparations 
using the SMART RACE cDNA amplification kit (Clonetech). 
Reverse Transcriptase-peR 
Reverse transcription was performed for each tissue sample in a final volume of 
20 ilL with 1 Ilg total RNA according to the protocol for the iScript™ cDNA Synthesis 
Kit (BioRad). PCR was performed with 1 ilL of RT product with iTaqTM DNA 
Polymerase (BioRad). The ,.specific prim(grs used were 5' -ggcccgtcctcatgcatgcttca-3' 
(Forward) and 5' -cttctcggtgaggtcgtccagctcg-3 ' (Reverse) to produce a 486bp product 
according to the following program: 95°C for 3 min, followed by 35 cycles of 95°C for 
30 sec, 65°C for 30 sec and 72°C for 45 sec. The nucleotide sequences of the control 
elongation factor la (EFla) primers were 5'-ccatgtgtgtggagagcttctca-3' (Forward) and 
5' -ggctcttgtgatggaccctaatg-3' (Reverse) yielding an amplification product of 290bp. 
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Analysis of the products was carried out on 1 % agarose gels in TAE buffer stained with 
ethidium bromide. 
Antibody preparation 
Antibodies were designed against a synthetic peptide from the predicted 'hinge' 
region of the NvRAR~2 covering the amino acid residues 175-188, between the DNA 
binding domain (DBD) and ligand binding domain (LBD). This region was chosen based 
on solvent accessibility of the predicted 3D structure using the NACCESS program 
(Hubbard and Thorton, 1993) and on the degree of antigenicity along the polypeptide 
.; 
chain using a bioinformatic tool called JaMBW (Toldo, 1997) with the ANTIGENIC 
PLOT function (predicted by the algorithm of Hopp and Woods, 1981). This custom 
made NvRAR~2 antibody was produced in New Zealand white rabbits and affinity 
purified from the antisera by Pacific Immunology Corp. A commercial antibody against 
human glyceraldehyde phosphate dehydrogenase (GAPDH) (Abcam Inc.) was also used 
in Western blotting procedures as a normalizing control. This human GAPDH antibody 
successfully recognizes the same GAPDH protein in the newt. 
Western Blot Analysis 
Immediately following tissue collection, the various organs and tail blastemas 
were frozen in liquid nitrogen and stored at -80°C until required for protein isolation. 
Each tissue sample was placed in lysis buffer and homogenized for 20 seconds using a 
PowerGen hand held tissue homogenizer (Fisher Scientific). In order to determine the 
protein concentration in each supernatant, the BCA protein assay (Pierce) was used, as 
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per the manufacturer's instructions. lOJlg of total protein from each sample was made up 
to 20ul with lysis buffer and combined with an equal volume of protein loading buffer. 
The prepared samples were loaded onto a 4% stacking, 12% resolving polyacrylamide 
gel and run at 100V for 2-3 hours. Gels were then blotted at 100V for 60 minutes onto 
nitrocellulose membrane (BioRad). Blots were blocked in blocking solution (3% non-fat 
skim milk powder/0.1 % Tween-20 in PBS) for 1 hour, followed by incubation overnight 
at 4°C with either one of two primary antibodies (1: 1000 custom-made NvRAR~2 
antibody in blocking solution; 1: 10,000 GAPDH antibody in blocking solution). 
Membranes were next washed 4 times, for 5 minutes each, in PBS/0.1 % Tween-20 and 
" 
incubated in the dark for 45 minutes in Alexa Fluor 680 goat anti-rabbit secondary 
antibody (1: 15,000 in blocking solution; Invitrogen). Membranes were then washed 
again with PBS/O.l % Tween20, with a final rinse of PBS. Membranes were stored in 
PBS in the dark at 4°C until visualization at 700nm using an Odyssey Infrared Imaging 
System (LI-COR Biosciences). The Western blot experiments were performed three 
times. 
Immunofluorescence of NvRARP2 
., 
For immunostaining experiments, the adult newt tail blastemas, at various stages 
of regeneration, were fixed in 4% paraformaldehyde in PBS at 4°C overnight, and 
washed in 10% sucrose/PBS for 2 hours, 20% sucrose/PBS for 2 hours, and then 
overnight at 4°C in 30% sucrose/PBS. After embedding the fixed tail blastemas in 
Optimal Cutting Temperature (O.C.T.) Compound (Tissue-Tek), serial 20Jlm sections 
were cut using a cryostat (Leica micro systems) and placed on Superfrost Plus slides 
42 
(Fisher Scientific). The samples were washed in PBS and then permeablized in 0.3% 
Triton X-IOO in PBS (PBT) for 30 min and blocked in 5% normal goat serum (NGS) in 
PBT for 1 hour at room temperature. The samples were then incubated at 4°C overnight 
with the primary NvRARp2-specific antibody diluted 1: 100 in blocking solution. As a 
control, some preparations were incubated only in blocking solution, without the primary 
antibody, at 4°C overnight. All samples were then washed in PBT 3 x 5 minutes and 
incubated in 1 :500 dilution of Alexa Fluor 488 goat anti-rabbit secondary antibody 
(Invitrogen) in blocking buffer at RT for 2 hours. The samples were then washed in PBT 
3 x 5 min, and then the nuclei were counterstained with PAPI for 2 min, followed by a 
<" 
final wash in PBS. An anti-fade Fluorosave mounting media (Calbiochem) was then 
applied to the slides and cover slips added. The samples were visualized on a laser 
confocal microscope (Nikon Canada Inc) and images were captured with NIS-Elements 
software (Nikon Canada Inc). 
Agonist and antagonist treatments of whole animals undergoing tail regeneration 
Adult newts were anaesthetized in MS-222 (as mentioned previously), and had 
the distal third of the tail ao:putated with .!l razor blade. Subsequently, the newts were 
maintained in dechlorinated tap water containing 1O-6M LE135 (an RARp-selective 
antagonist; a kind gift from H. Kagechika, Tokyo) or in a bath containing 0.01 % DMSO 
(vehicle control) for 21 days. Although DMSO is known to have cytotoxic effects at 
higher concentrations (above 2% v/v), concentrations less than 0.5% have been shown to 
be noncytotoxic (Sumida et aI., 2011). In fact, treatment of newts with 0.01 % DMSO did 
not appear to have any negative effects on health, or tail regeneration compared to 
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dechlorinated tap water treatment alone (data not shown). A separate senes of 
experiments was later performed with 1O-6M AC261066 (a highly isoform selective 
agonist for RAR~2; ACADIA Pharmaceuticals Inc.) with a separate group of 0.01 % 
DMSO controls, for 21 days. The newts were fed beef liver three times per week, and the 
solutions were changed twice weekly. If the solutions appeared cloudy (due to uneaten 
food particles and waste) before the assigned solution changes, then a quick filtering was 
performed with a Whatman ® filter for coarse particle removal. 
After 21 days, all of the newts were removed from their solutions and were 
photographed under a dissecting microscope using a Nikoij< DS-U2 camera equipped with 
-; 
NIS Elements software. The length of tail regenerates was determined and a Student's t-
test was performed to test for significant differences between the drug and DMSO 
treatments. Following measurements, the LE135- and DMSO-treated tails were removed 
for Western blotting, to compare NvRAR~2 protein levels in the tail regenerates. 
Following the AC261066 (and corresponding DMSO) treatments, the newts were placed 
back into dechlorinated tap water, and pictures of the tails were taken once again, 5 
weeks later. 
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2.04 Results 
The newt RARP shares a high degree of homology with other vertebrate RARP2s 
Using degenerate primers designed from other known vertebrate RAR~ 
sequences, I was able to generate an initial cDNA fragment from a mixture of newt brain 
and spinal cord tissue using a modified touchup RT-PCR protocoL Multiple rounds of 5' 
and 3' RACE from the initial cDNA fragment were needed to elucidate the full-length 
newt RAR~. The final full-length cDNA I obtained was 2,251 bp with a 1347 bp open 
reading frame that encodes a putative 448 amino acid protein (termed NvRAR~2; 
J 
<" 
accession no. AY847515; as found to be most similar to other vertebrate RAR~2s). Using 
the Basic Local Alignment Search Tool (BLAST) I determined that this NvRAR~2 has an 
overall amino acid identity of ~90% with RAR~2 sequences from other vertebrates 
including Rattus norvegicus (rat), Coturnix coturnix (common quail), and Homo sapiens 
(human) (Fig. 9). I was confident that this is an RAR~ isoform since the closest overall 
amino acid identity with RARa is 79% (Xenopus RARa; accession no. AAI69954) and 
with RARy is 73% (Xenopus RARy; AAB47116). As is commonly seen with other 
nuclear receptors, the most conserved regions in the NvRAR~2 protein sequence are the 
predicted DNA-binding domain (DBD; Region C), which shares ~99% amino acid 
identity with the rat RAR~2 DBD (accession no. XP _001059523) and the predicted 
ligand-binding domain (LBD; Region E) which shares 96% amino acid identity with the 
rat RAR~ LBD (Fig. 9). 
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Figure 9. The newt RARP2 sequence. Multiple alignment of the Notophthalmus 
viridescences RAR~2 (Newt RAR~2; accession no. AY847515), Rat RAR~2 (accession 
no. EDL94092), Human RAR~2 (accession no. NP _000956), and Quail RAR~2 
(accession# AAD23398) proteins. Note the overall high degree of amino acid 
conservation, especially in the C region which contains the DNA-binding domain (DBD) 
and in the large E region which contains the ligand-binding domain (LBD; where retinoic 
acid binds). 
46 
Of the RAR~ isoforms that are currently known (RAR~1 ~5), the differences in their 
amino acid sequence are primarily in the A domain at the N-terminus (except for RAR~5 
protein which is missing the A, B, and part of the C domain) (Nagpal et aI., 1992; Peng et 
aI., 2004; Zelent et aI., 1991). The remaining domains of the RAR~ isoforms (up to the 
terminal F domain) are identical in sequence homology within a given species. The 
differences in the A region of the different ~ isoforms not only pertain to the amino acid 
sequence, but also to the length of the A region. From Figure 9, the alignment of my 
newly found newt RAR~ sequence with other vertebrate RAR~2 protein sequences 
illustrates that the A region not only displays high amino;,acid similarity, but also shares 
an identical length with other RAR~2 receptors. 
NvRARP2 mRNA contains an unusually large 5'UTR region 
Previous work has shown that the mouse RAR~2 mRNA contains a long 5' 
untranslated region (5'VTR) of 46lbp that shares high homology with the human RAR~2 
5'UTR region (Zelent et aI., 1991). This region in the mouse is known to form very stable 
secondary structures and contains five upstream small open reading frames (sORFs) 
preceding the major open reading frame (l!l0RF). Through mutation of these sORFs in 
" 
mice embryos, it was determined that these sORFs play an important role in control of 
tissue specific expression and developmentally regulated gene expression of RAR~2 
(Zimmer et aI., 1994). In Figure 10, the 5' UTR of NvRAR~2 is depicted along with a 
portion of the A region of the mORF. This newt 5' UTR is exactly 795bp and is thus 
larger than either the mouse or the human 5' UTR. This makes it closer to the more 
elaborate 5' UTR (690bp) of the amphibian RAReSl sequence obtained from 
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1 GGTCCCTTCATTATTTACATTTTATTTGAATTTTTGATGCAGCATGGACCGATCCTAGAG 
sORFl M Q H G P I L E 
61 CCGGGGACCAGGGACCCCCTGCCCTTTACACGCCCCGGAGTTCATGTTAATAGATGCCAA 
P G T R D P L P F T R P G V H V NRC Q 
sORF2 M LID A N 
sORF3 M P 
121 CTTGGATTATTGCTACCCAAGTCGTCCACAGTGGCTTGGACCACTCCAGGATATTTTTAG 
L G L L L P K SST V A W T T P G Y F *** 
L D Y C Y P S R P Q W L G P L Q D I F S 
T W I I A T Q v V H S G L D H SRI F L 
181 CTGCCACAGCAGATTTTATGAAGGCGGTGGTATTTTTTATTTGACCAAGAAGTGGTAGGA S ' UTR 
C H S R F Y EGG G I F Y L T K K W *** 
A A TAD F M K A V V F F I *** 
241 GGGATGAAAGGCAGTTAAGCAACGGGTTGTGCGCCGCTGACCATTGAAGTTGGACCTCCT 
301 TACGTTGCTAGATACTATCTTACTTTGAACTTTTACTATAGGTGCTGGAGTACTTTGAGT 
361 TTAGTGGGTGTCCGCTTGGACCAACAGTACCCTCTATTCCTC~CAGTACGGAACCCAAC 
<" 
421 ATATTGCCCCCCACACCAGTTTGGTGTTACCATTTGTTGGACTAATGCACGTCATATACA 
sORF4 M H V I Y 
481 AACAAGCTTTGAAGTCATCAACCCTTCTTCAGATAGAGATGAACTCAATTTTATTCTGAG _ __ 
K Q A L K SST L L Q I E M N S I L F *** 
541 AGCTTTGCTAGTGAGAGGACCACATCCATTGCCCAATAGTAAGTTGTTGTGACTTCTCTC 
601 TCACCGAAGTGGCCTTCTGAGGTTACACGCTTGAACAAATGACACCCCTCTAACCTGCTT 
661 CGGCCTCCCCGAATACATGGTGTGGTGGGTCAAGACCTGGCATCAGACAGCGGGCCTAGA 
sORFS M v W W V K T W H Q TAG L E 
721 GTGGATGGGTTTGGCCACGCGCTGGCGCCCCATTTAACCTAGCGCCTAAAGAAGACACAC 
W M G L A TRW R P I ** * 
78 1 TGCCAAAGTGGCAC~~TGTTTGACTGCATGGACGTGCTGGCAGTGAGCCCCGGGCACATG 
.----______ '..JI~ M F D C M D V L A V S P G H M A 
8 41 CTGGACTTCTACACGACAGGCCCGTCCTCATGCATGCTTCAGGAGAAAGCCCTCAAGGCG I"egion 
L D F Y T T G P S SCM L Q E K A L K A 
901 
961 
TGCTTCAATGGGCTGGCACAGAGCGACTGGCAGCACCGACACAGCGCACAP ~CGATCGAA 
C F N G L A Q S D W.Q H R H S A Q S I E 
ACCCAGAGCACGAGTTCAGAGGAGCTGGTTCCGAGCCCCCCGTCGCCGCTGCCACCCCCG 
T Q S T SSE E L V P S P P S P L P P P 
1021 AGGGTTTACAAGCCATGTTTCGTGTGCCAGGACAAGTCGTCTGGGTACCACTATGGT . . . 
R V Y K P C F V C Q D K SSG Y H Y G .. . 
Figure 10. The newly cloned NvRARP2 cDNA contains an exceptionally long 5'-
UTR region. The 5 '-UTR (square bracket) and part of the ORF 'A' region (boxed) of the 
newly sequenced NvRAR~2 cDNA are shown above. All in frame termination codons 
which lie upstream to the major ORF are underlined. Below the NvRAR~2 5' -UTR 
sequence, the deduced amino acid sequences of all possible upstream sORFs are 
indicated. Three successive asterisks indicate a stop codon at the end of the sORFs. The 
black arrow indicates the site where, in mice and humans, RAR~2 differs in the 5 ' end 
from other known RAR~ isoforms. 
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Notophthalmus viridescens (Ragsdale, Jr. et aI., 1993). Interestingly, the NvRAR~2 5' 
UTR contains five sORFs (Fig. 10) which is the same number of sORFs in the mouse and 
human RAR~2s, though there is not a high degree of sequence homology between them. 
Whether these NvRAR~2 sORFS in the 5' UTR region playa role in tissue-specific or 
developmental gene regulation of NvRAR~2 remains to be determined. The NvRAR~2 5' 
UTR may also possess strong secondary structures such as predicted from the mouse 
RAR~2, as sequencing of the newt RAR~2 5' UTR region was difficult and often needed 
reagents such as betaine to relax GC rich areas. 
NvRAR(l2 mRNA expression in regeneration-competent tissues 
Although it has been previously shown that RA can induce regeneration III 
mammalian embryonic CNS tissue, it was reported that adult mammalian CNS cannot 
respond because RAR~2 is transcriptionally inactivated (Maden and Hind, 2003). I have 
shown that RAR~2 mRNA is present in the newt CNS, through its initial discovery using 
degenerate primers and subsequent sequencing of the entire mRNA. However, from this 
initial work, it was not evident whether the expression was restricted to either the spinal 
cord or the brain, or whether it was present _~n both. In the newt, both the brain and spinal 
cord are capable of extensive regeneration, as are other various organs such as the liver 
(Williams, 1959). My next aim was thus to determine, using RT-PCR, whether mRNA 
expression could be detected in tissues of the adult newt that are capable of regeneration. 
The results of the RT-PCR showed that NvRAR~2 mRNA was not only present in the 
brain and spinal cord, but was also present in the gut and to a lesser degree in the liver 
(Fig 11). The transcript was, however, undetectable in the kidney (Fig. 11) though, 
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Figure 11. NvRARP2 mRNA expression in regeneration-competent tissues. RT-PCR 
analysis revealed the presence of NvRAR~2 mRNA in the acutely isolated newt spinal 
cord, brain, gut, and low levels in the liver. There were no detectable levels of NvRAR~2 
mRNA in the kidney. The ne~t EFla was used as a control. 
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interestingly, there are no previous reports of kidney regeneration in the newt. Primers 
designed against the newt EFla were used as a control for RT-PCR. EF1a, a translation 
elongation factor, is a well-known housekeeping gene commonly used as a control in RT-
PCR experiments (Sturzenbaum and Kille, 2001). 
Previously, it has been shown that the limb blastema of newts, specifically the 
wound epithelium, synthesize and release RA (Viviano and Brockes, 1996). In order to 
transduce the RA signal, the RA must first bind to retinoid receptors. RAR8 and RARa 
sequences have been identified in newt limb blastemas, but no full-length RAR~ 
sequence has ever been cloned from a regenerating blaste,fIla. I next performed RT-PCR 
-; 
on amputated limb and tail tissue, in addition to their regenerate blastema tissue after 8 
days, in an attempt to identify an RAR~ transcript. In Figure 12, it is evident that there is 
a small, but detectable level of NvRAR~2 mRNA in both the limb and tail at the time of 
amputation. By day 8 post-amputation (P A), the results indicate that there is a higher 
level of NvRAR~2 mRNA in both the limb and tail blastemas compared to day 0 
(experiment repeated three times). These results indicate that at least at the level of 
transcription, NvRAR~2 expression is upregulated in the regenerating tail region as a 
result of amputation. 
NvRARP2 protein is present in some regeneration-competent tissues 
Given that the NvRAR~2 transcript is present in tissues of the newt that are 
known to regenerate, my next aim was to determine if the translation product is also 
present. Using a custom-made antibody against a. synthetic peptide from the 'hinge' 
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Figure 12. NvRARP2 mRNA expression increases in limb and tail blastemas after 
amputation. Low levels of NvRARP2 mRNA were detected in the acutely amputated 
newt limb and tail tissues. There was an increase in mRNA levels in the regenerating 
blastema tissues 8 days after amputation. The newt EFla was used as a control. Inverting 
the picture of the gel (white background, black bands) gave better contrast to view the 
faint 'day 0' bands. 
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regIon between the DBD and the LBD of NvRARP2, Western blot analysis was 
performed in order to determine the presence of NvRARP2 protein in regenerating and 
non-regenerating tissues. Tissues that displayed positive reactivity (spinal cord, brain and 
gut) revealed a band approximately 50 kDa in size, which is very close to the predicted 
molecular weight of 50.5 kDa. Although the RT-PCR experiments had previously 
indicated low levels of mRNA in the liver, the NvRARP2 protein was actually not 
detectable in the liver using Western blotting. NvRARP2 protein was, however, present 
in the spinal cord and brain, with levels appearing higher in the brain. This finding 
correlates well with the previous RT-PCR analysis showj;lg higher levels of NvRARP2 
-; 
mRNA in the brain compared to the spinal cord. Although I previously did not test for 
NvRARP2 mRNA in the gut, it is clear from the Western blot that the gut displayed the 
highest level of NvRARP2 protein expression (Fig. 13). This result is intriguing, since the 
gut is also known to retain regenerative capabilities in the adult newt (O'Steen and 
Walker, 1962). Consistent with the RT-PCR results, there were no detectable NvRARP2 
protein levels in the kidney. The housekeeping gene, glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; an enzyme in the glycolysis pathway) was used as a control for 
these Western blotting expen.ments. EF 1 a ~ould have been an ideal choice to maintain 
consistency with the RT-PCR experiments, but an antibody capable of detecting newt 
EF 1 a was not available. 
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Figure 13. NvRARP2 protein is detectable in some regeneration-competent tissues. 
Western blot analysis of various tissues revealed the presence of NvRARP2 protein in the 
acutely isolated gut, brain and to a lesser extent in the spinal cord, but undetectable levels 
in levels in the liver, kidney and spleen. The newt GAPDH was used as a control. 
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Stages of tail regeneration 
NvRARJl2 __ I ____ : _::~_~~_:~_;_:_:~:_:~_~- __III 
GAPDH I ~'!;·;"" I 
control _ ~ ! 
Figure 14. NvRARP2 protein levels rise in progressing stages of tail regeneration. 
Western blot analysis at 4 different stages of newt tail regeneration revealed a stepwise 
increase in the levels of NvRAR~2 protein from day 0 through day 21. The newt GAPDH 
was used as a control. 
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NvRARP2 protein is up regulated in the regenerating newt tail 
My next aim was to determine whether NvRARP2 protein was present in the 
regenerating tail blastema (containing the caudal tip of the spinal cord) and whether these 
levels are altered during the first 21 days after amputation. Western blotting indicated that 
at day 0, there was a very low expression level of NvRARP2, suggesting that there may 
be a basal level of NvRARP2 protein present in the unamputated tail, though this signal 
may likely originate from the caudal spinal cord (as described below). At day 7, the level 
of NvRARP2 protein increased, and it continued to increase by day 14, showing the 
highest expression on day 21 (Fig. 14). RARP protein h~~ shown similar elevated levels 
in transected sciatic nerves of rats (Zhelyaznik and Mey, 2006). However, I could not 
discern whether the newt RARP levels in this study were from the regenerating central 
nerves of the spinal cord, or from the other regenerating structures of the tail blastema. 
NvRARP2 is present in the spinal cord of the regenerating tail 
Our lab has previously shown that RA significantly enhances the outgrowth of 
neurites from cultured spinal cord explants of Notophthalmus viridescens, and that this 
outgrowth was inhibited bY,the RARp-sel.~ctive antagonist, LE135 (Dmetrichuk et aI., 
2005). Since RARP2 was previously suggested to be the key transducer of the 
regenerative RA signal in embryonic mouse DRG neurons (Corcoran et aI., 2000) and 
upregulation of RARP2 alone stimulated regeneration of neurites in the adult mouse 
spinal cord in vitro (Corcoran et aI., 2002), I next aimed to determine whether the newly 
identified NvRARP2 is expressed in the spinal cord of the regenerating tail, and if so, to 
determine its localization. Using the NvRARp2-specific custom-made antibody, I 
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perfonned immunohistochemistry on various stages of tail regeneration. When the tail 
was acutely isolated (day 0) and cross-sectioned, NvRAR~2 immunoreactivity was 
detected in the region known to contain ependymal cells surrounding the central canal of 
the spinal cord (Fig. 15Ai; red arrow). There was also strong staining around the 
periphery of the spinal cord (Fig. 15Ai; yellow arrow), consistent with the layer of 
meninges that surround and protect the CNS. Interestingly, the cells of the meninges are 
also known to secrete all-trans RA (Siegenthaler et aI., 2009) and have been implicated in 
guiding axons during newt spinal cord regeneration (Zukor et aI., 2011). The presence of 
NvRAR~2 in the spinal cord at day 0 is consistent with !pe detectable levels present in 
total protein from acutely isolated tails by the Western blot (day 0; Fig. 14). By day 7 PA, 
a cross-section of the tail blastema also revealed immunoreactivity in the ependymal cells 
surrounding the central canal (Fig. 15Bi, red arrow) and in the region known to contain 
the meninges (Fig. 15Bi; yellow arrow; which is similar in distribution to Figure 15Ai). 
On day 14 of tail regeneration, sagittal sections of the blastema were prepared and 
examined to determine the rostral-caudal distribution of NvRAR~2 protein in the 
ependymal tube extending into the blastema. Immunoreactivity is evident in this 
ependymal tube, which will,. eventually b~~ome the new spinal cord (Fig 15Ci; purple 
arrow). There is also reactivity in the ependymal bulb at the caudal tip of the ependymal 
tube (Fig. 15Ci; pink arrow). 
NvRAR(l2 signals in the spinal cord and epidermis of day 21 blastemas 
From the Western blot results in Figure 14, it was shown that the highest 
expression of NvRAR~2 protein in the newt tail regenerates occurred on day 21 P A. I 
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Figure 15. NvRAR(J2 is present in the spinal cord region of the regenerating tail. (Ai,ii) 
Immediately after amputation of the newt tail (day 0), immunostaining of a cross-section 
with the NvRARP2 antibody revealed a signal in the ependymal cells surround the central 
canal of the spinal cord (red arrows), and also the outer perimeter of the spinal cord (yellow 
arrows), which may contain some of the dura matter. (Bi,ii) Immunostaining of a similar 
cross-section at day 7 of tail regeneration with the NvRARP2 antibody also displayed signal 
in the ependymal cell region (red arrows) and periphery of the spinal cord (yellow arrows). 
(Ci,ii) Immunostaining of a sagittal section at day 14 of tail regeneration with the NvRARP2 . 
antibody revealed a signal throughout the blastema but a strong signal is seen along the 
ependymal tube (purple arrow) and into the ependymal bulb (pink arrow), which will 
eventually become new spinal cord in the fully regenerated tail. All scale bars: 250 !lm. 
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Figure 16. NvRARP2 is present in the spinal cord and mesenchyme region of the 
regenerating tail at day 21. (A) Strong immunoreactivity is still observed in the regenerating 
spinal cord at day 21 (white arrow). Scale bar: 150 /lm. (B) In the mesenchyme region towards 
the tip of the regenerating tail blastema, there are numerous cells that display strong 
immunostaining for NvRAR~2 (yellow arrows). Scale bar: 150 /lm. (C) Upon higher 
magnification of the mesenchymal region, the NvRAR~2 immunostaining in these cells 
appears to be localized to the cytoplasm. ,,Note the lack of NvRAR~2 staining in the nuclei 
stained blue with DAPI. Scale bar: 20 /lm. 
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next aimed to determine the localization of NvRAR~2 protein in sagittal sections of day 
21 tail regenerates. In Figure 16A (white arrow), day 21 tail blastemas showed expression 
of NvRAR~2 in the regenerating spinal cord within the blastema. In addition, a closer 
inspection of the mesenchyme region towards the tip of the tail blastema revealed strong 
immunoreactivity in a number of loose mesenchyme cells (Fig. 16B). It is known that 
the wound epidermis and mesenchyme are sources of RA synthesis during regeneration 
of the axolotl limb (Maden, 1998). If this is true during newt tail regeneration, and RA 
can upregulate RAR~2 as previously shown (Corcoran et aI., 2002), then this may 
explain the strong immunoreactivity for RAR~2 in this lI},senchyme area. Interestingly, 
.. 
higher magnification of this mesenchyme domain revealed that these NvRAR~2-positive 
cells display a cytoplasmic localization of RAR~2 as there is little overlap with the 
nuclear DAPI stain (Fig. 16C). 
An RARp-selective antagonist (LE135) inhibits tail regeneration 
It has previously been shown that the RAR~-selective antagonist LE135 can 
inhibit normal patterning during limb regeneration in the axolotl, Ambystoma mexicanum 
(del Rincon and Scadding, 2002) and can a~.so inhibit neurite outgrowth from spinal cord 
cultures of N. viridescens (Dmetrichuk et aI., 2005). However, an RAR~ cDNA had never 
been fully cloned from either the axolotl or the newt. Since I had found that NvRAR~2 is 
upregulated in newt tail regeneration (Fig. 14), I next aimed to use LE135 in order to 
elucidate a functional role for the RAR~2 receptor in this process. Adult newts 
undergoing caudal tail regeneration were bath-treated with the RAR~-selective antagonist 
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Figure 17. The RARfJ-selective inhibitor, LE13S, significantly reduces the length of 
tail regenerates. (Ai,ii) Two representative examples of newt tail regenerates after 21 
days of immersion in the vehicle control DMSO (0.01% in dechlorinated water). The 
mean length of all regenerates was 2.60±0.19mm (n=8). (Bi,ii) Two representative 
examples of newt tail regenerates after 21 days of immersion in 1O-6M LE13S. The mean 
length of these LE13S-treated regenerates was 0.38±0.09 mm (n=8) which was 
significantly less than the vehicle control group (C; student t-test, **p<O.Ol). All scale 
bars: 2 mm. (D) For both test and control conditions, the tail regenerates were removed 
following measurements at day 21 and total protein was extracted for Western blot 
analysis. Using the NvRAR~2 antibody, signal was detected in the DMSO-treated group, 
whereas no signal was apparent in the LE13S-treated group. 
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LE135 (10-6M), beginning at the time of amputation. The length of the tail regenerates 
was measured after 21 days of treatment (which coincides with the highest expression of 
NvRAR~2 protein) and I found that the LE135-treatment significantly inhibited the tail 
regeneration process (Fig. 17Bi&ii) compared to DMSO alone (Fig. 17 Ai&ii). The mean 
tail regenerate length in LE135-treated animals (0.38 ±0.09 mm) was significantly 
reduced (p<O.OI) compared to DMSO-treated control regenerates (2.6±0.16 mm) after 21 
days (Fig. 17C). Moreover, Western blotting demonstrated that LE135-inhibition of 
RAR~ signaling led to a decrease in the expression of NvRAR~2 protein at 21 days after 
amputation (Fig. 17D), suggesting a possible autoregulatory control for receptor 
" 
expression in the newt, (as seen previously with mammalian RAR~s) (de The et aI., 
1989). 
An RARp2-selective agonist (AC261066) inhibits tail regeneration 
Previous experiments have shown that treatment of frog tadpoles with high levels 
of vitamin A (the precursor to RA) can lead to multiple limb structures growing from 
previously amputated tails (called home otic transformation), indicating a severe 
disruption in proximal-distal patterning (Mahapatra and Mohantyhejmadi, 1994; 
.. 
Mohanty-Hejmadi et aI., 1992). Conversely, it has been previously shown that vitamin A 
treatment inhibited tail regeneration in the adult newt, N viridescens (Scadding, 1986). 
Since these experiments did not determine which receptor isoform may be involved in the 
aberrant effects of excessive or diminished vitamin A levels, I next aimed to determine 
whether the RAR~2-selective agonist, AC26l066, would mimic either of these effects 
previously reported. Tails were again amputated from N viridescens, AC261066 was 
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Figure 18. The RARIJ2-selective agonist, AC261066, significantly reduces the length 
of tail regenerates. (Ai,ii) Two representative examples of newt tail regenerates after 21 
days of immersion in the vehicle control DMSO (0.01 % in dechlorinated water). The 
mean length of the regenerates was 2.44±0.18mm (n=6). (Bi,ii) Two representative 
examples of newt tail regenerates after 21 days of immersion in 10-6M AC261066. The 
mean length of these AC261066-treated regenerates was 0.25±0.08 mm (n=8) and this is 
significantly less than the vehicle control group (C; student t-test, **p<O.Ol). All scale 
bars: 1 mm. 
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added by bath application at day 0, and the length of tail regenerates was measured at 21 
days. Interestingly, AC261066-treatment significantly inhibited the tail regeneration 
process (Fig. l8Bi&ii) compared to DMSO controls (Fig. l8Ai&ii). These results 
indicate that both the RAR~2 agonist and the RAR~ antagonist exerted similar effects on 
tail regeneration. The mean tail regenerate length in AC261066-treated animals (0.25 
±0.08 mm) was significantly reduced (p<O.Ol) compared to DMSO treated control 
regenerates (2.44±0.18 mm) after 21 days (Fig. l8C). 
Interestingly, when these AC261066-treated newts were removed from the 
agonist at 21 days (time of analysis) and then placed ba~J<: into normal pond water, tail 
.; 
regeneration commenced. Five weeks after removal from the AC26l066, the tail had 
regenerated, albeit with an alteration in the dorsal-ventral patterning (Fig. 19B) compared 
to a normal tail regenerate (Fig. 19A). It would appear from Fig. 19B that a greater 
portion of the tail regenerate mass was contained in the dorsal region, compared to an 
equal distribution between the dorsal and ventral regions in the DMSO treatment (Fig. 
19A). 
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Figure 19. Delayed regeneration 5 weeks after agonist treatment shows disrupted 
patterning (A) Representative example of a newt tail regenerate after 21 days of immersion in 
dechlorinated tap water with DMSO. (Bi,ii) Representative example of a newt tail regenerate 5 
weeks in dechlorinated tap water, after 21 days of immersion in 1O-6M AC261066. Note the 
abnormal tail regeneration w.ith a larger pGrtion of the regenerate mass in the dorsal region, 
compared to the ventral region. All scale bars: 2 mm. . 
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2.05 Discussion 
In this study, I have cloned a full length cDNA encoding the newt retinoic acid 
receptor ~2 subtype (NvRAR~2) and have characterized its spatial and temporal 
expression patterns in the regenerating tail and caudal spinal cord of adult newt, 
Notophthalmus viridescens. In addition, I have shown that interrupting RAR~ signaling 
with a selective agonist or antagonist, resulted in the inhibition of normal tail 
regeneration in the adult newt. 
Giguere et ai. (1989) first reported the presence of a functional RAR receptor in 
J 
the blastema of regenerating newt limb tissue. Though it was reported that this RAR was 
most similar to the ~ sub-type, it was later shown to be a chimera made up of two non-
overlapping cDNA clones (Ragsdale, Jr. et aI., 1989). The 3' end of the clone covered 
most of the E and F domains, including the 3' untranslated region, and was eventually 
determined to be a partial RAR8 sequence. The 5' clone, on the other hand, was more ~-
like and included a region equivalent to 155 amino acids covering the B, C, and D 
domains of what eventually would tum out to be a portion of the 448 amino acid 
NvRAR~2 sequence that I have cloned in this study. However, prior to my study (in the 
absence of a fully cloned RAR~-type receptor), it was hypothesized over the years that 
newts do not possess an RAR~ subtype (Maden and Hind, 2003). Hence, my results 
describe the first fully cloned newt RAR~ subtype from regenerating newt tissue. The 
predicted amino acid sequence of this newt RAR~ shares greater than 90% identity with 
all regions of many mammalian RAR~2 mRNAs. 
Indirect evidence for a functional RAR~ receptor came from previous studies in 
our lab by Dmetrichuk et ai. (2005), who used the RAR~-selective antagonist to inhibit 
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RA-mediated outgrowth from newt spinal cord explants. Here, I have provided further 
evidence for a functional role for RARP in newt spinal cord regeneration. The 
immunostaining experiments showed expression of an RARp-like protein in the 
regenerating spinal cord, as well as the blastemal tissue of the regenerating newt tails. 
It is important to note that the Western blots in this study used a custom-made 
antibody against the D domain (hinge region) of the NvRARP2 protein, and produced 
only one band at the predicted molecular weight. These data suggest that only one 
isoform of newt RARP is present. The D (hinge) domain of the various mammalian 
isoforms of RARP (I to 5) are identical, but the isofo~ would differ in their overall 
" 
molecular weight. Given this information, I would predict that (if similar to mammals), 
the D domain of the different newt isoforms of RARP would also be identical, and thus 
would all be detectable by our custom-made antibody. If multiple isoforms were indeed 
present in the regenerating newt tail, I would thus predict the presence of multiple bands, 
which did not occur. Though these data support the presence of one RARP2 isoform, I 
can not entirely rule out the presence of other P isoforms from the Western blotting alone. 
This newly identified NvRARP2 has an unusually long 5' -UTR of 795 bp, which 
is considerably longer than the 5' -UTR found in the mouse and human RARP2 (~460 bp; 
.. 
(Zimmer et at, 1994). Although the 5' -UTR of NvRARP2 is ~350bp longer than the 
mouse and human RARP2, it contains the sORFs preceding the mORF. These sORFs 
contain 'AUG' translational start sites that precede the 'AUG' for the mORF and can 
cause inhibition of downstream translation, thereby acting as a rate limiting factor in 
protein synthesis from the mORF (Zimmer et at, 1994). mRNAs that code for proteins 
involved in processes of cell growth and differentiation often contain these sORFs in the 
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5'UTR (Kozak, 1991). Since RA has been strongly implicated in cell growth and 
differentiation (Maden and Hind, 2003) and normally acts through nuclear receptor 
binding to transduce its signal, it is not surprising that NvRARP2 contains multiple 
sORFs in its 5'UTR. In the mouse RARP2, it has been shown that mutations in the 
start/stop codons of the sORFs can result in altered regulation ofRARP2 in the heart and 
brain regions of developing embryos (Zimmer et aI., 1994). Although the function of 
these sORFs of NvRARP2 was not determined in this study, it is quite likely that they 
exert some control over the expression of this receptor during regeneration. 
I have shown here that both NvRARP2 mRNA ar protein are expressed in the 
adult newt spinal cord and brain. Based on my immunofluorescent studies in newt tail 
regenerates, it appears that the highest levels of the receptor protein are expressed in the 
spinal cord and ependymal tube extending caudally into the blastema during the 
regeneration process. Corcoran et aI. (2002) had previously postulated that the absence of 
(or below-threshold) expression of the RARP2 receptor in the adult rat spinal cord, 
contributed to its inability to extend axons in response to injury. Indeed, even though all 
three RXRs and RARa were shown to be expressed and localized within the cytosol of 
neurons in uninjured adult rat spinal cord, no expression of RARP was reported prior to, 
-. 
or at any time points examined after the spinal cord crush injury (Schrage et aI., 2006). 
Conversely, in my study with the adult newt (which has spinal cord regeneration 
capabilities), I have demonstrated that both NvRARP2 mRNA and protein levels are not 
only present in the uninjured SC, but are then upregulated as a consequence of tail 
amputation. Increased expression occurred within the first 8 days after injury and 
continued to show higher levels throughout the first 21 days of regeneration. The time 
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course of this upregulation is consistent with previous studies on peripheral nerve 
regeneration in the rat, where protein levels ofRAR~ (as well as RARa and RXRa) were 
increased at 4, 7 and 14 days after sciatic nerve crush (Zhelyaznik and Mey, 2006). It is 
of importance to note that I have recently cloned the first reported newt RXR from the 
tail blastema of N viridescens (termed NvRXR; see Appendix 1). Interestingly, this 
NvRXR is highly expressed at day 0 of tail amputation, but is down-regulated during the 
first 21 days of regeneration (opposite to what was shown with NvRAR~2; Appendix 1). 
Future studies will be needed to determine the spatial distribution and function of this 
novel newt RXR in the process of tail regeneration. 
Within the spinal cord, I have shown that NvRAR~2 protein was localized to the 
ependymal cells and meningeal tissues surrounding the spinal cord in the non-
regenerating tail. The NvRAR~2 protein appears to be upregulated in the ependymal tube 
and bulb during the first 14 days after tail amputation with little expression in the 
blastemal mesenchyme. Ependymal cells of the spinal cord have been postulated to play 
an important early role in the regeneration of the caudal spinal cord of adult newts 
(Chernoff et aI., 2003). By the third day post amputation, these cells have migrated and 
sealed off the lumen of the cut spinal cord, creating the terminal ependymal bulb 
-.. 
(Chernoff et aI., 2003), while the ependymal cells just rostral to this cut site proliferate 
and extend an ependymal tube into the blastema (Zhang et aI., 2003). Stem cells within 
this population of ependymal cells will ultimately differentiate into glial cells, CNS 
neurons and peripheral ganglia, thereby restoring function (Chernoff et aI., 2003). 
Whether signaling through NvRAR~2 plays a role in these proliferating and 
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differentiating processes of the ependyma during newt tail regeneration, remains to be 
determined. 
Other cell types involved in retinoid signaling through RARP in the newt spinal 
cord after spinal cord injury (SCI) remain to be elucidated. For example, it is currently 
unclear where the ligand (all-trans RA) for this receptor is synthesized within the newt 
spinal cord, either before or after injury. Some of the earliest evidence for a role for 
retinoid signaling in SCI was provided by Mey et ai. (2005) in the rat spinal cord, who 
demonstrated that RALDH2, the enzyme catalyzing the conversion of retinaldehyde to 
all-trans RA, significantly increased as a consequence ~f a contusion injury by day 4 
<" 
post-injury, and then peaked at 8-14 days after the lesion. Before injury, RALDH2 was 
present in the meninges, whereas after lesioning, RALDH2 was upregulated in the 
meninges and colocalized with a population of oligodendrocyte precursors, thought to be 
derived from the meninges. These oligodendrocytes are postulated to migrate to the 
wound site and proliferate following SCI (Kern et aI., 2007; Mey et aI., 2005). 
Zukor et ai. (2011) have recently provided evidence for a role of meningeal cells 
in forming a permissive environment for axon regeneration in the newt after spinal cord 
transection injury. It would be interesting to determine if these newt meningeal cells were 
.. 
sites for all-trans RA synthesis. In mammalian development, meningeal cells are known 
to secrete RA (Shearer et aI., 2003) and after SCI they are known to significantly increase 
the extent of RALDH2 distribution, indicating an increase in the production of RA (Mey 
et aI., 2005). In the recently published newt model for spinal cord regeneration, Zukor et 
ai. (2011) have proposed that an increase in RA production from the meningeal cells may 
act as a guidance cue for regenerating axons. It was also proposed by Zukor et ai. (2011) 
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that in spinal cord transection in newts, meningeal cells are one of the first cell types to 
enter the lesion site. Since it is known that mesenchymal cells within the blastema can 
also produce all-trans RA (Maden, 1998), and since my experiments show RAR~2 
expression in the meninges, this process of meningeal cell migration into the lesion may 
involve signaling though RAR~2, although future experiments would be needed to 
confirm this. 
Our lab has already provided evidence that all-trans RA exerts chemotropic 
effects on regenerating neurites from newt spinal cord explants, and also provided 
evidence through the use of LE135, that this chemoatt~lilction involves an RAR~-like 
<" 
receptor. It is evident from my work here that NvRAR~2 protein is expressed early in the 
ependymal cells lining the central canal of the regenerating spinal cord, and so may be 
involved in guiding migration of these ependymal cells in response to RA. It is also 
interesting that the localization of NvRAR~2 protein, which I have shown to be mainly 
cytoplasmic in cells of the wound epidermis at the tip of the blastema (an area known to 
produce RA) at day 21, appears to have a non-nuclear distribution in these same 
ependymal cells (Fig. 15Ai&Bi; red arrows), although without DAPI staining, I cannot 
determine this with complete confidence. This non-nuclear distribution might even 
-.. 
suggest that the NvRAR~2 is exerting non-genomic effects, possibly in RA-mediated 
chemoattraction (as has been shown for other retinoid receptors; Farrar et aI., 2009). 
Interestingly, the RAR~ has recently been implicated in a rapid, non-genomic response 
involving transmitter release at developing neuromuscular synapses in Xenopus cell 
cultures (Liao et aI., 2004). Whether NvRAR~2 is acting non-genomically in the 
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regenerating tail, or whether it is translocated to the nucleus at various stages, in order to 
transduce its signal, would also need further investigation. 
The above results indicate that NvRARP2 may playa role in tail regeneration in 
the adult newt, possibly within the ependymal cells, meninges, and/or wound epithelium 
during the early post-amputation stages. In fact, bath treatment with the RARp-selective 
antagonist, LE135, resulted in a significant inhibition of adult newt tail regeneration by 
21 days. It is difficult to determine whether LE135 exerted its effects by inhibiting 
ependymal cell migration, mesenchyme proliferation, or whether it exerted its effects by 
inhibiting spinal cord regeneration. Inhibition of spinal ~yord regeneration alone might 
-; 
indeed be responsible, as there is strong evidence that regeneration of body parts depends 
on the nervous system, and denervation results in failure to regenerate. This is true for 
limb and tail regeneration ofurodeles, including the newt (Singer, 1952). Further support 
for this hypothesis comes from preliminary work in our lab that found that local 
application of LE135 directly into the central canal of the spinal cord also inhibited tail 
regeneration (Clark, 2010). When LE135-soaked beads were implanted into the spinal 
cord immediately after tail amputation, the length of the tail regenerate was significantly 
inhibited after 21 days (although this inhibition was not as pronounced as my LE135 bath 
' .. 
treatment condition). Further histological evidence suggested that the LE135 bead 
treatment negatively affected the growth of the ependymal tube. Interesting, ifthe LE135 
bead treatment was delayed for 6 days after tail amputation, there was no significant 
effect on regenerate length at 21 days (Clark, 2010). This would indicate that there is a 
critical period of RARP signaling (within the first 6 days PA) within and surrounding the 
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damaged caudal end of the spinal cord that appears to be required for normal tail 
regeneration. 
One of the most remarkable effects of retinoids on regenerating systems is the 
home otic transformation of tails into limbs in various species of frog tadpoles, which can 
be accomplished by treatment with high levels of all-trans RA and retinyl palmitate (an 
RA precursor) (Maden, 1993; Mohanty-Hejmadi et aI., 1992). A similar effect has also 
been reported in frog tadpoles with the RAR pan-agonist, TTNPB, further implicating a 
role for RARs in this process (Maden and Corcoran, 1996). In the adult newt, N. 
viridescens, it has been shown that higher levels ofRA can-cause entire limb structures to 
( ~ 
", 
grow from limbs amputated at the midforearm, producing an extra elbow joint (Maden, 
1998). Taken together, these effects of RAR agonists have been interpreted as a re-
specification of positional information along the appendage axis in a proximal direction. 
In this study I used the RAR~2-se1ective agonist, AC261066, to investigate whether 
stimulation of the NvRAR~2 receptor protein could elicit respecification of tail blastema 
cells resulting in either homeotic transformation, or some form of respecification along 
the rostral-caudal axis during tail regeneration. Although somewhat unexpected, bath 
treatment with AC261066 for 21 days after tail amputation produced significant 
-> 
inhibition of tail regenerate length, similar to that seen with LE135. However, other 
studies have also shown that excess exogenous RA can actually inhibit tail regeneration, 
in the axolotl, Ambystoma mexicanum, and in the newt, Notophthalmus viridescens 
(Pietsch, 1987; Scadding, 1986). The previous effects of RA on re-specification of 
positional information may perhaps have resulted from RA acting on other RARs 
(besides the ~ subtype), that may also play some role in appendage regeneration. From 
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the results of this study, it would appear that there may be a critical level of NvRARf32-
signaling that needs to occur for proper tail regeneration. Altering this signaling with 
either an RAR-selective antagonist or RARf32-selective agonist severely inhibited this 
process. 
Although AC261066 treatment did not result in respecification of positional 
information during tail regeneration after 21 days, an interesting phenomenon occurred 
after removal of the agonist. Within the first few weeks after being returned to normal 
pond water, the tail began to regenerate again, possibly due to a release of inhibition from 
AC261066. More importantly, 5 weeks after removal fro~AC261 066, it was evident that 
" 
the tail regenerate was altered in the dorsal-ventral plane. More specifically, a larger 
portion of the tail regenerate mass was located in the dorsal region of the tail, compared 
with the ventral region. It is difficult to explain this result, although it is well known that 
RA plays a role in the establishment of dorsal-ventral positional information (McCaffery 
and Drager, 1994; McCaffery et aI., 1999). There is a concentration gradient of all-trans 
RA along the anterior-posterior axis, in addition to the proximal-distal axis in axolotl 
blastemas (although only studied in the limb regenerates). However, it is the RAR82 
isoform that has previously been implicated in playing a role in dorsal-ventral 
-, 
respecification during limb regeneration in newts (Pecorino et aI., 1996). I can thus only 
speculate that the inhibition of NvRARf32 isoform may either have had an indirect effect 
in disrupting the RA gradient, or may have had an indirect effect on the signaling 
mediated by the RAR82 isoform. Alternatively, it is also possible that the NvRARf32 
isoform may play a specific, direct role in dorsal-ventral patterning during tail 
regeneration, but this remains to be determined. 
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In summary, I have cloned the first full-length RAR~2 cDNA from the adult 
newt, N viridescens, an adult species that possesses extensive regenerative capabilities of 
the eNS, limbs and tail. I have also shown for the first time, that an RAR~2 is 
transcribed, and that this transcript is translated within an adult vertebrate spinal cord and 
that treatment with either an RAR~-selective antagonist or an RAR~2-selective agonist 
can inhibit newt tail regeneration. These studies support the previous hypothesis that 
RAR~2 is the key transducer of RA signaling during nerve regeneration, and further 
support the hypothesis that expression of RAR~2 is a marker for neurons capable of 
undergoing regeneration. 
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Chapter 3: 
Developmental expression of a molluscan RXR and 
evidence for its novel, nongenomic role in growth cone 
guidance. 
In manuscript form as: 
Carter CJ, Farrar N, Carlone RL, Spencer GE (2010) Developmental expression of a 
molluscan RXR and evidence for its novel, nongenomic role in growth cone guidance. 
Developmental Biology 343:124-137. 
N. Farrar contributed to Figures 5 and 6 of manuscript only (these correspond to Figs. 24 
and 25 of thesis). 
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3.01 Abstract 
It is well known that the vitamin A metabolite, retinoic acid, plays an important 
role in vertebrate development and regeneration. We have previously shown that the 
effects of RA in mediating neurite outgrowth, are conserved between vertebrates and 
invertebrates (Dmetrichuk et aI., 2005; 2006) and that RA can induce growth cone 
turning in regenerating molluscan neurons (Farrar et aI., 2009). In this study, we have 
cloned a retinoid receptor from the mollusc Lymnaea stagnalis (LymRXR) that shares 
about 80% amino acid identity with the vertebrate RXRa. We demonstrate using Western 
,{ 
blot analysis, that the LymRXR is present in the developing Lymnaea embryo, and that 
treatment of embryos with the putative RXR ligand, 9-cis RA, or a RXR pan-agonist, 
P A024, significantly disrupts embryogenesis. We also demonstrate cytoplasmic 
localization of LymRXR in adult central neurons, with a strong localization in the neuritic 
(or axonal) domains. Using regenerating cultured motorneurons, we show that LymRXR 
is also present in the growth cones, and that application of a RXR pan-agonist produces 
growth cone turning in isolated neurites (in the absence of the cell body and nucleus). 
These data support a role for RXR in growth cone guidance and are the first studies to 
suggest a non-genomic action for RXR in tlie nervous system. 
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3.02 Introduction 
Retinoic acid (RA) is the active metabolite of vitamin A and is well known to 
influence morphogenesis during vertebrate development (Maden and Hind, 2003; Maden, 
2007). It can also act as a trophic factor and has been implicated in neurite outgrowth 
(Corcoran et aI., 2000; Maden et aI., 1998; Wuarin et aI., 1990), and regeneration 
(Dmetrichuk et aI., 2005) of the nervous system. Retinoic acid classically acts through 
nuclear receptors that act as transcription factors to affect downstream activation of 
various genes, including neurotrophins, cytokines, cell s,vrface molecules (reviewed in 
-. 
Gudas, 1994; Mey and McCaffery, 2004) as well as specific genes involved in neurite 
outgrowth, such as NEDD9 (Knutson and Clagett-Dame, 2008) and neuron navigator 2 
(Muley et aI., 2008). The nuclear receptors responsive to RA include the retinoic acid 
receptors (RARs) and the retinoid X receptors (RXRs) and at least 3 classes of each have 
been identified (a, p and y). RARs bind both all-trans and 9-cis RA isomers, whereas the 
RXRs (at least in vertebrates), bind only 9-cis RA (Heyman et aI., 1992). There is 
evidence that both RARs and RXRs playa role in neurite outgrowth and/or neurite 
regeneration; RARP plays a?Iajor role in ,the induction of neurite outgrowth from both 
embryonic (Corcoran et aI., 2000) and adult (Dmetrichuk et aI., 2005) spinal cord 
neurons, while RXR has been suggested to play a role in motor neuron innervation of 
limbs in mice (Solomin et aI., 1998). Both RARs and RXRs are found in vertebrate 
nervous systems, but until recently, it was generally believed that non-chordates 
possessed only RXRs. However, evidence for putative RARs has now emerged from 
EST/genomic databases in annelids and molluscs (Albalat and Canestro, 2009), and a 
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molluscan RAR has now been cloned (Carter and Spencer, 2009; acceSSIOn no. 
GU932671). 
It has become increasingly evident that many effects of retinoic acid are 
conserved between vertebrate and invertebrate species. The presence of RA in 
invertebrates has been implicated by the presence of retinoic acid binding proteins in the 
insect (Mansfield et aI., 1998) shrimp (Gu et aI., 2002) and marine sponge (Biesalski et 
aI., 1992). RA has also been detected in fiddler crab limb blastemas (Chung et aI., 1998) 
and in the locust embryo (Nowickyj et aI., 2008), suggesting a role in both limb 
regeneration and embryonic development. More recentl~, we have shown for the first 
<" 
time that RA is present in the invertebrate CNS (Dmetrichuk et aI., 2008) and 
demonstrated that (in the absence of other neurotrophic factors), it induces neurite 
outgrowth as well as growth cone turning in cultured neurons of the mollusc, Lymnaea 
stagnalis (Dmetrichuk et aI., 2006; Dmetrichuk et aI., 2008; Farrar et at, 2009). The 
mechanisms underlying the neurotrophic and chemotropic effects of retinoic acid in 
Lymnaea, are, at present, largely unknown, though we have recently shown that the RA-
induced growth cone turning involves a non-genomic mechanism that requires protein 
synthesis and calcium influx (Farrar et at, 2009). 
-. 
In this study, we have cloned a RXR from the CNS of Lymnaea that demonstrates 
a high sequence homology with the vertebrate RXRu. Our aim was then to determine 
whether this Lymnaea RXR plays a role in either embryonic development and/or 
neuronal regeneration of central neurons in Lymnaea stagnalis. 
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3.03 Materials and Methods 
Cloning of L. stagnalis RXR 
Lymnaea stagnalis used in this study were laboratory bred and kept in aerated, 
artificial pond water and fed lettuce and NutraFin Max Spirulina fish food (Hagen). RT-
PCR was performed on cDNA generated from total RNA extracted from the Lymnaea 
CNS. Briefly, reverse transcription was carried out with a mixture of poly A and random 
hexamer primers according to the iScript cDNA synthesis kit (BioRad). cDNA was then 
amplified with 40 pmol of forward (5'-CGA CAA AAG ACA GAG AAA CAG ATG 
YCA RTA YTG-3 ') and reverse (5'-GTC TCT GAA GTb TGG GAT TCT TTT NGC 
CCA YTC-3 ') degenerate primers. After 3 min of denaturation at 95°C, 35 cycles at 95°C 
for 30 sec, annealing at 55°C for 30 sec and elongation at 72°C for 1 min were performed 
with an Eppendorf Mastercycler Personal Thermocycler. Analysis of the product was 
carried out on 1 % agarose gels in T AE buffer stained with ethidium bromide. Fragments 
of interest were excised from the gel and cloned into the pGemTEasy vector system 
(Promega). Sequencing was performed by GenomeQuebec (Montreal, Canada) using 
3730xl DNA Analyzer systems from Applied Biosystems. Full-length cDNA was 
obtained by performing multiple rounds of 5' and 3' RACE with cDN A prepared from the 
same Lymnaea CNS preparations with the SMART RACE cDNA amplification kit 
(Clontech). 
Antibodies 
We designed antibodies against a synthetic peptide from the predicted 'hinge' 
region of the Lymnaea RXR covering the amino acid residues 183-198 between the DNA 
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binding domain (DBD) and ligand binding domain (LBD). This custom made LymRXR 
antibody was produced in New Zealand white rabbits and affinity purified from the 
antisera by Pacific Immunology Corp. (Ramone, California, USA). In some Western 
blotting procedures, a commercial antibody against human GAPDH (Abcam Inc.) was 
used as a cytosolic fraction marker, and a commercial antibody against human actin 
(Sigma-Aldrich) was used as a control. 
Lymnaea embryos 
In order to investigate L ymRXR protein levels dur~pg Lymnaea development, egg 
" 
masses were first incubated in pond water at 25°C and allowed to reach various stages of 
development, as described in Nagy and Elekes (2000). These stages included day 0 of 
embryogenesis (when egg mass is first laid and prior to first cleavage), the trochophore 
stage (approx 36 to 60 hrs of embryogenesis), the veliger stage (approx 60 to 96 hrs of 
embryogenesis), the adult-like stage just prior to hatching (96 to 192 hrs of 
embryogenesis) and hatchlings. When the embryos reached the desired stage, the 
capsules were removed from their gelatinous surroundings and total protein extracted and 
Western blotting performed, according to the protocol listed below for adult CNSs. These 
-.. 
experiments were performed twice. 
To determine if LymRXR plays a role in Lymnaea development, embryos were 
incubated in a synthetic RXR agonist (PA024, a kind gift from Dr. H. Kagechika, Tokyo) 
and 9-cis RA (Sigma-Aldrich). At day 0 of embryogenesis (when egg mass is first laid), 
capsules were teased out of the gelatinous surroundings in which they were embedded, 
and maintained in pond water at 25°C for 30 hrs (until the end of the gastrulation stage). 
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This separation of the capsules increased probability of penetration of the agonist P A024 
and 9-cis RA, while still allowing normal development of the egg inside the capsule 
(Creton et aI., 1993). The RXR agonist PA024 (10-7M), 9-cis RA (10-7M), or DMSO 
(0.001 %, vehicle control) were added to separate dishes of embryos at 30 hrs of 
embryogenesis (this was previously shown to be the most sensitive stage to disruption by 
RA; Creton et aI., 1993). At days 6-7 of embryogenesis, embryos showing eye and/or 
shell malformations, or arrested development at the trochophore stage, were scored and 
compared with the DMSO control embryos. These experiments were also performed 
twice with incubation of embryos in RXR antagonists alo~ (P A452, 10-6M; HX531, 10-
" 
6M, both a kind gift from Dr. H. Kagechika, Tokyo) in the exact same manner as 
described above. Statistical analysis was comprised of multiple Fisher Exact tests that 
were then Bonferroni-Holm corrected. 
Western Blotting 
To investigate the expression of LymRXR protein, the adult Lymnaea CNS (or 
whole embryos) were homogenized in lysis buffer containing 150mM NaCI, 50mM Tris 
HCI (pH7.5), 10 mM EDTA, 1% Trition X-100, ImM PMSF and 0.01% Protease 
· -t. 
Inhibitor Cocktail (Sigma-Aldrich) with a PowerGen handheld homogenizer (Fisher 
Scientific). The homogenates were centrifuged 20,000 x g at 4°C for 30 minutes. 15j.lg of 
protein from each extract was separated on a discontinuous SDS-polyacrylamide gel 
(12% Resolving, 4% Stacking) and electroblotted onto a nitrocellulose membrane 
(BioRad). For embryo experiments, gels were electrophoresed in duplicate under 
identical conditions; one was stained with Commassie blue to ensure equal loading of 
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protein, and the other was subjected to Western blot analysis. The membranes were 
washed for 5 minutes in lxPBS and then blocked in lxPBS/O.l % Tween-20 (PBT) with 
3% skim milk powder (w/v) for I hour. The membranes were then incubated with 
affinity purified Lymnaea RXR antibody at a dilution of 112500 in PBT/3% skim milk 
overnight at 4°C with gentle horizontal shaking. This was followed by 4 x 5 min washes 
at RT in PBT and incubation with a 1115000 dilution of AlexaFluor 680 goat anti-rabbit 
secondary antibody (Invitrogen). After 4 x 5min washes in PBT and one wash in lxPBS, 
the membranes were imaged with the LI-COR Odyssey Infrared Imaging System at 
700nrn wavelength. 
To investigate the subcellular expression of LymRXR in the Lymnaea CNS, as 
well as in embryos just prior to hatching, total protein from the cytoplasmic, membrane 
and nuclear compartments was isolated according to directions from the Qproteome Cell 
Compartment kit (Qiagen). These protein fractions were loaded onto a discontinuous 
SDS-polyacrylamide gel and LymRXR was detected by Western blotting technique as 
previously described above. Anti-GAPDH (Abcam Inc.) was used as a cytosolic fraction 
marker and successful isolation of protein from all three compartments of the CNS was 
confirmed by staining for actin. These experiments were performed twice for embryos 
-.. 
and four times for the adult CNS. 
Immunostaining 
For immunostaining, the CNSs isolated from the snails were fixed in 4% 
paraformaldehyde in PBS at 4°C overnight and washed in 10% sucrose/PBS for 2 hours, 
20% sucrose/PBS for 2 hours, and then 30% sucrose/PBS overnight at 4°C. After 
83 
embedding the fixed CNSs in Optimal Cutting Temperature (O.C.T.) Compound (Tissue-
Tek), serial 20~m sections were cut using a cryostat (Leica microsystems) and placed on 
Superfrost Plus slides (Fisher Scientific). For immunostaining of cultured neurons 
following outgrowth (24 to 36 hrs), cells were fixed in 4% paraformaldehyde in PBS at 
4°C overnight. Form this point on, all immunostaining procedures were the same for 
CNSs and cultured neurons. The samples were washed in PBS and then permeablized in 
0.3% Triton X-I00 in PBS (PBT) for 20 min and blocked in 5% normal goat serum 
(NGS) in PBT for 1 hour at RT. The samples were then incubated with the primary 
LymRXR antibody diluted 1:100 in blocking solution a~( 4°C overnight. As a control, 
-; 
preparations were also incubated only in blocking solution, without the primary antibody, 
at 4°C overnight. All samples were then washed in PBT 3 x 5 minutes and incubated in 
1 :500 dilution of Alexa Fluor 488 goat anti-rabbit secondary antibody (Invitrogen) in 
blocking buffer at RT for 2 hours. The samples were washed in 3 x 5 min in PBT and 
counterstained with DAPI for 2 min to visualize the nuclei. After a brief wash in PBS, the 
specimens were coverslipped with anti-fade Fluorosave mounting media (Calbiochem). 
Cell culture procedures 
All cell culture procedures were performed as described previously (Dmetrichuk 
et aI., 2006; Farrar et aI., 2009; Ridgway et aI., 1991). Briefly, under sterile conditions, 
the central ring ganglia were isolated, subjected to a number of antibiotic washes and 
enzymatic treatment, and then pinned down in a dissection dish and bathed in high 
osmolarity (L-15 derived) Defined Medium (DM) (Ridgway et aI., 1991). Using a pair of 
fine forceps, the connective tissue sheath surrounding the ganglia was removed and 
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identified Pedal A (PeA) motorneurons were individually extracted using gentle suction 
applied via a fire-polished pipette attached to a micro-syringe. The individual identified 
PeA somata were plated directly on poly-L-Iysine coated dishes (onto a glass coverslip) 
containing brain-conditioned medium (eM) (Wong et al., 1981) and all-trans RA (l0-7M) 
to promote outgrowth. Cells were maintained in the dark at 22°C overnight. An inverted 
microscope (Zeiss Axiovert 200) was used for all phase and fluorescent imaging of 
cultured cells. 
Growth cone assays 
Growth cone assays were performed in an identical manner to those described in 
detail elsewhere (Farrar et al., 2009). Briefly, a pressure pipette (Eppendorf-Femtojet; 4-
811m) containing 9-cis RA (1O-5M), or the RXR agonist, PA024 (l0-5M or 10-6M) was 
positioned 50 to 100 11m from an actively growing growth cone. Pressures between 5 and 
12hPa were used to apply the agonists, while holding pressures of 1-2hPa were used 
during rest periods to prevent backflow of bath solution. Concentrations detected at the 
growth cone were likely 100-1000 times less than those present in the pipette (Lohof et 
al., 1992). Control experime~ts using the p'MSO vehicle solution for the agonist (0.1 %) 
were performed in the exact same manner. For isolated growth cone experiments, 
neurites were mechanically separated from the cell body using a sharp glass electrode 
(Farrar et al., 2009). In order to test whether the RXR agonist-induced turning was 
inhibited in the presence of RXR antagonists, P A024 was applied to the growth cones, 
either in the presence of bath-applied DMSO vehicle control (final bath concentration 
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0.01 %), or in the presence of the RXR antagonists PA452 (final bath concentration 10-
6M) or HX531 (final bath concentration 1O-6M). 
Growth cone behaviour in both intact and isolated neurites in response to drug 
application was monitored for at least one hour, and the maximum turning angle 
recorded. A one-way analysis of variance (I-way ANOVA) was performed on growth 
cone data sets, and a Tukey-Kramer post-hoc test was used to determine statistical 
significance. Results are expressed as mean ± standard error of the mean (SEM) and were 
deemed significant when p<0.05. 
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3.04 Results 
Sequencing of LymRXR 
Using RT-PCR with degenerate primers designed from other known RXR sequences, we 
obtained an initial cDNA fragment from the CNS of Lymnaea stagnalis. A full-length 
RXR cDNA was elucidated by multiple rounds of 5' and 3' RACE from the initial cDNA 
clone. The final full-length cDNA we obtained was 1593bp, with a 1308bp major open 
reading frame that encodes for a 436aa RXR protein (we termed LymRXR; accession no. 
AY846875). This LymRXR has an overall amino acid igentity of 97% with the RXR 
.; 
from a closely related mollusc, Biomphalaria glabrata (BgRXR; accession no. 
AAL86461). Of the various vertebrate RXR subtypes, LymRXR is most similar to the 
RXRa subtype. The predicted DNA-binding domain (DBD) of LymRXR shares ~89% 
amino acid identity with the Rattus norvegicus RXRa (accession no. NP 036937), while 
the predicted ligand-binding domain (LBD) shares ~81 % amino acid identity with rat 
RXRa (Fig. 20). 
LymRXR in the developing embryo 
RA, acting as a transcriptional activator, is well known to playa role in vertebrate 
development. Our first aim following the identification of LymRXR, was thus to 
determine whether the RXR protein was present in the developing Lymnaea embryo. 
Lymnaea embryogenesis is intracapsular, lasting about 8 days in total. There are three 
major developmental stages, defined as the trochophore stage (approx 36 to 60 hrs of 
embryogenesis,), veliger stage (60 to 96 hrs of embryogenesis) and the postmetamorphic 
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Figure 20. The Lymnaea RXR sequence. Multiple sequence alignment of the Lymnaea 
stagnalis RXR (LymRXR; accession no. AY846875), Biomphalaria glabrata RXR 
(BgRXR; accession no. AAL86461), Rattus norvegicus RXR alpha (RatRXRalpha; 
accession no. NP 036937) and the amphioxus, Branchiostoma jloridae RXR 
(AmphiRXR; accession no. AAM46151) proteins. Note the high conservation of amino 
acids in the DNA-binding domain (DBD) and the ligand-binding domain (LBD). Amino 
acid residues reported to interact with the RXR natural ligand 9-cis RA (Egea et aI., 
2000) are indicated by green circles above the aligned sequences. 
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stage (96 hrs to hatching). It is during the veliger stage where ganglia are first detected 
(Nagy and Elekes, 2000) and many of the organs begin to develop (Meshcheryakov, 
1972). Following hatching at about 8 days, the animal starts its juvenile, free-living 
existence. 
A custom made antibody against a synthetic peptide from the 'hinge' regIOn 
between the DBD and LBD was used to detect the LymRXR protein during the various 
stages of embryogenesis. Western blot analysis of Lymnaea embryo total protein revealed 
a band of approximately 47 kDa in size, close to the predicted molecular weight of 48kDa 
(Fig. 2lA). LymRXR protein was present as early as the ~rpchophore stage (approx 36 to 
60 hrs) and was present in all subsequent stages studied, with its expression appearing 
maximal at the hatchling stage (Fig. 21A). RXR is typically known for its role as a 
nuclear hormone receptor and transcription factor. Thus, in order to determine its nuclear 
localization in cells of the Lymnaea embryo, total protein fractions were isolated from the 
cytoplasm, membrane and nucleus of embryos, immediately prior to hatching, using a 
Qproteome Cell Compartment kit (Qiagen). Western blot analysis showed a positive 
signal for RXR in the nuclear compartment of embryos, but also in the cytoplasmic and 
membrane compartments (Fig. 21B). 
It is well documented that disruptions of RA signaling in vertebrates, 
either by inhibition of its synthesis, or by exogenous addition of RA, can lead to a wide 
array of developmental defects in limb, CNS and main body axis formation (Durston et 
aI., 1989; Sive et aI., 1990; Stratford et aI., 1996). Creton et aI., (1993) have also 
previously shown that RA disrupted embryogenesis in Lymnaea, mainly by affecting eye 
and shell development. Having determined that RXR is present in the embryo, we next 
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Figure 21. Embryonic RXR plays a role in Lymnaea development. (A) Western blot 
analysis at five different stages of Lymnaea embryogenesis revealed its presence as early 
as the trochophore stage, and showed maximal expression at hatching. A commassie blue 
stain of the acrylamide gel, prior to transfer, was used as a loading control. (B) Western 
blot analysis performed on subcellular fractionations o(~mbryos, using the LymRXR 
antibody, showed a signal in the cytoplasmic, membrane and nuclear compartments. 
Actin staining as a control also showed staining in all three compartments. (C) DMSO 
(0.001 %) added to the Lymnaea embryos as a vehicle control, did not affect development. 
All of the animals showed normal eye and shell development (compared to embryos in 
the absence of DMSO). Green arrows indicate the outline of the normally developed 
shell, and yellow arrows indicate the presence of both eyes. Scale bar: 200llm. (Di) 
Representative image of a control embryo in DMSO showing the clear presence of an eye 
(yellow arrow) (ii) Representative example of an under-developed eye, reduced in size 
(yellow arrow), following incubation in the natural RXR ligand, 9-cis RA (l0-7M); (iii) 
Representative example of an embryo missing an eye (yellow arrow indicates where eye 
should be located) following incubation in the synthetic RXR agonist PA024 (l0-7M); 
Scale bar (Di-iii): 150llm (E) Green arrows indicate malformation of the shell following 
incubation in 9-cis RA (l0-7M); Scale bar: 200llm (F) PA024 halted some embryos at the 
trochophore stage. Scale bar: lOOllm. For graphs (G) through (J), 9-cis RA (n=40) and 
PA024 (n=40) treatments were compared to the DMSO (n=40) treatment (* p<0.05, ** 
p<O.Ol). 
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aimed to determine whether known RXR agonists/ligands would disrupt the normal 
pattern of development in Lymnaea. We also used eye and shell formation as indicators 
of normal growth because these are easily visualized and characterized using light 
microscopy, shortly after the veliger stage. Eyes normally become pigmented at the end 
of the veliger stage (at about 96 hrs) and the shell extends over the visceral masses just a 
few hours later (Nagy and Elekes, 2000). 
Lymnaea embryos were maintained within their capsules, but were removed 
from their gelatinous surroundings. Capsuled embryos were treated with a synthetic RXR 
pan-agonist, PA024 (l0-7 M; n = 40), the putative RXR ligpnd, 9-cis RA (l0-7M; n = 40), 
-; 
and DMSO as the vehicle control (0.001 %; n = 40). These treatments were started at the 
gastrula stage (30 h) and continued for the next 5 days of embryonic development. In the 
presence of DMSO, both shell (Fig. 21C) and eye (Fig. 21C, Di) development appeared 
normal. However, we found that treatments with 9-cis RA and P A024 produced defects 
in both eye (Fig. 2IDii-iii, G) and shell formation (Fig. 2IE, H) in a significant number 
of embryos. Eye defects included either missing eyes (Fig. 2lDiii), or those noticeably 
reduced in size (Fig. 2lDii). Interestingly, PA024 displayed a higher number of 
abnormalities than 9-cis RA, including a number of embryos that exhibited halted 
development at the trochophore stage (Fig. 2lF, J). 
Similar experiments were next performed with incubation of embryos in RXR 
antagonists, in order to determine the effect of inhibiting RXR signaling during 
embryogenesis. Incubation in the RXR antagonist, HX53I (l0-6M), produced shell 
defects in all embryos (48 of 48 embryos; 100%), but not in eye development (0 of 48 
embryos; 0%). Interestingly, incubation in the RXR antagonist, P A452 (l0-6M), did not 
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produce any observable defects in either eye or shell development (0 of 44 embryos; 0%; 
data not shown). 
Together, these data strongly suggest a role for RXR in Lymnaea development. 
LymRXR is present in the adult eNS 
We have previously shown that both all-trans RA and 9-cis RA exert trophic and 
tropic effects on adult CNS neurons of Lymnaea (Dmetrichuk et aI., 2006; Dmetrichuk et 
aI., 2008), but little is known of the underlying cellular and molecular mechanisms. We 
next aimed to determine whether RXR expression is main~~ined following the embryonic 
-; 
stages and specifically, to determine whether it is present in the adult (non-regenerating) 
CNS. Western blot analysis of adult Lymnaea CNS total protein again revealed a band of 
approximately 47 kDa in size (Fig. 22A). Using the same LymRXR-specific antibody, 
we next performed immunohistochemistry on frozen sections of acutely isolated 
Lymnaea CNSs (n=30). Immunoreactivity was detected in neurons of all central ganglia. 
There was strong immunoreactivity in the neuropil and nerve bundles radiating from the 
brain, suggesting staining of the axonal tracts (Fig. 22B, D). Interestingly, there was little 
to no apparent staining of RXR (traditionally considered to be a nuclear receptor) in the 
-. 
nuclear region of the neurons, given that there was no RXR signal overlapping with the 
nuclear DAPI staining (Fig. 22C). Some ganglia also showed strong punctuate-like 
staining around the periphery of the ganglia (Fig. 22D), which may have been due to 
RXR immunoreactivity of glial networks and cell bodies in the neural sheath. Control 
CNS sections with no primary antibody added (n=6) demonstrated no immunostaining 
(Fig. 22E). 
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In order to confinn the neuritic localization of RXR, immunofluoresence was also 
perfonned on acutely isolated axons. During cell isolation from the intact ganglia, axonal 
segments up to ~200 )lm in length can be acutely isolated, removed from the cell body 
and then plated in cell culture (Spencer et aI., 2000). We showed that LymRXR 
immunostaining was indeed present in the acutely isolated axons in culture (n = 3 of 3; 
Fig. 22F), which confinned the above observation that RXR is present in the neuritic 
processes of neurons in the intact, adult CNS. 
To further identify the neuronal compartmentalization of LymRXR in the adult 
CNSs, we isolated total protein fractions from the cytopl,~;;m, membrane and nucleus of 
the adult Lymnaea CNS using a Qproteome Cell Compartment kit (Qiagen). In Fig. 22G, 
Western blot analysis showed a positive signal for RXR in the cytoplasmic and 
membrane compartments, but not in the nucleus. Successful isolation of protein in the 
nuclear fraction was confinned by staining for actin, which is now well known to reside 
in the nucleus (Fig 22J) (Bettinger et aI., 2004; Franke, 2004). Anti-GAPDH was also 
used as a control on the same protein fractions and as expected, GAPDH showed only 
positive immunoreactivity in the cytoplasmic compartment (Fig. 22H). In order to further 
confinn the absence of nuclear RXR in the adult CNS cellular fractions, two additional 
' .. 
CNS samples were again run, but this time in parallel with embryonic tissue. In the CNS 
fractions, the RXR was present in both cytoplasmic and membrane compartments, but 
was again absent in the nuclear compartment (data not shown), whereas the embryonic 
fractions revealed nuclear RXR (as seen in Fig. 21B). 
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Figure 22. Cytoplasmic localization of LymRXR in the adult, non-regenerating 
nervous system. 
(A) Western blot analysis of total protein extracted from the Lymnaea CNS showed a 
band near 47 kDa that closely matches the predicted molecular weight of LymRXR from 
our cloned sequence. (B) and (C) LymRXR immunoreactivity was detected in the neurons 
of ganglia of the CNS (Visceral ganglion shown), primarily in the cytoplasm of the cell 
body (yellow arrow), axons (red arrow), neuropil (blue arrow) and nerve bundles 
radiating from the brain (purple arrow). Note the absence,pf RXR staining in the nuclei, 
stained blue using DAPI (C; white arrow). Scale bars: l00/-lm. (D) Some ganglia (Right 
Pedal ganglion shown) produced strong punctuate-like staining near the periphery (white 
arrow). Scale bar: 50/-lm. (E) Control staining was also performed under the same 
conditions, only in the absence of the primary LymRXR antibody. No immunostaining 
was visible (inset is a phase-contrast image of the same ganglia). Scale bar: lOO/-lm. (F) 
Acutely isolated axons from the Lymnaea CNS, plated in vitro, also displayed strong 
immunoreactivity. Inset is a phase-contrast image ofthe same axon. Scale bar: 30/-lm. (G) 
Western blot performed on subcellular fractionations using the LymRXR antibody, 
showed a signal in the cytoplasmic (Cyt) and membrane (Mem) compartments, but not in 
the nuclear (Nuc) compartment. (H) GAPDH is an abundant glycolytic enzyme in 
cytoplasm, and a GAPDH antibody, used as a control, showed signal only in the 
cytoplasmic compartment of the same samples. (J) Actin staining served as a positive 
control to demonstrate successful isolation of protein from the nuclear compartment. 
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LymRXR is present in the neurites and growth cones of regenerating cultured 
neurons 
Retinoic acid is known to promote neurite regeneration in many species, including 
neurons from Lymnaea (Dmetrichuk et aI., 2006; Dmetrichuk et aI., 2008). Our next aim 
was to determine the localization of RXR immunofluorescence in regenerating central 
neurons in culture. PeA motomeurons were individually isolated from the intact ganglia 
and given 24-36 hours to regenerate in cell culture (Fig. 23Ai). Following outgrowth, 
cells were then fixed and stained with the LymRXR antibody. RXR immunoreactivity 
was visualized in the cell body of every cultured PeA neuron, whether it was actively 
J 
regenerating neurites or not (n = 96 of 96). In the neurons that displayed outgrowth (n = 
35), RXR immunoreactivity was observed in the majority of neurites (Fig. 23Aii), though 
there appeared to be a differential distribution of the RXR signal in the neurites of some 
cells. Figure 23Bii illustrates an example of a neurite emanating from a cell body that 
displayed strong immunoreactivity over most of its length, while another neurite from the 
same cell body showed very little RXR staining. Furthermore, while most of the growth 
cones located at the tips of the neurites, demonstrated positive immunoreactivity for RXR 
(n = 95 of 102), there were some neurites that displayed little, if any RXR staining along 
the neurite leading to the gr6wth cone. Immunostaining of the RXR was evident in the 
central or C-domain of the growth cones, but very little to no staining was evident in the 
peripheral or P domain (lamellipodia and filopodia; Fig. 23Cii). Control regenerating 
PeA neurons, under the same staining conditions except in the absence of primary 
antibody, did not demonstrate RXR immunoreactivity (n = 6; data not shown). 
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Figure 23. LymRXR is present in the neurites and growth cones of regenerating 
motorneurons in vitro. (Ai) Phase-contrast image of a cultured Lymnaea Pedal A neuron at 
48 hrs in CM, with regenerated neurites. (Aii) Immunostaining of the same PeA cell with 
LymRXR antibody revealed a signal in the cytoplasm of the cell body and the regenerating 
neurites. Scale bars Ai-ii: 50llm. (Bi) Phase-contrast image of two neurites from the same 
cell. (Bii) Immunostaining with the LymRXR antibody showed differential staining in the 
two branches. White arrows indicate staining of one branch, while the other branch displayed 
little, to no staining (red arrow). Scale bars Bi-ii: 20llm. (Ci) Phase-contrast image of a PeA 
growth cone in vitro. (Cii) Immunostaining with the LymRXR antibody showed a signal in 
the neurite leading to the growth cone (X), in the central domain of the growth cone (D), but 
no staining in the lamellipodia and filopodia (F). Scale bars Ci-ii: 101lm. 
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An RXR agonist induced growth cone turning 
. We have previously shown that retinoic acid (both all-trans and 9-cis isomers) 
can induce positive growth cone turning of regenerating Lymnaea growth cones 
(Dmetrichuk et al., 2006; Dmetrichuk et al., 2008; Farrar et al., 2009). We have also 
shown that this growth cone turning is dependent on protein synthesis and calcium influx 
(Farrar et al., 2009). Because we had demonstrated that this turning response occurred in 
isolated growth cones and involved a localized, non-genomic mechanism, we had not 
previously investigated a role for the retinoid receptor. However, having now determined 
that the RXR is present in the regenerating growth .:,"ones and neurites, we next 
investigated whether it was involved in the localized growth cone turning response to 
RA. 
We have previously reported growth cone turning toward 9-cis RA in VF neurons 
(Dmetrichuk et a1., 2008). However, 9-cis RA was applied again in this study, in order to 
directly compare its effects on PeA growth cone behaviour, with those of a RXR agonist. 
Here, we showed that 9-cis RA produced attractive growth cone turning of intact PeA 
neurites with an average turning angle of 24.8 ± 7° (n = 6; Fig. 24Ai-iii). We next 
pressure applied the RXR pan-agonist P A~~4, on to the PeA growth cones, to determine 
whether it would mimic the growth cone turning induced by 9-cis RA. Indeed, P A024 
induced positive growth cone turning of intact neurites with a mean angle of 30.6 ± 4.0° 
(n = 14; Fig. 24Bi-iii). As PA024 is dissolved in DMSO, control experiments with 
DMSO in the pipette were also performed and were shown not to produce positive 
growth cone turning (-16.9 ± 8.3°; n = 7; Fig. 24Ci-iii). Statistical analysis revealed that 
growth cone turning toward the RXR agonist P A024, was significantly different from the 
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Figure 24. Intact PeA growth cones turn toward the RXR agonist. (Ai-ii) Representative 
example of a PeA growth cone turning toward 9-cis RA (}: 0 mins; ii: 27 mins after start of 
application). Approximate pipette location is indicated. Scale bar: 30Jlm. (Aiii) Histogram 
depicts maximum turning angle of intact growth cones to 9-cis RA and each bar represents 
one growth cone. Positive values represent a tum toward the pipette and negative values a 
tum away from the pipette. (Bi-ii) Representative example of a PeA growth cone turning 
toward the RXR pan-agonist P A024 (i: 0 mins, ii: 60 mins after start of application). Scale 
bar: 30Jlm. (Biii) Histogram depicts maximum turning angle of intact growth cones to PA024 
and each bar represents one growth cone. Positive values represent a tum toward the pipette 
and negative values a tum away from the pipette. (Ci-ii) Representative example of a PeA 
growth cone that did not tum toward DMSO (vehicle control) (i: 0 mins, ii: 26 mins after 
start of application). Scale bar: 30Jlm. (Ciii) Histogram depicts maximum turning angle of 
intact growth cones to DMSO and each bar represents one growth cone. Positive values 
represent a turn toward the pipette and negative values a tum away from the pipette. 
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Figure 25. Isolated PeA growth cones turn toward the RXR agonist. Neurites were 
physically isolated from the cell bodies and the RXR agonist PA024 was applied to the 
isolated growth cones. (A) Representative example of an isolated growth cone turning toward 
PA024 (i) before PA024 application and following (ii) 8 mins, (iii) 17 mins and (iv) 30 mins 
of PA024 application. Scale bar: 25~m. (B) Histogram depicts maximum turning angle of 
isolated growth cones to P A024 and each bar represents one growth cone. Positive values 
represent a tum toward the pipette and negative values a turn away from the pipette. (C) 
Summary graph of mean growth cone turning angles under all conditions. Error bars 
represent standard error of the mean (S.E.M.). * p<0.05 when compared to DMSO controls. 
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DMSO control (p < 0.05), but was not significantly different from growth cone turning 
toward 9-cis RA. 
We previously showed that neurites physically transected and isolated from their 
cell body could also tum toward RA, demonstrating that a local mechanism was 
involved. We next aimed to determine whether the RXR agonist would also induce 
turning in growth cones of transected neurites, physically isolated from their cell body. 
Once again, PA024 induced attractive growth cone turning (Fig. 25A) with a mean angle 
of 23.9 ± 13.80 (n = 11; Fig. 25B), which was not significantly different from that 
produced by PA024 in intact neurites (data summarized il)(Fig. 25C). These data suggest 
", 
that RXR, located in neurites and growth cones of regenerating neurons, plays a novel, 
non-genomic role in RA-induced growth cone turning, at least in Lymnaea PeA 
motorneurons. 
The RXR agonist-induced growth cone turning is inhibited in the presence of an 
RXR antagonist 
We next aimed to determine whether we could block the RXR agonist-induced 
growth cone turning in the presence of a RXR antagonist. First of all, we showed that 
application of the RXR agonist PA024 (lO-6M) to intact PeA growth cones in the 
presence of the vehicle control (DMSO; 0.01%) produced growth cone turning (Fig. 
26Ai-ii) with a mean angle of 36.3 ± 8.70 (n = 7; Fig. 26B). We next applied the RXR 
agonist PA024 (l0-6M) in the presence of the RXR antagonist PA452 (final bath 
concentration 10-6M). In the presence of the RXR antagonist P A452, the mean turning 
angle in response to application of the agonist, was significantly reduced to 3.3 ± 10.30 (n 
= 9; P < 0.05; Fig. 26E). However, despite the overall reduced mean turning angle, 6 of 
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Figure 26. The agonist-induced growth cone turning is inhibited by RXR 
antagonists. The RXR agonist, P A042 was pressure applied (10-6M) to intact PeA 
growth cones, in the presence of either DMSO (vehicle), or RXR antagonists in the bath. 
(A) An example of a growth cone that turned toward the RXR agonist PA024, in the 
presence of bath-applied DMSO (0.01%). i) Before application of PA024 and ii) 
following 29 mins of application. Note that the growth ,Vone continued to grow in the 
direction of the pipette. Scale bar: 30 !lm. B) Histogram <depicts turning angles of intact 
growth cones to PA024 in the presence of DMSO, and each bar represents one growth 
cone. C) Representative example of a growth cone that turned toward P A024 in the 
presence of bath-applied RXR antagonist, PA452 (1O-6M). i) before application of 
PA024 and ii) following 35 mins of application. Scale bar: 30!lm. D) Representative 
example of a growth cone that turned away from P A024 in the presence of bath-applied 
RXR antagonist, PA452 (10-6M). i) before application of PA024 and ii) following 14 
mins of application. Scale bar: 30!lm. E) Histogram depicts turning angles of intact 
growth cones in response to P A024 in the presence of the RXR antagonist P A452. F) 
Representative example of a growth cone that turned away from P A024 in the presence 
of bath-applied RXR antagonist, HX531 (1O-6M). i) before application of PA042 and ii) 
following 49 mins of application. Scale bar: 30!lm. G) Histogram depicts turning angles 
of intact growth cones to PA024 in the presence of the RXR antagonist HX531. H) 
Summary graph of mean growth cone turning angles in response to PA042 , in the 
presence of either DMSO or RXR antagonists. Error bars represent standard error of the 
mean (S.E.M.). * p<0.05 and.** p<O.Ol, w~en compared to DMSO controls. 
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the 9 growth cones maintained a positive turn toward the RXR agonist in the presence of 
PA452 (Fig. 26Ci-ii), with an average turning angle of 22.5 ± 4.0°. The remaining 3 
growth cones turned away from the pipette (Fig. 26Di-ii), with a mean turning angle of 
-35± 12.3° (n = 3). 
We next chose to use a different RXR antagonist, HX531, to determine whether 
we could block the agonist-induced growth cone turning. In these experiments, we 
recorded the growth cone turning angle in response to application of the RXR agonist, in 
the presence of HX531 (lO-6M). This time, the growth cone turning toward P A024 was 
completely abolished in 9 of the 10 growth cones tested (pig. 26Fi-ii). The mean turning 
angle in the presence of HX531 was -19.4 ± 7.5°, away from the pipette (Fig. 26G), 
which was significantly different from the turning angle in DMSO (p < 0.01; Fig. 26H). 
We also confirmed that the turning of isolated PeA growth cones toward the RXR agonist 
was abolished in the presence of HX531 (n = 4 of 4; data not shown). 
In summary, these data suggest that RXR, located in neurites and growth cones of 
regenerating neurons, plays a novel, non-genomic role in RA-induced growth cone 
turning, at least in Lymnaea PeA motorneurons. 
106 
3.05 Discussion 
In this study, we have cloned a full-length RXR from the mollusc, Lymnaea 
stagnalis, and have shown that this retinoid receptor is present in the developing embryo, 
as well as in the non-regenerating, adult eNS, where it was found in the neuritic domains 
of central neurons. Using regenerating cultured motomeurons, we have provided 
evidence that it plays a role in the chemotropic response of growth cones to retinoic acid. 
RXRs are highly conserved members of the steroid/retinoid family of nuclear 
hormone receptors and have been identified in species ranging from the phylogenetically 
,{ 
oldest metazoan phylum, (the sponge), to mammals< (Mangelsdorf et at, 1992). 
Interestingly, the RXR from Lymnaea (a lophotrochozoan, non-chordate mollusc and true 
invertebrate outside of the chordate lineage) shows higher amino acid identity with the rat 
RXRa than the RXR from Polyandrocarpa, a urochordate species and closest living 
relative of the vertebrates (Borel et aI., 2009). Furthermore, it has previously been shown 
that a molluscan RXR (from Biomphalaria glabrata; BgRXR) functionally interacts with 
vertebrate RXR binding partners, strongly suggesting that retinoid signaling may be 
shared between the lophotrochozoan branch of the protostomes, and the deuterostomes 
(which contain the chordate branch). 
RXRs from mammals have been studied most extensively, and it has been shown 
that they can form homodimers, heterodimers or even homotetramers, and regulate target 
gene expression when bound with their proposed ligand, 9-cis RA (Kersten et at, 1995). 
Interestingly, the amino acids in mouse RXR that interacted with 9-cis RA (Egea et at, 
2000) are all perfectly conserved in the BgRXR sequence (Bouton et aI., 2005) as well as 
in our LymRXR sequence. The BgRXR can also transactivate transcription when treated 
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with exogenous 9-cis RA (Bouton et aI., 2005). Though there is evidence that 
invertebrate RXRs, like the vertebrate RXRs, bind 9-cis RA (Kostrouch et aI., 1998), a 
recent study showed that both 9-cis and all-trans RA isomers bind with similar affinities 
to the locust RXR (Nowickyj et aI., 2008). All-trans RA also up-regulates RXR mRNA 
in the marine sponge Suberites domuncula (Wiens et aI., 2003) and increases the 
abundance of RXR mRNA in blastemas during limb regeneration in the fiddler crab Uca 
pugilator (Chung et aI., 1998). We have recently shown using HPLC and MS, that both 
9-cis and all-trans RA isomers are present in the Lymnaea CNS (Dmetrichuk et aI., 
2008), and so we cannot rule out that both isomers may b~:paturalligands for LymRXR. 
RXR expression in the developing embryo 
Our results indicate that RXR expression occurred in Lymnaea embryos as early 
as the trochophore stage and continued through the postmetamorphic stage, reaching 
maximal expression at hatching (juvenile form). We do not know whether this expression 
occurred in the nervous system, or whether it was associated with other organs. However, 
demonstration of RXR expression at the veliger stage correlates with the first 
ultrastructural detection of cerebral and pedal ganglia (Nagy and Elekes, 2000). However, 
-.. 
at this developmental stage, the authors detected only 2 to 3 cells per ganglia, and only a 
small number of axon profiles, with no evidence of filopodial processes or developing 
synapses. In the later stages of embryonic development (postmetamorphic, adult-like 
stage), when we observed increased RXR expression, Nagy and Elekes (2000) observed 
the whole central ring ganglia and neuropil densely packed with axon profiles, though 
there was no evidence of glia or the neural sheath. Interestingly, the authors proposed that 
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the absence of the neural sheath during these stages would facilitate trophic and/or 
hormonal influences in the developing ganglia, which we propose may include trophic or 
tropic support provided by RA. By hatching, at which stage we saw maximal RXR 
expression, Nagy and Elekes (2000) demonstrated that the CNS had significantly 
increased in size, with enlarged neuropil and more axon profiles, as well as the first 
evidence of glia and a neuronal sheath. In summary, we found that RXR is expressed in 
our Lymnaea embryos prior to the metamorphic stage, which is thought to be the time 
when the neuropil is undergoing substantial reorganization, likely indicating a period of 
substantial migration and reorganization ofaxons (Nag~(and Elekes, 2000). It is quite 
-; 
feasible therefore, that the RXR plays a role in Lymnaea nervous system development. 
Creton et al (1993) have previously demonstrated that application of 1O-7M RA 
during the gastrulation stage of Lymnaea embryos, produced only eye defects (no shell or 
CNS deformations), and only in 15% of embryos. In our study, both eye and shell 
deformations were found following incubation in 1O-7M 9-cis RA and P A024. Though 
not explicitly stated, we presume that the isomer used in the previous studies was all-
trans RA, possibly explaining the difference in teratogenicity observed. If this is indeed 
the case, it might suggest that 9-cis RA is a more potent teratogen in Lymnaea than all-
-.. 
trans RA. It should be noted however, that in vertebrates, 9-cis RA activates RARs, in 
addition to RXRs. It is thus possible that 9-cis RA might also be activating an RAR. We 
believe this unlikely, as despite our recent cloning of an RAR in Lymnaea, we have not 
yet been able to detect it in the early embryonic stages of development (Carter and 
Spencer, 2009). This suggests that if the RAR is indeed present, it is likely at much lower 
levels than the RXR. In support of our hypothesis that 9-cis RA is likely acting via the 
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RXR , the effects of 9-cis RA were closely mimicked by P A024, which was developed as 
a RXR-selective agonist (Ohta et aI., 2000). The demonstration that the RXR was present 
in the nuclear compartments of embryonic protein fractions, strongly suggests that the 
teratogenic effects of the RXR agonist and 9-cis RA were likely mediated via genomic 
actions of the RXR. However, we were unable to distinguish cellular localization of the 
RXR in specific tissues of the embryo, and as its presence was also shown in cytoplasmic 
and membrane compartments, we cannot rule out the possibility of non-genomic effects 
during embryogenesis. 
-< 
Cytoplasmic localization of RXR, and its role in growth cone turning behaviour 
Though we could not determine where in the Lymnaea embryo the RXR was 
specifically expressed, we were able to clearly determine the expression and sub-cellular 
localization of RXR in neurons of the adult CNS. We found that LymRXR protein was 
localized to the cytoplasm and membrane of adult neurons, and staining in the neuropil 
strongly suggested localization in the axonal tracts. This axonal staining was further 
confirmed following immunostaining of acutely isolated axonal segments from the CNS, 
plated in culture. These findings were i~!eresting, since RXR traditionally acts as a 
ligand-activated transcription factor and would thus be expected to show nuclear 
localization. Some nuclear receptors, including steroid and thyroid hormone receptors 
can, however, shuttle between the nucleus and cytoplasm (DeFranco, 1997; Kaffman and 
O'Shea, 1999). RXRa also shuttles between the nucleus and cytoplasm (either in the 
absence or presence of its ligand 9-cis RA), and can also act as a shuttle for the orphan 
receptor TR3, a process stimulated by 9-cis RA (Lin et aI., 2004). 9-cis RA was also 
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found to enhance nuclear translocation of RXRa in COS-7 cells, by means of association 
with importin~ bound to a RXRa nuclear localization signal (NLS). Phosphorylation of a 
conserved serine/threonine in the NLS of nuclear receptors inhibits their ability to 
trans locate to the nucleus, and if threonine is mutated into aspartic acid in human RXRa, 
nuclear localization is significantly hindered (Sun et aI., 2007). Our LymRXR protein 
shares an identical NLS with the human RXRa, suggesting that phosphorylation of this 
threonine in LymRXR may playa role in its cytoplasmic localization. 
In embryonic cultured rat hippocampal neurons, RXR isoforms exhibited 
differential nuclear and cytoplasmic staining. All RXR J~oforms except RXR~2, were 
shown to be present in the cytoplasm, but RXRa was the only RXR isoform that was 
expressed in the axonal compartment (Calderon and Kim, 2007). RXRa was also evident 
in the axonal compartment of newly regenerating axons following sciatic nerve crush 
injury (Zhelyaznik and Mey, 2006), possibly supporting a role for RXR in neural 
regeneration. In our regenerating adult Lymnaea neurons, RXR immunoreactivity was 
found in most of the neuritic processes, though some differential distribution between 
neurites of the same cell was observed. The cellular distribution of RXRa has also been 
shown to be time-dependent during regeneration in acutely isolated rat spinal cord tissue, 
.. 
varying between dendritic and nuclear localization, depending on days following surgery 
(Schrage et aI., 2006). Interestingly, these authors also determined the presence of 
retinoid receptors in the cytoplasm of neurons and glia cells in the non-injured spinal 
cord, similar to our observations of LymRXR distribution in the non-regenerating CNSs. 
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Having demonstrated neuritic localization of LymRXR, both in non-regenerating 
and regenerating neurons, we next demonstrated that a RXR pan-agonist, applied to the 
growth cones of cultured PeA motorneurons, induced growth cone turning and mimicked 
the growth cone response to 9-cis RA (and all-trans RA seen previously; Dmetrichuk et 
aI., 2008). We should note however, that this RXR pan-agonist was designed for the 
vertebrate RXR and we have no knowledge of its binding affinity to the LymRXR, 
(though our LymRXR shows over 80% homology to the LBD of vertebrate RXRa and the 
9-cis RA-interacting amino acids are 100% conserved). Likewise, both RXR antagonists 
used in this study were designed against the vertebrate ~, yet our data show that both 
antagonists significantly reduced the growth cone turning response to the RXR agonist. 
Interestingly, the results with the RXR antagonist P A452 were more ambiguous than with 
the antagonist HX531. In the presence of PA452, even though the overall mean turning 
angle was significantly reduced compared to controls, the RXR agonist was still able to 
induce a positive turning response in 6 of the 9 growth cones tested. This was not the case 
with HX531, where only 1 of 10 growth cones showed any positive turning response to 
the RXR agonist. In 9 of the 10 growth cones, the attractive turning was completely 
abolished in HX531. It appears, therefore, that HX531 is a more effective antagonist for 
-. 
the LymRXR than PA452, though the reason for this is not known. This is also supported 
by our finding that HX531 produced some teratogenic effects during Lymnaea 
embryogenesis, whereas PA452 had no obvious effect. 
Together with our evidence that LymRXR is localized in neurites and growth 
cones, our data showing RXR agonist-induced growth cone turning (that is subsequently 
inhibited in the presence of an RXR antagonist), strongly implicate a role for RXR in 
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regeneration and growth cone guidance. In support of this conclusion, Zhelyaznik and 
Mey (2006) recently showed that RXRa transcript and protein levels were up-regulated 
after sciatic nerve crush injury in rats. Furthennore, they demonstrated that the increase 
in RXRa immunoreactivity after injury did not occur in the degenerating nerve stump, 
but was observed in regenerating axons. This led the authors to propose that regulation of 
RXRa was connected with processes related to axon growth. 
As mentioned previously, an RAR has also recently been cloned from the 
Lymnaea CNS (Carter and Spencer, 2009). We do not yet know whether this receptor 
also exists outside the nucleus, and thus cannot rule out t~r possibility that the RXR may 
<" 
be acting in conjunction with the RAR to produce growth cone turning. We also have not 
yet detennined whether the endogenous retinoid isomers might be activating other 
parallel pathways (such as direct interactions with enzymes) to produce growth cone 
turning, and so the exact contribution of RXR activation in the turning response produced 
by 9-cis and all-trans RA is yet to be detennined. 
A non-genomic role for RXR in growth cone turning 
A significant finding of our current study is that the RXR agonist also produced 
-> 
growth cone turning of isolated growth cones, in the absence of the cell body and 
nucleus, suggesting a novel, non-genomic role in growth cone steering. There are a 
number of reports in the literature of RA exerting non-genomic actions. Some of these 
involve activation of messengers such as ERK1I2 and RSK (Aggarwal et aI., 2006), and 
direct binding with PKC (Ochoa et aI., 2003). Other reports implicate non-genomic 
actions of RARs. For example, RA rapidly enhanced spontaneous acetylcholine release 
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at developing neuromuscular synapses in Xenopus cell culture and an RAR~ agonist 
alone mimicked this effect (Liao et aI., 2004). Another study demonstrated RARa in rat 
hippocampal dendrites and demonstrated a non-genomic role in translational control of 
GluRl (Poon and Chen, 2008). The activation of phosphatidylinositol-3-kinase during 
RA-induced differentiation of neuroblastoma cells is also proposed to occur via non-
genomic actions of the RAR (Masia et aI., 2007). Though there are no previous reports of 
non-genomic actions of RXR in the CNS, RXRs were recently shown to exert non-
genomic effects in human platelets (Moraes et aI., 2007). RXRa and RXR~ were present 
in the cytosolic and membrane fractions of the platelt?P; and (despite the lack of a 
-; 
nucleus) the proposed RXR ligand, 9-cis RA, inhibited platelet aggregation. It was 
determined that the platelet RXR bound to the G protein Gq/l\, and that this association 
was strengthened within 3 minutes of 9-cis RA stimulation. This led the authors to 
propose that the RXR-GqlII binding event induced by 9-cis RA prevents Gq;1I from 
activating Rac and the subsequent aggregation-dependant pathways (Moraes et aI., 2007). 
Though we have previously shown a role for protein synthesis and calcium influx in the 
non-genomic actions of RA in Lymnaea growth cone turning, where and how the RXR 
may be involved in this signaling pathway, is currently unknown. 
' .. 
In summary, we have cloned the first retinoid receptor in the mollusc Lymnaea 
stagnalis, and demonstrated its presence and potential role during embryonic 
development. Significantly, we have demonstrated a cytoplasmic and neuritic 
localization for LymRXR, both in non-regenerating adult CNSs, as well as in regenerating 
motomeurons in vitro. Finally, we have shown that LymRXR is present in regenerating 
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growth cones, and provide the first evidence that RXR may play a novel, non-genomic 
role in mediating the chemotropic effects of RA. 
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Chapter 4: -< 
Cloning of a novel, non-chordate retinoic acid receptor 
and its role in invertebrate development. 
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4.01 Abstract 
Retinoic acid signaling in vertebrates is mediated by two classes of nuclear 
receptors, the retinoid X receptors (RXRs) and the retinoic acid receptors (RARs). 
Despite less being known about RA signaling in invertebrates, some effects of RA are 
conserved between vertebrates and invertebrates, though the RARs are thought not to 
exist in non-chordate invertebrates. However, invertebrates have been shown to contain 
both isomers of retinoic acid (9-cis RA and all-trans RA), even though the all-trans RA 
does not bind to the RXRs (at least in vertebrates). This raises the interesting question as 
J 
to why invertebrates possess the all-trans RA isomer, if it 'has no RAR to bind to. 
In this study, I have fully cloned the very first invertebrate, non-chordate RAR 
from the pond snail, Lymnaea stagnalis (LymRAR), and have studied its distribution and 
expression in the developing embryo, adult eNS, as well as regenerating cultured 
neurons. I then determined a functional role for this novel RAR in invertebrate 
development, and showed that RAR antagonists can disrupt embryonic development. 
These data strongly suggest that the role of the invertebrate RAR is conserved with the 
known roles ofRARs in vertebrates. Interestingly, the expression pattern of the LymRAR 
in non-regenerating neuron's of the adult Lymnaea eNS, showed a non-nuclear 
distribution. This was also the case in the regenerating cultured neurons, where LymRAR 
expression was also found in the growth cones. These findings indicate that the LymRAR 
may also playa non-genomic role in RA-mediated chemoattraction, as shown for the 
LymRXR. 
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Overall, this is the first study to fully clone and show functional expression of a 
non-chordate, invertebrate RAR, and sheds light on why invertebrates may possess the 
all-trans RA isomer. 
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4.02 Introduction 
In the previous chapter, I cloned an invertebrate RXR from L. stagnalis and, 
together with N. Farrar, provided the first evidence that this RXR may playa role in 
mediating the chemotropic effects of RA on cultured Lymnaea neurons (Carter et aI., 
2010). Specifically, we demonstrated that a RXR-selective pan-agonist mediated growth 
cone turning, which was not significantly different from the turning produced by the 
natural ligand, 9-cis RA (Carter et aI., 2010). I then showed that this RXR-agonist-
induced growth cone turning was prevented in the presence of two different RXR 
,{ 
antagonists, providing compelling evidence for an important role of the RXR. However, 
it has not yet been determined whether the RXR actually mediates the 9-cis RA-induced 
growth cone turning (Dmetrichuk et aI., 2008), which is the natural ligand for RXR, at 
least in vertebrates. 
Interestingly, the vertebrate RAR ligand, all-trans RA is also known to produce 
growth cone turning in Lymnaea neurons, and its role as both a neurotrophic and 
chemotropic factor in Lymnaea has been well documented (Dmetrichuk et aI., 2006; 
Dmetrichuk et aI., 2008). Despite the evidence for the presence and function of this all-
trans RA isomer in the Lymnaea CNS (Creton et aI., 1993; Dmetrichuk et aI., 2006; 
Dmetrichuk et aI., 2008), in addition to some other invertebrates (Nowickyj et aI., 2008), 
a full-length RAR has never been cloned from any non-chordate, invertebrate species. 
In vertebrates, RA signaling involves binding to the nuclear receptors, RXR and 
RAR. The active ligands for the RARs include both all-trans RA and 9-cis RA, whereas 
9-cis RA acts as the ligand for RXRs. RXR is a promiscuous partner that . can 
heterodimerize with many different receptors including RAR, thyroid receptor (TR) , 
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Vitamin D receptor (VDR) and peroxisome proliferator-activated receptor (PPAR). RXR 
is also found in almost all metazoan species from insects to nematodes, including the 
non-metazoan marine sponge, Suberites domuncula (Simoes-Costa et aI., 2008). 
Conversely, RAR is only known to partner with RXR to mediate RA-signaling. 
The machinery responsible for RA metabolism includes the enzymes responsible 
for RA synthesis, called retinaldehyde dehydrogenases (ALDHla, formerly RALDH), 
and the enzyme responsible for RA degradation (Cyp26). Until recently, ALDHla, 
Cyp26, and RAR were only described in chordates, and the presence of these three genes 
was thought to be an important step for the innovati?p of the chordate body plan 
(Fujiwara and Kawamura, 2003). Most studies investigating the action of all-trans RA 
(e.g. on patterning embryonic axes) have thus almost exclusively used chordates. For 
example, after removal ofRA from the diet of quail embryos (with a vitamin A deficient 
diet), the posterior hindbrain fails to develop normally (Maden, 2002). In mouse 
embryos, knocking out RALDH2, one of the enzymes that synthesize all-trans RA, 
causes neural tube defects, a reduction in the trunk region and defects to specific organs 
such as the heart (Niederreither et aI., 1999). Conversely, treatment with higher levels of 
exogenous all-trans RA resulted in abnormal development of the caudal midbrain and 
..•. 
anterior hindbrain regions in zebrafish embryos (Hill et aI., 1995), and was also shown to 
significantly alter neural cell shape and polarity in developing rat sympathetic ganglia 
(Chandrasekaran et aI., 2000). 
Until recently, all-trans RA signaling was thought to be a vertebrate innovation. 
Recent studies with invertebrate chordates have revealed evidence for RA signaling 
machinery throughout the chordate lineage, including the invertebrate chordate species 
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cephalochordates (Branchiostoma floridae) and the urochordates (Ciona intestinalis). 
Together with the vertebrates, the cephalochordates and urochordates belong to the 
deuterostomes, a sub-taxon of the bilateria branch (see Fig. 27). Vertebrates possess three 
different RARs (cr, ~ and y) and three different RXRs ( cr, ~ and y), whereas 
cephalochordates and urochordates have a single representative of each type of receptor. 
The only non-chordate, deuterostome RAR identified to date (predicted through genome 
screening) belongs to the sea urchin Strongylocentrotus purpuratus. 
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Figure 27. Tree diagram of the bilaterians 
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The other subtaxon of the bilateria branch is the protostomes, and this includes 
species such as molluscs and annelids (which belong to lophotrochozoans), and 
nematodes, crustaceans, and insects (which belong to ecdysozoans). Recently, genome 
screening of various protostomes has predicted the presence of an ancestral RAR in the 
annelid, Capitella capitata, and in the mollusk, Lottia gigantea. These predicted RAR 
sequences are the first evidence of an RAR in the protostome branch of bilaterians, but 
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neither of these sequences has been cloned, nor has the presence and/or role of the RAR 
protein been determined. To date, no RARs have been fully cloned from any protostome 
speCIes. 
The main aim of this study was to determine whether an RAR exists in the 
invertebrate, non-chordate protostome, Lymnaea stagnalis, and if so, to attempt to clone 
the full mRNA sequence and determine whether the RAR plays a similar role as it does in 
vertebrates. 
J 
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4.03 Materials and Methods 
Cloning of L. stagnalis RAR 
All of the animals used in this study were laboratory-bred in aerated artificial 
pond water and were kept on a diet consisting of romaine lettuce and NutraFin Max 
Spirulina fish food (Hagen). Total RNA was isolated from the Lymnaea CNS using a 
PowerGen handheld homogenizer (Fisher Scientific) and purified according to the 
Norgen Total RNA isolation kit (Norgen Biotek Corp, Thorold, ON). Reverse 
transcription was carried out with a mixture of poly A and random hexamer primers 
J 
according to the iScript cDNA synthesis kit (BioRad). Amplification was carried with 40 
pmol of forward (5'-GTS AGY TCC TGT GAG GGC TGC AAG-3') and reverse (5'-
GW A CAC GTT CAG CHC CTT TAA CGC-3') degenerate primers generated from 
conserved areas of the closest related species where an RAR had been identified. After 3 
min of denaturation at 95°C, 30 cycles at 95 °c for 40 sec, annealing at 55°C for 30 sec, 
and elongation at 72 °c for 30 sec, were performed with an Eppendorf Mastercycler 
Personal Thermocycler. The product was analysed on a 1.2% agarose gel containing 
ethidium bromide in TAE buffer. Bands of interest were excised from the gel according 
to MoBio gel purification" kit and cloned into a pGemTEasy vector (Promega). 
Sequencing of the inserts was performed by GenomeQuebec (Montreal, Canada) using a 
3730xl DNA Analyzer system from Applied Biosytems. From a partial RAR-like 
sequence, a full-length cDNA was generated from multiple rounds of both 5' and 3' 
RACE according to the SMART RACE cDNA amplification kit (Clontech). 
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Antibodies 
From the full-length ammo acid sequence for Lymnaea RAR, I designed 
antibodies against a synthetic peptide from a predicted 'hinge' region 
(AVRNDRNKKRKQKPES) covering the amino acid residues 188-203 located between 
the DNA binding domain (DBD) and ligand binding domain (LBD). The custom-made 
antibody was generated in New Zealand white rabbits by Pacific Immunology Corp. 
(Ramone, CA, USA) and was affinity-purified from the crude antisera. Commercial 
antibodies against human GAPDH (Abcam Inc.) and human actin (Sigma-Aldrich) were 
used as a cytosolic fraction marker and a control ~9r the nuclear compartment, 
-; 
respectively. 
Lymnaea embryos 
In order to investigate L ymRAR protein levels during Lymnaea development, egg 
masses were first incubated in pond water at 25°C and allowed to reach various stages of 
development, as described in Nagy and Elekes (2000). These stages included day 0 of 
embryogenesis (when egg mass is first laid and prior to first cleavage), the trochophore 
stage (approx 36 to 60 hrs of embryogenesis), the veliger stage (approx 60 to 96 hrs of 
'. 
embryogenesis), the adult-like stage just prior to hatching (96 to 192 hrs of 
embryogenesis) and hatchlings. When the embryos reached the desired stage, the 
capsules were removed from their gelatinous surroundings, total protein was extracted 
and Western blotting was performed, as described in the next section for adult CNSs. 
However, LymRAR signals were not detected in early stages of embryogenesis, so 
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Western blotting was only performed on late veliger/metamorphosis stage embryos 
(approx. 84-108 h of embryogenesis). 
Western Blotting 
To investigate the expression of LymRAR protein, adult Lymnaea CNSs (or whole 
embryos at the late veliger/metamorphic stage of development) were homogenized in 
lysis buffer containing 150mM NaCI, 50mM Tris RCI (pR7.5), IOmM EDTA, 1% Triton 
X-100, ImM PMSF and 0.01% Protease Inhibitor Cocktail (Sigma-Aldrich) with a 
PowerGen handheld homogenizer (Fisher Scientific). The)lOmogenates were centrifuged 
-; 
20,000 x g at 4°C for 30 minutes. 15~g of protein from each extract was separated on a 
discontinuous SDS-polyacrylamide gel (12% Resolving, 4% Stacking) and e1ectroblotted 
onto a nitrocellulose membrane (BioRad). The membranes were washed for 5 minutes in 
lxPBS and then blocked in lxPBS/O.l % Tween-20 (PBT) with 3% skim milk powder 
(w/v) for 1 hour. The membranes were then incubated with affinity purified Lymnaea 
RAR antibody at a dilution of 111000 in PBT/I % skim milk overnight at 4°C with gentle 
horizontal shaking. This was followed by 4 x 5 min washes at room temperature in PBT 
and incubation with a 1115000 dilution of Alexa Fluor 680 goat anti-rabbit secondary 
-. 
antibody (Invitrogen). After 4 x 5min washes in PBT and one wash in lxPBS, the 
membranes were imaged with the LI-COR Odyssey Infrared Imaging System at 700nm 
wavelength. 
To investigate the subcellular expression of LymRAR in the Lymnaea CNS, total 
protein from the cytoplasmic, membrane and nuclear compartments was isolated 
according to directions from the Qproteome Cell Compartment kit (Qiagen). Briefly, 
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20mg of CNS tissue (which equates to approximately 15 adult Lymnaea CNSs) was 
isolated and immediately placed into a 2ml centrifuge tube with 500llL of the 
manufacturer's buffer solution (CE1) that contains a protease inhibitor. The tissue was 
disrupted on the lowest speed with a PowerGen homogenizer (Fisher Scientific) for only 
5 . sec. The tissue was further disrupted by centrifugation for 2 min at 4°C in a 
QIAshredder homogenizer tube (Qiagen). After end-over-end mixing at 4°C for 10 min 
and centrifugation, the resulting supernatant should primarily contain cytosolic proteins. 
By sequential addition of other different extraction buffers to a cell pellet, proteins in 
other different cellular compartments can be selectively ~~olated by this method. Equal 
amounts of cytoplasmic, membrane, and nuclear fractions were loaded onto a 
discontinuous SDS-polyacrylamide gel (12% Resolving, 4% Stacking) and LymRAR was 
detected by Western blotting technique as described above. Anti-GAPDH (Abcam Inc.) 
was used as a cytosolic fraction marker and successful isolation of protein from all three 
compartments of the CNS was confirmed by staining for actin. These experiments were 
performed three times. 
Immunostaining 
For immunostaining, the CNSs isolated from adult snails were fixed in 4% 
paraformaldehyde in PBS at 4°C overnight. For Lymnaea embryos, the capsules from egg 
masses at the late veliger stage were teased out of the gelatinous surroundings and 
washed in distilled water. The capsules were then fixed in 4% paraformaldehyde in PBS 
at 4°C overnight. Both fixed embryo capsules and CNSs were then washed in 10% 
sucrose/PBS for 2 hours, 20% sucroselPBS for 2 hours, and then 30% sucrose/PBS 
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overnight at 4°C. After embedding the fixed embryonic capsules and CNSs in Optimal 
Cutting Temperature (O.C.T.) Compound (Tissue-Tek), serial 20l-lm sections were cut 
using a cryostat (Leica micro systems) and placed on Superfrost Plus slides (Fisher 
Scientific). For immunostaining of cultured neurons following outgrowth (24 to 36 hrs), 
cells were fixed in 4% paraformaldehyde in PBS at 4 DC overnight. From this point on, all 
immunostaining procedures were the same for embryo capsules, adult CNSs, and 
cultured neurons. The samples were washed in PBS and then permeablized in 0.3% 
Triton X-IOO in PBS (PBT) for 20 min and blocked in 3% normal goat serum (NGS) in 
PBT for 1 hour at RT. The samples were then incubat¢ with the primary LymRAR 
antibody diluted 1 :50 in blocking solution at 4°C overnight. As a control, different 
preparations were incubated only in blocking solution, without the primary antibody, at 
4°C overnight. All samples were then washed in PBT 3 x 5 minutes and incubated in 
1 :500 dilution of Alexa Fluor 488 goat anti-rabbit secondary antibody (Invitrogen) in 
blocking buffer at R T for 2 hours. The samples were washed for 3 x 5 min in PBT and 
after a brief wash in PBS, the specimens were coverslipped with anti-fade Fluorosave 
mounting media (Calbiochem). 
Lymnaea embryonic development 
To determine if LymRAR plays a role in Lymnaea development, embryos were 
incubated in a synthetic RAR pan-agonist (TTNPB, Tocris Bioscience), a synthetic RAR 
pan-antagonist (LE540, a kind gift from H. Kagechika, University of Tokyo), a synthetic 
RARp-selective antagonist (LE 135, Tocris Bioscience), all-trans RA (Sigma-Aldrich), 
and DMSO as a control. At day 0 of embryogenesis (when egg mass is first laid), 
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capsules were teased out of the gelatinous surroundings in which they were embedded, 
and maintained in pond water at 25°C for 30 hrs (until the end of the gastrulation stage). 
This separation of the capsules increased probability of penetration of the agonists and 
antagonists while still allowing normal development of the egg inside the capsule (Carter 
et aI., 2010; Creton et aI., 1993). The RAR pan-agonist TTNPB (1O-6M and 10-5M), the 
RAR pan-antagonist LE540 (10-6M), the RARp-selective agonist LE135 (1O-6M and 10-
5M), all-trans RA (l0-6M), or DMSO (0.001%, vehicle control) were added to separate 
dishes of embryos at 30 hrs of embryogenesis (this was previously shown to be the most 
sensitive stage to disruption by RA; Creton et aI., 1993; G~rter et aI., 2010). The specific 
-. 
concentrations of agonist and antagonists used in these experiments were chosen partly 
on advice from Dr. Hiroyuki Kagechika (University of Tokyo, Japan) who developed 
LE540 and LE135, and from previous transactivation experiments (Pignatello et aI., 
1999; Umemiya et aI., 1997). At days 6-7 of embryogenesis, embryos showing eye 
and/or shell malformations, or arrested development at the trochophore stage, were 
scored and compared with the DMSO control embryos. Statistical analysis was 
comprised of multiple Fisher Exact tests that were then Bonferroni-Holm corrected. 
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4.04 Results 
Sequencing of a Lymnaea RAR 
In my search for an invertebrate RAR gene, I first designed degenerate primers 
utilizing sequences for putative RAR genes of two species (Lottia gigantean and 
Capitella capitata) outside of the deuterostome lineage, that were previously discovered 
through surveys of genomic databases (Albalat and Canestro, 2009). Using these primers, 
I obtained an initial cDNA fragment from the CNS of Lymnaea stagnalis. Multiple 
rounds of 5' and 3' RACE from this initial fragment generated a full-length RAR cDNA 
J 
that was 2280 bp, with a 1434 bp open reading frame thai encodes for a 478 amino acid 
RAR protein (termed LymRAR; accession no. GU932671). This LymRAR has an overall 
amino acid identity of 55% with the vertebrate RAR~ from Homo sapiens, although 
similar identity is also seen with RARa and RARy from other vertebrates such as 
Xenopus laevis (54% identity and 55% identity respectively). Interestingly, the LymRAR 
shows higher amino acid identity to vertebrate RARs than to the invertebrate chordate 
RARs. For example, it shares only 51 % amino acid identity with the invertebrate 
chordate RARs from Ciona intestinalis (CionaRAR) and the amphioxus, Branchiostoma 
jloridae (AmphioxusRAR). As is commonly seen with other nuclear receptors, the most 
conserved regions in the LymRAR protein sequence are the predicted DNA-binding 
domain (DBD), which shares 85% amino acid identity with the DBD of Homo sapiens 
RAR~ (accession no. NP _990657), as well as the predicted ligand-binding domain 
(LBD), which shares 58% amino acid identity with the LBD of Homo sapiens RAR~ 
(Fig. 28). 
129 
HumanRARbeta 
.l\mphio:-: usPAR 
CionaRAR 
LymnaeaRAR 
Huma nRARbeta 
Amphi ozusRAR 
CionaRAR 
LymnaeaRAR 
HumanRl\Rbeta 
JI.mphiozus RJI.R 
Ci onaRAR 
LymnaeaRAR 
HumanRARbeta 
Amphio;wsRAR 
CionaRAR 
Lymnae aRAR 
Huma nRl\Rbeta 
AmphiozusRJI.R 
CionaRl\R 
LymnaeaPAR 
HumanRARbeta 
Amphi ozusRAR 
Ciona RAR 
LymnaeaRAR 
HumanRARbe t a 
AmphioxusRAR 
Ci onaRAR 
LymnaeaRAR 
HumanRl\Rbeta 
AmphiozusRAR 
CionaRl\R 
LymnaeaRAR 
HumanRARbeta 
Amphi ozusRAR 
Ciona RAR 
LymnaeaRAR 
---------------------------------------MEDOIDVLSVS PGQl LD EYTA 
- - - - - - --- - ---- -- - - - - - - - -- -- - - - -- - - -- - -- -- -MI'IED.l\SMSQGEKLLPRLA 
MMNVMEEQEQ,'/RNRMNGI LS DM EH PTSTI CDAMTGMP RSHNTMASMI DS P PPLQNLT I HS 
----MNPNSMGTQSAGS HSGDSSSSDATSSNHGNNGSSS LTHDlHGGMTVLPGPPSYSSF 
S PS SCMLQEKALKACESGLTQT EI'IQHR- HTAQS I ETQSTSS EELVP- - S P PS P LP PPRVY 
RAWEJI,NIAEVFWQTHHAGDS,WDQRS SNHQS DRC l TDQSSS EEMEP- - S P PS PP PP PRVY 
NNYPRQ YYQ PPYYQA.iDYSQRSSPDSVGLSSTGSSYSGS ESDGLHPGQC PPSPPP PPRl Y 
PQVTMAYGHYNLYDKVGVMPSMAKDGGNMYDPNSMYGAlHGNSMLTSEPNMSPPPPPRIY 
** **** :* 
K FVCQDKSSGYHYGVSAC EGCKGFERRS I QKNMIYTCHRDKNCVlNKVTRNRCQYCRL 
K 'FVCSDKSSGYHYGVASCEGCKGFFRRS I QKNMQYVCHRDKNCVlNKVTRNRCQFCRL 
K FVCGDKSSGYHYGVASC EGCKGFFRRSVQKNMQYTCHRNKQC Ll NKSTRSRCQYCRL 
K VVCNDKSSGYHYGVSSCEGCKGFFRRSVQKNMQYTCHKEKNCVINKVTRNRCQYCRL 
*** . ** *** ***** *~ : : **.*~+.**** : **** * . **: : * : * : *** ** . *** : *** 
KESVRNDRNKKK--KETSK--QECTESYEMTAELDD LTEKIRKAHQET PS 
KESVRNDRNKKR--KDKTQSLEKHTLSYNWTPEIQTlITTVREAHi'IAT PD 
RESVRNDRNKKRGKEKEGKSDQNGVDEPSCSPElEALVTSVHKFHVET PL 
KEAVRNDRNKKR-- - - KQKPESTSGGP DEVTEDDQI'ILI QEVLDAHRDT PD 
* * 
LCQLGKYTTNS - -:-------- - ----- - - ------SJI.D HRVR LDLGLWDK FtSELAS KCII 
MGKLPKYKVKN -- - - - - - - - - - - - - - - - - - - - - - - Ai'.EQRG PT D1 ELWQH flS DLCT ET I I 
SS ELKKYQl PSP----------- -- - ------- PIVKDr~AKTDSNLWEKflAELST KC l V 
GVNGSTLPGSSSGAATSSMAANSSPTVATSTS ETKS EDDSGSSGVFLWEKI TELSSAGI V 
* * : : : : : * . : * : 
00 00 0 0 
KI VEFAKRLPGFTGLTIADQITLLKA.lI.CDDlLiI LF\I CT RYTPEQDTMT FS DGLTLNRTQM 
KlVQFAK!I.\!PGFTTFGTADQITLLKAACLDILf LRLATRLDKESDTVT INGMMLSRTQM 
KlVEFAKGVPGFQDFTIADQlTLLKCACLEVLFL~ICSRFS PEHDTMT f1S DGLTLTRKQM 
NIVDFAKKIPGFLSLSTSDQlTLLKAACLElNlL l Sl R1f ELDTDTMQ8SNGLSLTREQL 
"A* : * "k* : *** : ** : "A: : * : *.* * : 
0 0 
HNAGFtGP LTDLVFTFANQLL PLEMDDTETGLLSAICL I CGDRQDLEEPTKVDKLQEPLLE 
HNAG,FGP LTDGVFTFJI.EGMQKLLFDETEI GLNCSlCLVCGDRQGLEDl QRAENLQEPLLE 
RVCGEGP I TEQVFSFAQSLHPLNAD.lI.TElGLLS.lI.ICLVS}\DRVDLEEPDKVELLQESLVE 
QRGGFGP Lll'STlFSFAASLKRMNCDETE1fANLSSlCLI SGDRSGLHDTEKlEQMQEPLLE 
** ** : * . : * : ** * ** .: :.: *** : .. ** .*.: : : :* * . *:* 
00 
ALKIYIRKRRPSKPHNFPKlLMKITDLRS I SAKGAERV'ITLKNEI PG-SMPPLI QEMLEN 
ALKAYSRRRl PDDPQRFPKtlIMKITDLRSI SSKGAERVlTLKMELS S- PMP PLI AEI WEK 
GLK YYARKRRP HTPQVFPKLllKI SDLRSl SLKGAD RWTVKTEI PCGAMPPLJo1S EMLEN 
ALKHY IRS RR P DQ KHT FAKNLMKLTD LRS I SVKGJI,EKVLHL RL ERYJI. - QLP PL 'vVEMLER 
** * * * * . "* * .. ... .. *****-,A;: *** . . * . .. "* 
HEPLTPSSSGNTAEHSPSlSPSSVENSGVSQSPLVQ 
LS---------------------------------
DE E-------- ---------- --- --------------
VE CLP~---- ------- - -- ~L----- --------- -
DBD 
LBO 
Figure 28. The Lymnaea RAR sequence. Multiple sequence alignment of the Homo 
sapiens RAR (HumanRARbeta; accession no. BAH02279), the cephalochordate 
amphioxus (an invertebrate chordate) RAR of Branchiostomajloridae (AmphioxusRAR; 
accession no. AAM46149), the urochordate tunicate (also an invertebrate chordate) RAR 
of Ciona intestinalis (CionaRAR; accession no. NP _001072037), and Lymnaea stagnalis 
RAR (LymnaeaRAR; accession no. ADF43963). The conserved DNA-binding domain 
(DB D) and ligand-binding domain (LBD), regions that are common to all retinoid 
receptors, are outlined in red. Amino acid positions that are implicated to be in direct 
contact with all-trans RA are indicated by a green circle above. Exact matches to human 
RARbeta are shaded green. 
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The only invertebrate, non-chordate RARs that I can compare with LymRAR are 
from the predicted RAR sequences from Lottia giantia and Capitella capitata (previously 
mentioned above). LymRAR shares 61 % amino acid identity with the predicted RAR 
from the annelid, Capitella capitata, and 65% identity with the closest related RAR, that 
was predicted from the mollusc, Lottia gigantea. 
Conservation of LBD residues 
Previous studies have identified specific amino acids in the ligand binding pocket 
(LBP) of vertebrate RARs that are implicated in having ~llect contact with RA (Renaud 
et at, 1995). Table 1 shows these amino acids of the LBP with a comparison of aligned 
protostome and deuterostome RAR sequences, and reveals a significant degree of 
conservation between the two branches ofbilaterians. In fact, of the fourteen sites that are 
shown in Table 1, the number of amino acids in the closest related non-chordate RAR 
(from C. intestinalis) that are conserved with the human RARs (a, ~ and y) is twelve, 
whereas this number is only ten in the amphioxus RAR, nine in L. gigantea RAR and 
eight in the C. capitata RAR. Interestingly, the number of conserved amino acids 
between the human RARs and my newly found invertebrate, non-chordate Lymnaea RAR 
-.. 
is ten. Thus, the RAR from L. stagnalis displays a high conservation of direct ligand 
binding residues with human RARs, one that is comparable to that of the amphioxus 
RAR, a receptor that has previously been found to bind, and be activated by, the RAR 
ligand all-trans RA. 
Table 2 lists other known amino acid sites that have recently been found in mouse 
to directly interact with all-trans RA (Escriva et aI., 2006). When comparing L. stagnalis 
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and amphioxus RARs with the mouse RARs, the L. stagnalis RAR has seven of the 
twelve amino acids conserved, while the amphioxus RAR has eight amino acids 
conserved. Of the amino acids that are not perfectly conserved with mouse RARs, the 
Lymnaea RAR contains three conservative amino acid substitutions, while the amphioxus 
contains two. Although not conclusive, the evidence provided here from Tables 1 and 2, 
show a similar degree of conservation between the LymRAR and AmphiRAR with the 
human and mouse RARs. 
In summary, although there is currently no direct experimental evidence to 
suggest that RAR may be a functional receptor for all-trqns RA in protostomes, it is at 
-; 
least plausible that the RAR of L. stagnalis might bind the endogenous ligand, all-trans 
RA. 
LymRAR in the developing embryo 
Given our previous finding of the presence of LymRXR in the Lymnaea embryo 
during various stages of development, my first aim here was to determine whether the 
newly found LymRAR was also present at various developmental stages in Lymnaea. A 
custom-made antibody against a synthetic JJeptide from the 'hinge' region between the 
DBD and LBD was used to detect the LymRAR protein in frozen sections of Lymnaea 
embryos at the late veliger stage (Fig. 29). I chose this stage of development for the 
immunostaining since this is the earliest developmental stage with which I could detect a 
positive signal with Western blotting (Fig. 29C). Immunoreactivity was detected in 
various regions of the Lymnaea embryo, but stronger signals were seen within the shell 
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Table 1. Conservation of residues contacting all-trans RA in the LBD of RARs. 
Depicted below are the amino acid residues that are known to contact RA in the ligand 
binding pocket of human RARy. Other metazoan RARs are aligned with the human 
RARs in order to show conservation of these RA-interacting residues. Amino acids 
marked red are exact matches to RARy and boxes shaded blue are the amino acid 
positions of human RARy that are known to interact with the carboxylate moiety (-
COOH) of RA. The asterisk (*) above Met272 indicates the position where there is a 
difference between Human RARy, RARa and RARP (modified from Campo-Paysaa et 
aI., 2008). 
* 
Human Phe Leu ,.' CY' Leu Met, Arg l ie ""', Phe 
Rt.Ry 230 23) • ", ,237 U1, 272 274 I 275 , I' 288 
:[' I Phe Gly Le u 
,.q ]04', J'1J 400 I , 
PM Leu ll$ tyl ,Leu lit! At, lie .va IIbI! SI!r libe City I..t!u 
Ph. Leu ~ ( ys L.u lIe Art , .. All Ph. ' Sill Pbe Gl~ Leu 
rIW Leu I.~ Cys f.eg JIbe ,q lie Aq Pt!. 5er' Phe Gr ViJi 
PM leu GItJ Thr Leu lie Ara Leu Art PhI! :Ill!' Phi! Gly U!u 
ViII IMt AI'I Ala Met lie k: Nt ..... TIIr Phit 
lle leu Gly Gly Met lie Na Leu Art Ph. S« Pbe Gly I.eu 
val 1.*" Ser Gly Lell vat NI Leu ~ libe Thr Phi! City Leu 
L. stagnalis lie Leu Ala Gly Met lie Arg lie Arg Phe Ser Phe Gly Leu 
RAR 
_ Vertebrate, chordates (deuterostomes) 
_ Im'ertcbralc. chordales (deuleroslomcs) 
_ lm'ertcbrale. non-chordale (dcuteroslome) 
_ InveJ1ebmtc, non-chol'datcs (Ilrotostomes) 
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Table 2. Conservation of additional residues that have recently been implicated in 
contacting all-trans RA in the LBD of RARs. Depicted below are additional amino acid 
residues that are implicated in having direct contact with RA in the ligand binding pocket 
of mouse RARs. Other metazoan RARs are aligned with the mouse RARs in order to 
show conservation of these RA-interacting residues. Amino acids marked red are exact 
matches to mouse RARy and blue amino acids are exact matches to either mouse RARB 
or RARa (modified from Escriva et aI., 2006). The asterisk (*) above Ala234 and Ala397 
indicates the positions where there is a difference between the mouse RARy, RARa and 
RARB. The symbol (I) indicates a conserved amino acid substitution (information for this 
table is taken partly from Escriva et aI., 2006). 
/ 
" 
* RARy(mouse) Phe(20l) Trp(227) Ala(234) Cys(237) Leu(268) Gly(303) 
RARu(mouse) Phe Trp Ser Cys Leu Gly 
RARp(mouse) Phe Trp Ala Cys Leu Gly 
AmphiRAR Leu+ Trp Cys Thr Leu Gly 
LymRAR Thr Trp Ser Gly Leu Gly 
Arg(396) * Met(408) lIe(412) Met(415) RARy(mouse) Leu(307) Ala(397) 
RARu(mouse) Leu Arg Val Met lIe Met 
RARp{mouse) Leu Arg Val Met lIe Met 
AmphiRAR Leu .Arg V~I Met lie lIe+ 
LymRAR Leu Lys+ Val Leu+ Val+ Met 
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region (white arrows; Fig. 29Ai). One of the structures within the shell region resembled 
an early neural cell (as seen in Croll et aI., 1996) with a long process emanating from the 
cell body (Fig. 29Aii). The only other clearly recognizable structure that displayed strong 
LymRAR immunoreactivity was the lining of the pharynx/esophagus (yellow arrows; Fig. 
29Bi,Bii) which appears in the shell region of the Lymnaea embryo. Western blot 
analysis of Lymnaea embryos total protein revealed a band of approximately 52 kDa in 
size, which matches the molecular weight predicted from the full ORF (Fig. 29C). 
However, as mentioned above, I was only able to detect LymRAR protein by Western 
blotting in the latter stages of embryogenesis. The Weste91 blot shown in Figure 29C is 
<' 
from embryos taken near the late veliger/metamorphic stage. 
LymRAR plays a role in embryonic development 
Having previously shown a role for RXR in L. stagnalis embryogenesis, I next 
aimed to determine whether the same is true for the newly cloned RAR. Previously, both 
RXR agonists and antagonists were shown to disrupt various aspects of embryonic 
development (Carter et aI., 2010) and so here, I again tested the effects of both agonists 
and antagonists of the RAR, as well as the ~own RAR ligand, all-trans RA (with DMSO 
controls). Specifically, I aimed to determine whether these treatments would disrupt the 
normal pattern of development in Lymnaea, and again, used eye and shell formation as 
indicators of normal growth, as these are easily visualized and characterized using light 
microscopy, shortly after the veliger stage. 
Lymnaea embryos were maintained within their capsules, but were removed 
from their gelatinous surroundings. Capsuled embryos were treated with one of the 
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Figure 29. LymRAR immunoreactivity in the developing embryo. (Ai) A section of a 
Lymnaea embryo at the late veliger stage of development shows more intense 
immunoreactivity for RAR in the shell region (white arrows) and at the interface between 
the shell and the foot region (red arrow). Scale bar: lOO/lm (Aii) Upon higher 
magnification of the boxed region of Ai, the structure shown by the red arrow appears to 
be a cell body with a long process emanating from it. Given the size and shape, this may 
be an early nerve cell (as seen in Croll et. at, 1996). Scale bar: 20/lm (Bi) Another 
structure in the shell region that shows RAR immunoreactivity (yellow arrow) appears to 
be the pharynx/esophagus of the embryo. Scale bar: lOO/lm (Bii) Higher magnification of 
the boxed region in Bi reveals strong staining around the inner lining of this putative 
pharynx/esophagus (yellow arrow). Scale bar: 20/lm. (C) Western blot indicating the 
presence of the LymRAR in the late-stage embryo (as well as in the adult CNS for 
comparison). 
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following: a synthetic RAR pan-agonist, TTNPB (lO-6M, n = 40; 1O-5M, n = 42), a 
synthetic RAR pan-antagonist, LE540 (IO-6M, n = 35), an RAR~-selective antagonist, 
LE135 (l0-6M; n=27), the RAR ligand, all-trans RA (lO-6M; n = 24), or DMSO as the 
vehicle control (0.001 %; n = 40). These treatments were started at the gastrula stage (30 
h) and continued for the next 5 days of embryonic development. In the presence of 
DMSO, both shell and eye development appeared normal (Fig. 30A). However, I found 
that treatment with the antagonist LE135 (lO-6M; Fig. 30B), as well as the ligand all-
trans RA (Fig 3IA,B), produced defects in both eye and shell formation in a significant 
number of embryos (Fig. 32B,C). Eye defects included eitJ;1er missing eyes (Fig. 3IA), or 
-; 
those noticeably reduced in size (not shown). Interestingly, TTNPB did not display any 
eye or shell abnormalities at 1O-6M (Fig. 3IC) compared to all-trans RA at the same 
concentration (Fig. 3IB), although increasing the TTNPB concentration to 1O-5M 
produced complete lysis of all embryos after 12 hours of treatment (Fig 3ID), similar to 
the effects seen with IO-6M LE540 and 1O-5M LE135 treatments (Fig. 30D, 32A). 
Together, these data strongly suggest a role for RAR in Lymnaea development. 
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+ LEllS(to-'M) 
D 
+ LE540(10·6M) 
Figure 30. RAR-selective arftagonists inhfbit Lymnaea development. 
(A) Representative example showing that addition of DMSO (0.001%) to Lymnaea 
embryos (as a vehicle control), did not affect development. All of the animals showed 
normal eye and shell development (when compared to embryos that were not treated with 
DMSO; not shown). Green arrows indicate the outline of the normally developing shell, 
and yellow arrows indicate the presence of both eyes. Scale bar: 200flm. (B) 
Representative example of a Lymnaea embryo incubated in the RARp-selective antagonist 
LE135 (1O·6M). Green arrows indicate malformation of the shell. Scale bar: 200flm (C) 
Representative example of a halted embryo at the trochophore stage following incubation 
in LE135 (l0-6M). Scale bar: 100flm. (D) In some of the conditions, the halting of 
embryogenesis was due to early lysis of the normal spherical embryonic structure. This 
example was treated with RAR pan-antagonist, LE540 (10-6M). Scale bar: 100flm. 
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A B 
+ all-transRA{lO-6M) 
+ TTNPB(lO-6M) - + TTNPB(lO-5M) 
Figure 31. An RAR-selective agonist can inhibit Lymnaea development. 
• 
-
(A) Representative example of a Lymnaea embryo missing an eye (yellow arrow indicates 
where eye should be located) following incubation in all-trans RA (10-6M); Scale bar: 
200llm. (B) Treatment of embryos with all-trans RA (1 0-6M) also caused malformations of 
the shell (green arrows); Scale bar: 200llm. (C) All of the animals showed normal eye and 
shell development when incubated in the RAR pan-agonist, TTNPB (10-6M). Scale bar: 
200llm. (D) When the concentratration of rTNPB was increased to 1O-5M, it resulted in 
complete lysis in 100% of the Lymnaea embryos early in development. Scale bar: 80llm. 
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Figure 32. RAR agonists and antagonists cause varying degrees of abnormalities in Lymnaea 
development. Embryos were treated with RAR agonists and antagonists at different 
concentrations and the % of embryos halted at the trochophore stage (A), % with eye defects (B) 
and % with shell formations (C) are shown graphically above. All-trans RA (all-trans RA; n=24), 
LE135 (10-6M; n=27), LE135 (10-5M; n=32), LE540 (n=35), and the RAR-selective agonist 
TTNPB (1O-6M; n=40; 1O-5M; n=42) treatments were compared to the DMSO (n=40) treatment 
(* p<0.05, ** p<O.OI). 
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LymRAR is expressed in the adult eNS 
Recently, it has been shown that all-trans RA can exert both trophic and tropic 
effects on adult CNS neurons of L. stagnalis (Dmetrichuk et al., 2005). As these adult 
neurons of Lymnaea can respond to the RAR ligand, all-trans RA, my next aim was to 
determine the localization and expression of the L ymRAR in the adult CNS of L. 
stagnalis. Western blot analysis of the adult Lymnaea CNS total protein revealed a band 
of approximately 52 kDa in size (as shown previously in Fig. 29C). Using the same 
LymRAR-specific antibody, I next performed immunohistochemistry on frozen sections 
of acutely isolated Lymnaea CNSs (n=22). Immunoreacti~ity was detected in neurons of 
" 
all ganglia of the CNS. Specifically, the signal appeared to be located in the cytoplasmic 
region (Fig. 33B; yellow arrow) and axonal tracts (Fig. 33B; red arrow) of the central 
neurons, as well as in the neuropil (Fig. 33A; blue arrow). There was also strong 
immunoreactivity in the sheath surrounding the ganglia (Fig. 33B). This sheath 
immunoreactivity may have been due to RAR immunoreactivity of glial networks and 
cell bodies in the neural sheath, though this has not been conclusively demonstrated. 
Interestingly, there was little to no apparent staining of RAR (traditionally considered to 
be a nuclear receptor) in the nuclear reg~~:m of the neurons (Fig. 33B; white arrow). 
Control CNS sections with no primary antibody added (n=8) demonstrated no 
immunostaining (Fig. 33D). 
To further identify the neuronal compartmentalization of LymRAR, I next isolated 
total protein fractions from the cytoplasm, membrane and nucleus of the Lymnaea CNS 
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Figure 33. Cytoplasmic localization of LymRAR in the adult, non-regenerating nervous 
system. (A) and (B) LymRAR immunoreactivity was detected in the neurons of ganglia of the 
CNS (Visceral ganglion shown), primarily in the cytoplasm of the cell body (yellow arrow), 
axons (red arrow) and neuropil (blue arrow). Note the absence of RAR staining in the area that 
contains the nucleus (B; white arrow). Scale bars: A=100/lm, B=50/lm. (C) Immunoreactivity 
was also observed in axon tracts of the neuropil (blue arrows) that extend into a nerve bundle 
(nb) that connects to an adjacent ganglion. Scale bar: 80/lm (D) Control staining was also 
performed under the same conditions, only in the absence of the primary LymRAR antibody. 
Scale bar: 200/lm. 
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Cyt Mem Nue Cyt Mem Nue Cyt Mem Nue 
I 
.. 
Figure 34. LymRAR does not appear to be present in the nuclear fraction. Western blot 
performed on subcellular fractionations using our custom made LymRAR antibody displayed 
a weak signal at the predicted molecular weight (arrow) in the cytoplasm (Cyt) and 
membrane (Mem) compartments, but was absent in the nuclear (Nuc) compartment. The 
abundant cytoplasmic enzyme GAPDH was used as a control and showed signal only in the 
cytoplasmic compartment of the same samples. Actin staining was used as a control to 
demonstrate successful isolation of protein from the nuclear compartment. 
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using a Qproteome Cell Compartment kit (Qiagen). In Fig 34, Western blot analysis 
shows a positive signal for RAR in the cytoplasmic and membrane compartments, but not 
in the nucleus. Anti-GAPDH was used as a control on the same protein fractions and as 
expected, GAPDH showed positive immunoreactivity only in the cytoplasmic 
compartment. The actin control demonstrated successful isolation of protein from all 
three compartments. 
LymRAR is present in the neurites and growth cones of regenerating cultured 
neurons 
J 
Previously, our lab has shown that the all-trans RA isomer can not only induce 
neurite outgrowth from cultured Lymnaea neurons, but can also exert a chemoattractive 
effect on the growth cones of these same neurons (Dmetrichuk et aI., 2006). Despite not 
knowing whether all-trans RA is the natural ligand for this novel LymRAR, I aimed to 
determine the presence and distribution of this L ymRAR in regenerating central neurons 
in culture. Pedal A (PeA) motor neurons were individually isolated from the intact 
ganglia and given 24-36 hours to regenerate in cell culture. Following outgrowth, these 
cells were then fixed and stained with the custom-made LymRAR antibody. RAR 
immunoreactivity was visualized in the celT body of every cultured PeA neuron, whether 
it was actively regenerating neurites or not (n = 38 of 38). In the neurons that displayed 
outgrowth (n = 18), RAR immunoreactivity was observed in the majority ofneurites (Fig. 
35Ci; red arrows). Most of the growth cones located at the tips of the neurites also 
demonstrated positive immunoreactivity for RAR (Fig. 35Bi,Ci; white arrows). 
Interestingly, a closer look at the cell body of these neurons (Fig. 35Ai) revealed 
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Figure 35. LymRAR is present in the neurites and growth cones of regenerating 
motorneurons in vitro. (Ai,ii) Immunostaining of a cultured PeA cell with LymRAR 
antibody revealed a signal in the cytoplasm of the cell body. Note the reduced RAR 
staining in the nucleus stained with DAP!. (Aii; blue) Scale bars: 10 11m. (Bi) 
Immunostaining with the LymRAR antibody showed staining in the cell body and in the 
growth cone domains (white arrows) (Bii) Phase-contrast image of the same PeA cell. 
. Scale bars Bi-ii: 50llm. (Ci) Immunostaining with the LymRAR antibody also showed a 
signal in some neurites (red arrows) leading to the growth cones (white arrows) (Cii) 
Phase-contrast image of the same PeA cell. Scale bars Ci-ii: 40llm. 
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immunofluorescence in the cytoplasmic region (Fig 35Ai), as indicated by the lack of 
RAR signal in the nuclear region stained with DAPI (Fig. 35Aii). Control regenerating 
PeA neurons, under the same staining conditions except in the absence of primary 
antibody, did not demonstrate RAR immunoreactivity (n = 6; data not shown). 
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4.05 Discussion 
In this study, I have cloned a full-length RAR cDNA from the mollusc, L. 
stagnalis and have shown that this retinoid receptor is present in the embryo and in non-
regenerating adult CNS, where it was found in the neuritic domains of the central 
neurons. Using regenerating cultured motor-neurons, I have revealed evidence for strong 
non-nuclear staining of RAR in the cytoplasm, neurites and growth cones. This finding is 
similar to the expression pattern of RXR of these same PeA motor neurons (Carter et aI., 
2010). 
,{ 
This newly identified LymRAR is the first full-Ieri~th RAR cloned from any non-
chordate invertebrate species, and more importantly, from a species outside of the 
deuterostome lineage. This protostome RAR shares high homology with the only other 
molluscan RAR that was recently predicted from screening the genome of the mollusc 
Lottia gigantea. LymRAR has an overall amino acid identity of 66% with L. gigantea 
RAR and approximately 55% with other vertebrate RARs of all types (a, ~ and y). The 
similar homology of LymRAR with all three vertebrate RAR classes is not surprising 
since the mollusc, L. stagnalis, may only contain a single copy of RAR, similar to the 
single copy of amphioxus RAR. There IS increasing evidence that the three known 
vertebrate RAR subtypes arose through two periods of genome duplications, one before 
the split of agnathans (e.g. hagfish), and one before the split of cartilaginous fishes 
(Escriva et aI., 2006). 
I have also cloned a full-length RALDH cDNA (now known as Aldhla) from the 
CNS of L. stagnalis (Appendix II). After the initial conversion of retinol to retinaldehyde, 
the Aldhla enzyme irreversibly transforms retinaldehyde to RA. The Aldhla enzyme was 
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initially thought to be a chordate innovation until the recent discovery of Aldhla in 
cephalochordates, urochordates and hemichordates (Canestro et aI., 2006), and later 
discovered through the help of genome sequencing in the lophotrochozoans, including 
two predicted Aldh sequences in the mollusc L. gigantea. My cloning of an Aldhla and 
an RAR in L. stagnalis, along with the detection of all-trans RA in the CNS (Dmetrichuk 
et aI. , 2008) further supports a putative role for all-trans RA and its signaling machinery 
in Lymnaea, and also indicates an ancient origin of RAR and the Aldhla enzymes, at 
least in the common ancestor of the bilaterians. We have not yet discovered the RA-
catabolizing enzyme Cyp26 from L. stagnalis, but recent,,€vidence has uncovered genes 
.; 
that are predicted to code for Cyp26 enzymes from the non-chordate, protostome species 
L. gigantea and Capitella sp. (Albalat and Canestro, 2009). 
The ligand-binding domain (LBD) of most nuclear receptors, including RAR, is 
made up of an anti-parallel, three-layered, helical sandwich consisting of 12 helices. 
These helices form a hydrophobic ligand-binding pocket (LBP), and studies with 
vertebrate RARs show that the LBD consists of approximately 250 amino acids. It has 
been determined through studying the crystal structure of RARy, that there are 
approximately 25 amino acids localized in _!he LBD of the RAR that make direct contact 
with the known ligand all-trans RA (Escriva et aI., 2006; Renaud et aI., 1995). Most of 
these predicted sites are shown in Figure 28 (green circles above sequence), and there is 
close to complete homology between LymRAR and the vertebrate RAR~ sequence at 
these same sites. Although we have not provided any direct evidence for all-trans RA 
binding with LymRAR, there are functional studies that provide strong evidence from 
invertebrate chordates (cephalochordates and urochordates) and invertebrate non-
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chordates (echinodenn species), that retinoid receptors can activate transcription in the 
presence of all-trans RA (Escriva et aI., 2002; Nagatomo and Fujiwara, 2003). More 
recently, work by Campo-Paysaa et aI. (2008) has predicted that the protostome RAR 
from the mollusc L.gigantea might bind all-trans RA providing in silica evidence from 
conserved amino acids within the LBD. Our lab has provided evidence that all-trans RA 
is present in the Lymnaea CNS (Dmetrichuk et aI., 2008), which, together with this new 
evidence for expression of RAR and Aldhla in the Lymnaea CNS, suggests that a good 
portion of the machinery is present for all-trans RA-signaling. 
I have shown using Western blotting of Lymnae~,..embryo total protein near the 
<" 
late veliger/metamorphosis stage (approx. 84-108 h of embryogenesis), the presence of 
LymRAR at the predicted molecular weight of 52 kDa. I was unable to detect a LymRAR 
signal during earlier stages, possibly because RAR expression is below the detectable 
limits of my Western blotting procedure. There are other bands present (as shown in 
Figure 29C), and although I cannot conclude what these other bands are, they may 
represent cross-reactions of our custom-made LymRAR antibody with other proteins, or 
they may be other isofonns of RAR. Multiple isofonns of RAR in our model system 
seems unlikely since in the few non-chorda~~ species where RAR has been reported, there 
has only been one fonn of the receptor found in each species. Future work should include 
an immunizing peptide blocking experiment as a control to neutralize the custom-made 
LymRAR antibody during Western blotting. In this way, the staining specific for the 
epitope of the LymRAR antibody should be absent from the blot, and any bands that 
remain should be considered non-specific. Interestingly, the LymRAR antibody-treated 
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membrane compartment in Figure 34 displays only one solid band at the predicted 
molecular weight of LymRAR. 
Previously, when we investigated the presence of LymRXR in the embryo, we 
were unable to determine whether the signal was occurring in the nervous system or in 
other organs of the embryo. With the LymRAR antibody, I thus performed 
immunohistochemistry on Lymnaea embryos at the later veliger stage of development 
(approx. 84-96 h of embryogenesis) to localize the expression. Early in this veliger stage, 
FMRFamide-reactive cells begin to form some of the first elements of the nervous 
system, and their presence remains into the later stage~ of L. stagnalis development 
-. 
(Croll and Voronezhskaya, 1996). These FMRFamide-reactive cells are thought to form 
the scaffold upon which the central ganglia and interconnecting pathways later develop. 
These cells are specifically referred to as Early FMRFamide-like immunoreactive 
Anteriorly Projecting (EF AP) cells, and can be further classified by position as central, 
left, or right (c-, 1-, and r-) EFAP cells. The first ganglia (that will eventually circle the 
esophagus) may begin to appear within this time frame, but it is difficult to view them 
using light microscopy (Nagy and Elekes, 2000). In this study, I detected a strong 
LymRAR signal in what appears to be a cell body with an elongated process emanating 
-. 
from it. The size and location of this cell are very similar to that seen with the 1- and r-
EF AP cells. I also detected staining in what appear to be thin processes extending across 
the embryo which may correspond to fibers projecting from early embryonic neurons as 
seen in Croll and Voronezhskaya (1996). The other staining I observed was around the 
lining of what appears to be the pharynx/esophagus. Again, these could be nerve fibers, 
but without any staining specific for nervous tissue, these hypotheses are speculative. 
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Therefore, in the absence of any neural-specific marker, I am unable to conclude the 
exact localization of the RAR within neural tissue at this time. My main aim here was, 
however, to show the presence of LymRAR in the developing embryo. 
In Chapter 3, I demonstrated that exposure of L. stagnalis embryos at the gastrula 
stage (approx. 30 h of embryogenesis) to 9-cis RA (10-7 M) caused specific 
developmental defects including eye defects, shell malformations and in some extreme 
cases, even halted development. The occurance of each of these defects increased when 
exposed to the RXR agonist PA024 alone (at the same concentration as the 9-cis RA 
isomer). Although all-trans RA was also shown to cause,,rSimilar effects in L. stagnalis 
<" 
embryos at 10-6 M (Creton et aI., 1993), there was no previous evidence for an RAR in 
non-chordates, so no synthetic RAR agonist or antagonists were previously used to 
investigate these all-trans RA-mediated effects. In this study, 10-6 Mall-trans RA 
(typically a vertebrate RAR ligand) was also found to cause eye and shell malformations 
but the synthetic RAR pan-agonist, TTNPB, at 10-6 M did not have any effects on L. 
stagnalis embryogenesis. However, at 10-5 M, TTNPB caused complete lysis of 100% of 
the embryos after only 12 hours of treatment. This result could suggest that TTNPB does 
not bind as efficiently with t~e LymRAR a~. it has been shown to in vertebrates, where it 
is effective at concentrations as low as 10-8 M (Pignatello et aI., 2002). Interestingly, an 
RARB-selective antagonist, LE135, was found to cause eye and shell malformations at 
10-6 M, but treatment with an RAR pan-antagonist, LE540, caused complete lysis of the 
embryos after 12 hours. This result is not surprising since my examination of the 
LymRAR sequence has revealed that it does not show strong similarity towards one 
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specific subtype of RAR, but instead displays some similarities to all three vertebrate 
subtypes. 
It is also possible that in L. stagnalis, all-trans RA may exert its effects through 
LymRXR. Though the vertebrate RXR does not show binding affinity for all-trans RA, 
there is evidence from other invertebrates (e.g. locust embryos) that RXRs can bind both 
9-cis and all-trans RA with similar affinities (Nowickyj et aI., 2008). However, LymRXR 
shares a higher amino acid similarity with the LBD of vertebrate RXRa than the locust 
RXR (data not shown), suggesting that LymRXR is more likely to share binding affinities 
with vertebrate RXRs. In addition, there is supporting ev!pence that arthropods (such as 
locusts) do not possess an RAR (Albalat and Canestro, 2009; Campo-Paysaa et aI., 2008; 
Simoes-Costa et aI., 2008) so the locust RXR may have a different binding affinity for 
all-trans RA than LymRXR, as their functional roles may be very different. 
From the immunostaining of the L. stagnalis embryos, I could not get a clear 
picture of the exact localization of the LymRAR signal, especially in the region of the 
nervous system, given the lack of a specific neural tissue marker. However, staining of 
the adult L. stagnalis CNS revealed LymRAR signals in the cytoplasm and axons of 
neurons, with strong staining in the axonal !;acts of the neuropil. Surprisingly, the nuclear 
region of the neurons shows little, if any, staining of LymRAR. In fact, Western blot 
experiments revealed no discernable RAR signal in the nuclear compartment, but the 
LymRAR protein was present in the cytoplasmic and membrane compartments of acutely 
isolated CNSs. These data mirror my previous findings with the LymRXR, which also 
showed a non-nuclear distribution in the acutely isolated Lymnaea CNS. Again, these 
findings are interesting since RARs (like RXRs) have been classically defined as 'nuclear 
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receptors' and have been shown to regulate gene expression by binding to RA-response 
elements (RAREs) in the regulatory regions of direct target genes in the nucleus (Maden, 
2007). Recently, however, there have been a number of reports of non-nuclear 
localization of RARs (Maghsoodi et a1., 2008; Schrage et a1., 2006) and there is also 
evidence of RARs (specifically RARa) shuttling between the nucleus and cytoplasm as a 
result of nerve injury (Schrage et a1., 2006). Although we cannot rule out that the 
LymRAR may translocate to the nucleus upon injury or in the presence of specific 
ligands, the presence of LymRAR in the cytoplasm and axons may indicate a non-
genomic role for LymRAR. 
It has been demonstrated in regenerating neurons of the adult L. stagnalis CNS, 
that local application of all-trans RA can induce growth cone turning (Dmetrichuk et al., 
2006). Although the exact mechanism for this growth cone turning was not determined, 
the presence of LymRAR in the vicinity of the growth cone may shed some light on a 
possible non-genomic mechanism involving LymRAR. In fact, our lab has already 
provided evidence that this all-trans RA-mediated growth cone turning can occur in 
isolated neurites (without the cell body that contains the nucleus), and is dependant on 
local protein synthesis and calcium in~?x (Farrar et al., 2009). Other studies in 
vertebrates have also provided strong evidence supporting non-genomic roles of RAR in 
the nervous system. RARP has been implicated in a rapid, non-genomic response 
involving transmitter release at developing neuromuscular synapses in Xenopus cell 
cultures (Liao et al., 2004). Also, RARa has been implicated in a non-genomic role as an 
RNA binding protein that directly regulates translation of glutamate receptor subunits in a 
RA-gated manner in dendrites (Poon and Chen, 2008). Immunostaining of our 
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regenerating adult Lymnaea neurons resulted in LymRAR signals in the neuritic 
processes, including the growth cones. Although the presence of LymRAR in the growth 
cones, along with the previous work showing all-trans RA-mediated growth cone turning 
(Dmetrichuk et aI., 2006) suggests a chemotropic effect involving LymRAR, future work 
is required to provide evidence for this. Interestingly, preliminary work by C. Rand in our 
lab has indeed shown evidence that the RAR pan-antagonist, LE540, can abolish both all-
trans and 9-cis RA mediated turning. 
In summary, I have cloned the first, full-length RAR cDNA from a non-chordate 
species and have provided the first evidence that it may J)lay an important role in non-
.; 
chordate embryonic development. This work thus provides evidence for an important 
conservation of the role of RARs between vertebrate and invertebrate species. As with 
the LymRXR, we have also shown that LymRAR has a cytoplasmic and neuritic 
localization in both regenerating and non-regenerating adult CNS neurons. The presence 
of LymRAR in regenerating growth cones suggests a possible mechanism for all-trans 
RA-mediated turning, possibly in conjunction with LymRXR. Future work is needed to 
elucidate whether LymRAR and LymRXR are indeed working in conjunction with each 
other. 
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5. Conclusions 
The overall aim of this thesis was to first identify novel retinoid receptors present 
in specific vertebrate and invertebrate species, and to then investigate their expression 
patterns and functional roles. From the invertebrate species, Lymnaea stagnalis, I cloned 
a novel RXR and then showed for the first time that this receptor was important during 
molluscan development and (together with N. Farrar) in axon guidance. Furthermore, I 
cloned the very first invertebrate, non-chordate RAR and provided evidence for its 
conserved functional role in development. 
J 
In the vertebrate species, N viridescens, I was the first to clone a full-length 
RAR~ subtype. Although human, rat and mouse contain an RAR~, it was previously thought 
that newts did not possess the ~ subtype (Maden and Hind, 2003). I also showed for the first 
time in any adult vertebrate CNS, that an RAR~2 can be transcriptionally active in the 
adult brain and spinal cord. This was the first demonstration of a full-length RAR~2 in a 
vertebrate species capable of regenerating many anatomical structures and organs, such as 
the CNS, limbs and tail. 
Role of NvRARJJ2 in newt ttlil regeneration 
Previous studies had found a strong correlation between axonal regeneration and 
expression of RAR~2 receptors in developing mammals. For example, embryonic mouse 
spinal cord tissue extended neurites after application of RA in vitro, and this corresponded 
well with the expression of RAR~2. However, tissue from adult mouse spinal cord did not 
regenerate neurites after application of RA and did not show an upregulation of RAR~2. If 
the adult spinal cord tissue was then transfected to over-express RAR~2, prolific neurite 
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outgrowth occurred (Corcoran et aI., 2002). These previous studies strongly suggest that the 
ability of adult spinal cord to regenerate is highly dependent on expression levels ofRAR~2. 
In this study, I investigated the expression of a novel RAR~2 receptor in a species 
capable of spinal cord regeneration. In particular, I investigated its role in both tail and spinal 
cord regeneration in the adult newt, N viridescens. After the fIrst seven to eight days of tail 
regeneration, I found that the expression levels of RAR~2 mRNA and protein increase. 
These data indicate that RARP2 is transcriptionally and translationally upregulated in 
response to tail regeneration. I have shown with immunostaining that RARP2 expression 
is present in the spinal cord during the tail regeneration process. However, whether the 
J 
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upregulation of RARP2 occurred only in the spinal cord, or whether it occurred in the 
regenerating peripheral nerves, or non-neural regenerate tissue of the tail blastema, is 
currently unknown. Expression of RARP2 in the regenerating spinal cord following tail 
amputation corresponds well with the previous fIndings of Dmetrichuk et aI. (2005). Our 
lab had previously shown that all-trans RA was capable of inducing directed neurite 
outgrowth from cultured newt spinal cord explants and that the RARp-selective 
antagonist, LE135, could inhibit this regenerative response (Dmetrichuk et aI., 2005). I 
have now shown in this study that the RARP receptor subtype is not only important for 
spinal cord regeneration, but also for whole tail regeneration, as LE135 signifIcantly 
reduced the length of tail regeneration compared to controls. The importance of the P2 
subtype was studied by treating newts undergoing tail regeneration with the RARP2-
selective agonist, AC261066. Interestingly, this agonist treatment induced similar effects 
to the RARP antagonist, (although it is well documented that both increased and 
decreased levels of RA can interrupt physiological processes). The only other literature 
pertaining to the effects of RAR agonists on tail regeneration involved the use of high 
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levels of exogenously applied retinol palmitate (Vitamin A; a precursor of RA which is a 
RAR pan-agonist). Specifically, Scadding (1986) showed that retinol palmitate caused an 
inhibition of tail regeneration in the newt N. viridescens, which is a similar result to that 
found in my study with the RAR~2-selective agonist. Likewise, in the closely related 
axolotl, Ambystoma mexicanum, all-trans RA treatment also inhibited overall growth of 
the tail regenerate by some 73% (Pietsch, 1987). Conversely, in frog tadpoles, increased 
levels of retinol palmitate caused aberrant regeneration by inducing numerous hindlimbs 
to regenerate from the cut site (Maden, 1993). It is not clear why the effects on these 
tadpoles were different from those in adult newt. H~}Vever, despite these previous 
contradictory findings, my studies on the novel RAR~2 receptor in the adult newt 
strongly suggest that there may be a critical level of receptor signaling involved in normal 
tail regeneration. That is, alteration of its actions with either selective agonists or 
antagonists has profound downstream effects. Taken together, these results provide 
strong evidence for a crucial role for RAR~2 signaling in newt tail regeneration. 
Non-nuclear distribution of the novel retinoid receptors in the eNS of Lymnaea 
stagnalis 
Most previous studies on RA-medfated regeneration of the nervous system have 
been conducted in vertebrate systems, and little is known about the role of retinoid 
receptors in the invertebrate nervous system. Previous work from our lab has shown that 
both 9-cis and all-trans RA isomers are present in the CNS of the mollusc, Lymnaea 
stagnalis, and that both can exert neurotrophic and chemotropic effects on adult 
molluscan neurons (Dmetrichuk et aI., 2006; Dmetrichuk et aI., 2008; Farrar et aI., 2009). 
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However, despite these observed physiological effects of RA, no retinoid receptors had 
previously been identified in this mollusc. 
In this study, I have cloned the first retinoid receptor from the CNS of L. 
stagnalis. First, I identified a full-length RXR (LymRXR), and then I determined that it 
shares high homology with the vertebrate RXRa isoform. Whereas other molluscan 
RXRs had previously been cloned, no full-length invertebrate, non-chordate RAR had 
ever been cloned. Despite the absence of any cloned RAR cDNA from the invertebrate 
non-chordates, its natural ligand, all-trans RA, had been shown to exert numerous 
morphogenic effects in invertebrates. For example, all-trans RA exerts morphogenic 
-; 
effects in the marine sponge (Imsiecke et aI., 1994), disrupts limb regeneration in the 
fiddler crab (Hopkins and Durica, 1995) and produces developmental defects in molluscs 
(Creton et aI., 1993), to name but a few. In this study, I cloned the first full-length 
invertebrate non-chordate RAR, a finding that may ultimately explain the means by 
which all-trans RA may be exerting its varied effects in numerous non-chordates. 
In looking at the distribution of the LymRXR and LymRAR, I found that both of 
these (traditionally "nuclear") receptors were located in non-nuclear domains. This was 
the case for both the non-re~enerating CN§ as well as the regenerating adult neurons in 
culture. Interestingly, this suggests that both the LymRXR and LymRAR may have the 
potential to act in a non-genomic manner, although I cannot rule out the possibility that 
under certain circumstances they may translocate from the cytoplasm to the nucleus, as 
has been shown for other retinoid receptors (Park et aI., 2010; Schrage et aI., 2006; 
Yasmin et aI., 2005). 
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My discovery of LymRXR expression III the growth cones of actively 
regenerating neurites suggested that it may be playing a novel, non-genomic role in RA-
mediated growth cone guidance. Dmetrichuk et al (2006) had previously shown that RA 
could induce growth cone turning in isolated neurites, in the absence of the nucleus. In 
Carter et al. (2010) we demonstrated that RXR agonists could also induce growth cone 
turning of isolated neurites, and as such, the RXR was likely mediating a non-genomic 
role in axon guidance. This is the first demonstration of a non-genomic role for RXR in 
the nervous system of any species. I then went on to confirm the role of RXR, by 
specifically showing that the RXR pan-antagonists, ~31 and P A452, inhibited the 
<" 
PA024-induced growth cone turning. 
Once the L ymRAR was cloned, the immunostaining studies also provided 
evidence for its presence in regenerating neurites and growth cones. This finding makes it 
plausible that the RAR may also be exerting non-genomic effects, as it has been shown to 
do in previous vertebrate studies. A colleague, Christopher Rand, now has preliminary 
evidence that LymRAR is also involved in mediating RA-induced growth cone guidance. 
In particular, he has shown that the RAR pan-antagonist, LE540, significantly reduces the 
all-trans and 9-cis RA-induced growth ~one turning in neurons from L. stagnalis 
(unpublished observations). However, whether LymRAR is also mediating its effects in a 
non-genomic manner (as does the LymRXR) has yet to be determined. 
A conserved role for the invertebrate retinoid receptors in development 
Both RXRs and RARs are well known to play important roles in the development 
of vertebrates (Niederreither and Dolle, 2008), but less is known about their specific roles 
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in non-chordate development, especially in the case of the RARs. In this study, I showed 
that both LymRXR and LymRAR are expressed in L. stagnalis embryos. Although I was 
specifically able to show that LymRXR was present in the nuclear compartment in 
embryos, I was unable to distinguish whether the embryonic expression of either receptor 
was localized to the nervous system. However, with the use of selective RXR and RAR 
agonists and antagonists, I provided compelling evidence that both retinoid receptors play 
a role in Lymnaea development. This is the first evidence for a role of either an RXR or 
an RAR in the development of an invertebrate, non-chordate species. 
Do the invertebrate receptors act together, and are they isomer specific? 
The data presented here, for this non-chordate species implicate a role for both 
RXR and RAR in very similar processes of development as seen in many chordate 
species. Interestingly, the data also showed that the LymRXR and LymRAR have similar 
distribution expressions in the adult Lymnaea eNS. Even though vertebrate RXRs and 
RARs are well known to heterodimerize in order to bind to DNA and affect gene 
expression, I have no evidence that the same event is taking place in Lymnaea. The 
evidence for RXRlRAR heterodimers c_?mes primarily from studies in vertebrate 
systems, mainly due to the fact that there are very few invertebrate RARs known, and of 
these, all have previously been found in chordates. However, there is one invertebrate 
chordate, Polyandrocarpa misakiensis (budding ascidians), where both an RXR (termed 
PmRXR) and an RAR (termed PmRAR) have been cloned. In this invertebrate, it was 
shown that the PmRXR and PmRAR can indeed hetermodimerize to form a 
PmRXRlPmRAR complex and can also then function as a transcriptional activator in 
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response to RA (Kamimura et aI., 2000). There is also evidence from a closely related 
species of mollusc, Biomphalaria glabrata, that the RXR can function as a heterodimer 
with a mammalian RARa, suggesting that it also has the potential to bind with a RAR 
(although no RAR has been cloned from B. glabrata) (Bouton et aI., 2005). Considering 
that my newly cloned LymRXR cDNA is almost identical (97% amino acid identity) to 
the B. glabrata RXR, this suggests that the LymRXR may have similar capabilities of 
binding with an RAR. Future experiments, however, are needed to explore the possibility 
that LymRXR and LymRAR may act as heterodimeric partners in RA-mediated signaling. 
There is also currently no evidence from any species to iIIJ,Plicate an RXRIRAR complex 
<" 
acting in a non-genomic manner, so it would be interesting to determine if this is the case 
during RA-mediated growth cone turning in Lymnaea. 
In this study, it is interesting that some of the effects of all-trans and 9-cis RA 
appeared to be very similar, as was the case in the embryogenesis experiments. Both 
endogenously applied all-trans and 9-cis RA had very similar effects in producing eye 
defects, shell malformations, and/or halted development. There is also evidence from our 
lab that both all-trans and 9-cis RA have very similar effects on enhancing neurite 
outgrowth, mediating grow~h cone tumi~g and enhancing electrical excitability of 
cultured neurons. However, there are other studies from our lab that indicate isomer-
specific effects ofRA on Lymnaea neurons. For example, it has been shown that all-trans 
RA can induce acute effects on firing properties of neurons, but that 9-cis RA has no 
significant effect (Vesprini and Spencer, 2009). These data suggest that all-trans and 9-
cis RA might possibly be capable of acting independently of each other. In vertebrate 
systems, it is known that RARs bind both all-trans and 9-cis RA, whereas RXRs only 
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bind 9-cis RA (Heyman et aI., 1992). However, in the locust (non-chordate), there is 
evidence that the RXR binds both all-trans and 9-cis RA with similar affinities 
(Nowickyj et aI., 2008). Future experiments will be required to determine the binding 
affinities of both LymRXR and LymRAR for all-trans and 9-cis RA. Once this has been 
determined, we can then investigate whether the effects shown here, involving non-
chordate development and regeneration, support a combinatorial role of these newly 
discovered retinoid receptors. 
Perspectives 
RA has long been known to play an important role in embryonic development, but 
its role in invertebrate development is far less clear. Furthermore, although RA and its 
various signaling components have been identified in adult species, and its role in adult 
regeneration has been implicated, the exact processes involved have not been determined. 
In this study, I undertook the task of identifying key genes involved in mediating the 
effects of RA on adult vertebrate regeneration, as well as invertebrate development and 
neurite outgrowth. My identification of these novel retinoid receptors and the evidence 
presented here for their functional roles ~ their respective systems, will significantly 
contribute to future research into retinoid-mediated effects on both development and 
regeneration. 
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Figure 36. The partial Notophthalums viridescens RXR protein sequence. Multiple 
sequence alignment of the partial N. viridescens RXR that I have cloned 
(Notophthalus_RXR; accession no. ADI24671) with the full-length Human RXRalpha 
subtype (accession no. AAH63827). Within the partial Notophthalus_RXR sequence, 
there is 85% amino acid identity, and 93% amino acid similarity with the Human 
RXRalpha. This region contains most of the ligand binding pocket which corresponds 
with the E domain. 
175 
Stages of tail regeneration 
~ ~ 
0 t--- ~ N 
~ ~ >. >. = = ~ ~ Q Q 
,f 
" 
NvRXR III . IiIUiii ' 11111 a 
GAPDH L, 
___ -_, ______________________ ___ 
_ _ _ "" iUMaN IlOi i_ 
Figure 37. NvRXR protein levels decrease in progressing stages of tail regeneration. 
Western blot analysis at 4 different stages of newt tail regeneration revealed a stepwise 
decrease in the levels of NvRXR protein from day 0 through day 21. The newt GAPDH 
was used as a control. 
176 
8. Appendix II 
Human RALOH 
Lymnaea_RALOn 
Human RALOH 
Lymnaea_RALOH 
Human RALOH 
Lymnaea_RALOH 
Human RALOH 
Lymnaea_RALOH 
Human R.lU.OH 
Lym."laea_RALOH 
Human RALOH 
Lym."laea_RALOH 
Human RALOH 
Lym.'1aea _ RALOH 
Human RALOH 
Lym.'1aea _ R.lU.OH 
Human RALOH 
Lymnaea_RAtOH 
I1TSSKIEHPGEVI<AOPAALHASLHLLPSPTPNLEIKYTKIFINNE\'1QNSESGRVFPVYNP 60 
HSN-------------- ---------FTPNKNPEIKYTQLFINNEFVNSVSGI<TFPTL"lP 37 
* : . 
ATGEQVCEVQEADKAOIOKAVQAARLAFSLGSVwRRMOASERGRLLDKLADLVERDRAVL 120 
ATGQKIADIQEADKEDIOKAV:><AA..~DAFALGSPYRTHDASARGRLLYKVADLIERDINYI 97 
ATHESLNGGKPF-LQAFYVDLQGVII<TFRYYAGWADKIHGI1TIPVDGDYFTFTRHEPIGV 179 
ASLETLONGKAFALHGSIGDAYFSALVFRYYAGWADKICGKTIPIDGSYFAYTRHEPVGI 157 
CGQI I PWNFPLLHFAW:-<IAPALCCGNTVVIKPAEQTPLSALYHGALlKEAGFPPGVINIL 239 
CGQITPWNYPLVHAAWKIAPAVAAG~lVLKPAEQT1LTALYLAAL'lKEAGFPAGV'~.~ 217 
**** *k* : k* : k *~***** : .. * • . *.:*k**~~** : .~* :. k* : k*k*** . ** : * :: 
PGYGPTAGAAIASHIGIDKIAFTGSTEVGKLIQEAAGRSNLKRVTLELGGKSPNIIFADA 299 
PGYGPTAGAAITSHPDINKVTFTGSTEIGQIILQAAGASNIKRTTLELGGKSPCVVFDDV 277 
DLDYAVEQAHQGVFFNQGQCCTAGSRIFVEESlYEE~lRRSVEruL~RR\~GSPFDPTTEQ 359 
DVDWAVAEAQEAC11TNHGQCCVAGTRTYVHENIYDEFVSKTRELA..r{TRKIGDPFDSNTVN 337 
GPQIDK:-<QYNKILELIQSGVAEGAKLECGGKGLGRKGFFIEPTVFSNVTDDMRIA-~EEIF ~19 
GPQI DQEQLNKILE LIE SGK".<EGAI(VEHGGERHGDQG FFITPTVFSNVTDDHRIA-r{EE I F 397 
k*.**: : * ~****** : *. **k*:* ** : * : **** **k*k~******** •• k** 
GPVQEILRFI<TMDEVIERANNSDFGLVAAVFTNDIW-<ALTVSSM1QAGTVWINCYNALNA ~79 
GPVQQILKFKDLDOVLKRANNTTYGLGAAVFTNDIW-<ALTFk~GVQAGTVWINSYNHVSP ~57 
QSPFGGFKHSGNGREHGEFGLREYSEVKTVTV:><:IPQKNS 518 
QAPFGGF~~SGLGRELGEYGLQNYIGVKNVVVRIPQKNS ~96 
Figure 38. The full-length Lymnaea RALDH protein sequence. Multiple sequence 
alignment of the Lymnaea stagnalis RALDH (accession no. ACL79834) with the Human 
RALDH (accession no. 094788). There is 64% amino acid identity, and 80% amino acid 
similarity between this non-chordate and chordate RALDH. 
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